MODERN
HEALTHCARE
TECHNOLOGY
ANNUAL REPORT
年報 2019/20
(formerly known as MODERN BEAUTY SALON HOLDINGS LIMITED) (前稱現代美容控股有限公司)
(Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立的有限公司)
Stock Code 股份代號:919
UNCOMPROMISING
CONTENT
Corporate Profile | 2 |
Corporate Information | 5 |
Milestones and Key Events | 6 |
Management Discussion and Analysis | 8 |
Investor Relations and Financial Calendar | 15 |
Biography of Directors and Senior Management | 16 |
Corporate Governance Report | 18 |
Report of the Directors | 27 |
Independent Auditor's Report | 38 |
Consolidated Statement of Profit or Loss | 46 |
Consolidated Statement of Profit or Loss and | 47 |
Other Comprehensive Income | |
Consolidated Statement of Financial Position | 48 |
Consolidated Statement of Changes in Equity | 50 |
Consolidated Cash Flow Statement | 51 |
Notes to the Financial Statements | 53 |
Properties Held by the Group | 111 |
Five Years Financial Summary | 112 |
002 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
CORPORATE PROFILE
ANNUAL REPORT 2019/20 003
CORPORATE
PROFILE
Modern Healthcare Technology Holdings Limited (formerly known as Modern Beauty Salon Holdings Limited) ("the Company") and its subsidiaries ("the Group" or "Modern Healthcare") is a leader of the beauty industry in Hong Kong offering professional treatments as well as quality services and products with natural ingredients. We are positioned at the high-end of the beauty industry that is dedicated to providing beauty and wellness services to customers who pursue a rejuvenating experience from the highest level of technical expertise and impeccable guest service. Our business operation is composed of five service lines as follows:
004 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
CORPORATE
PROFILE
Beauty and Facial
Modern Beauty Salon offers a wide range of treatments by our well trained beauty therapists. Our beauty consultants review customers' usage regularly and recommend suitable treatments to our customers. We also customise specific treatments according to the needs of our VIP customers. Our senior management closely monitors the latest trends of beauty industry and acquires state-of-the-art beauty machines in order to maintain a pipeline of new treatments.
Slimming
Slim Express offers a series of weight management programs that deliver stunning results. These programs are specially designed to kick-start the metabolism and bring awareness to healthier food choices. Together with our practical solutions offered by advanced equipments and machines, customers will rediscover esteem that brings balance into their lives.
Spa and Massage
Our spa and massage treatments provide a form of escapism and offer an immersive opportunity for our customers to experience pampering styles and grooming techniques inspired by the luxurious living in the 21st century. "be sanctuary spa" provides resplendent bathroom furnishings and a hydrotherapeutic pool decorated with fresh flowers and carved statues, which fill the room with an aura of nature. Yue Spa is the first spa centre adopting the Five Elements - the traditional Chinese philosophy as its theme. It provides spa treatment sets named according to Destiny, Soil, Metal, Wood, Water, Fire and Earth that effectively reduce stress and improve the skin conditions. Moment of Serenity is a foot treatment centre that offers foot spa, foot treatment and foot massage services.
Aesthetics Services
As the world of advanced skin care and anti-ageing services develops and matures, aesthetics services emerge. Present day cosmetic laser technicians can use a specific form of energy to tighten skin, stimulate the production of collagen to eliminate wrinkles and fine line, remove tattoos or unwanted hair, or a myriad of other highly sought after services. Aesthetics services include skincare treatments, professional consultation and referral service on plastic reconstruction, which is most specialised and effective and with the highest quality.
Sales of Skincare and Wellness Products
We have been selling skincare and wellness products through many brands, such as "be", "FERRECARE" "p.e.n", "Y.U.E", "Advanced Natural", "Malu Wilz", "BeYu", "Fanola", "Byotea", "Mila d'Opiz", "Care Plus", "Cellnoc", "Mu-lan Spa", "Veribel", "Castille", "IconX". The Group launched distributor brands "Malu Wilz", "Fanola", "Byotea", "BeYu" as well as further promoted our self-owned brands "p.e.n", "be", "FERRECARE", "Y. U. E.", "Advanced Natural" with the aim of expanding our product sales business and potential clienteles through providing diversified high quality skincare products. All products are built on cleanliness and nature, and utilise natural ingredients to enhance the quality of inner and outer skin, and optimise the natural beauty of skin from within. With sales points across Hong Kong, Kowloon and the New Territories, we strive to seek for high quality and efficient skincare and wellness products and updated information on beauty, to bring pure beauty with zero burden resulting from state-of-the-art technology to women today.
As at 31 March 2020, we had 32, 3 and 10 service centres in Hong Kong, Mainland China and Singapore, respectively. These service centres are integrated in nature and provide different business combinations at different locations wherever appropriate. Our retail network, which operates under the brands of "be Beauty Shop", had 10 outlets as at 31 March 2020.
CORPORATE INFORMATION
Board of Directors
Dr. Tsang Yue, Joyce (Chairperson)
Mr. Yip Kai Wing
Ms. Yeung See Man
Ms. Liu Mei Ling, Rhoda
(Independent Non-executive Director) Dr. Wong Man Hin, Raymond (Independent Non-executive Director) Mr. Hong Po Kui, Martin (Independent Non-executive Director) Mr. Lam Tak Leung
(Independent Non-executive Director) (resigned with effect from 1 March 2020)
Authorised Representatives
Mr. Wong Shu Pui
Mr. Yip Kai Wing
Company Secretary
Mr. Wong Shu Pui
Audit Committee
Ms. Liu Mei Ling, Rhoda (Chairperson)
Dr. Wong Man Hin, Raymond
Mr. Hong Po Kui, Martin
Nomination Committee
Dr. Tsang Yue, Joyce (Chairperson)
Dr. Wong Man Hin, Raymond
Mr. Hong Po Kui, Martin
Ms. Liu Mei Ling, Rhoda
Remuneration Committee
Dr. Wong Man Hin, Raymond (Chairperson)
Dr. Tsang Yue, Joyce
Mr. Hong Po Kui, Martin
Ms. Liu Mei Ling, Rhoda
Registered Office
PO Box 309
Ugland House
Grand Cayman, KY1-1104
Cayman Islands
ANNUAL REPORT 2019/20 005
Head Office and Principal Place of Business in Hong Kong
Workshops Nos. 66-68, 6th Floor Sino Industrial Plaza
9 Kai Cheung Road Kowloon Bay Kowloon
Hong Kong
Auditor
KPMG
Public Interest Entity Auditor registered in accordance with the Financial Reporting Council Ordinance
Certified Public Accountants 8th Floor, Prince's Building 10 Chater Road
Central Hong Kong
Share Registrar and Transfer Office
Tricor Investor Services Limited
Level 54, Hopewell Centre
183 Queen's Road East
Hong Kong
Principal Bankers
The Hongkong and Shanghai Banking Corporation Limited
1 Queen's Road Central
Hong Kong
Standard Chartered Bank (Hong Kong) Limited
4-4A Des Voeux Road Central
Hong Kong
Stock Code
919
Investors Relation
Email address: ir@modernhealthcaretech.com
Website
www.modernhealthcaretech.com
006 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
MILESTONES AND KEY EVENTS
2019
April
- Opening of new Modern Beauty Salon in Hang Ying Building, North Point
May
- Opening of new Modern Beauty Salon in Optimall, Tsuen Wan
May
- Opening of new Modern Beauty Salon in Landmark North, Sheung Shui
- Opening of new Be Beauty Shop in Lai Chi Kok
- Received the "Caring Company Award" from the Hong Kong Council of Social Service for the eighth consecutive year
ANNUAL REPORT 2019/20 007
MILESTONES AND
KEY EVENTS
June
- Official signing ceremony for the new ambassador, Miss Grace Chan Hoi Lam
- Opening of new Modern Beauty Salon in Ma On Shan Plaza
September
- Received "My Favourite Awards" during Hong Kong Beauty and Fitness Expo
- Opening of new Modern Beauty Salon in Winner House, North Point
008 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
MANAGEMENT
DISCUSSION AND ANALYSIS
Business Review
Overview
During the financial year ended 31 March 2020 ("FY2020" or "the year under review"), revenue of the Group amounted to approximately HK$522.6 million, representing a decrease of 9.3% compared with approximately HK$576.0 million for the year ended 31 March 2019 ("FY2019" or the "same period last year"). The receipts from sales of prepaid beauty packages during the year under review was HK$496.3 million, a decrease of 8.6% over the same period last year. The employees benefit expenses and occupancy costs and depreciation charge of other properties leased for own use decreased by 2.3% to HK$311.7 million and decreased by 19.4% to HK$92.2 million respectively as compared with the same period last year. The Group recorded an operating loss of HK$17.3 million during the year under review (FY2019: operating loss of HK$2.2 million).
Below is the key statistics: | |||
For the year ended 31 March | |||
2020 | 2019 | Change | |
Revenue (HK$ million) | 522.6 | 576.0 | -9.3% |
Operating loss margin (%) | -3.3 | -0.4 | -2.9 percentage points |
Net loss margin (%) | -6.1 | -2.2 | -3.9 percentage points |
Number of shops | 55 | 59 | -4 |
Employee benefit expenses (HK$ million) | 311.7 | 319.1 | -2.3% |
Occupancy costs and depreciation charge of other | |||
properties leased for own use: | |||
- Occupancy costs (HK$ million) | 43.8 | 114.5 | -61.7% |
- Depreciation charge of other properties leased | |||
for own use (HK$ million) | 48.4 | - | N/A |
92.2 | 114.5 | -19.4% | |
Total dividend per ordinary share (HK cents) | Nil | Nil | - |
Annual dividend pay-out ratio (%) | N/A | N/A | - |
ANNUAL REPORT 2019/20 009
MANAGEMENT
DISCUSSION AND ANALYSIS
Hong Kong
The China-US trade tensions and social events in Hong Kong, followed by the global outbreak of COVID-19 has deepened the economic recession in Hong Kong in the first quarter of 2020, with real GDP contracting sharply by 8.9% year-on-year, the steepest for a single quarter on record.
During the financial year ended 31 March 2020, with the restructure of our shop portfolio and streamlined optimisation of our workforce, both the employees benefit expenses and occupancy costs and depreciation charge of properties leased for own use were reduced compared with that of last year. We will continue to ensure the safety and quality of the services and products offered in our beauty and wellness centres.
Revenue for the year under review decreased by 8.1%. Revenue from services rendered and receipts from prepaid beauty packages for the year under review were HK$429.1 million and HK$441.5 million respectively (FY2019: HK$471.2 million and HK$475.4 million). Revenue from sales of skincare and wellness products was HK$22.3 million in FY2020 (FY2019: HK$20.1 million). Our customers in Hong Kong amounted up to a total of approximately 424,000 during the year under review, representing an increase of 1.2% as compared to approximately 419,000 in the same period last year.
Various comprehensive high quality beauty, slimming and facial services are offered to the general public including, inter alia, skincare, slimming, hairstyling, cosmetics, manicures, pedicures, electrology, and aesthetics services. In an effort to further strengthen its leading market
position, the Group introduced a number of innovative beauty, slimming and anti-aging treatments and machineries during the year under review, such as the Salus Talent which is a therapeutic device for transcutaneous magnetic stimulation. It non-invasively optimises circulation of the nervous system, increases tissue energy conversion, successfully increases muscle mass and at the same time reduces body fat.
In terms of the sales of skincare and wellness products, as of 31 March 2020, the Group had a total of 10 stores under the names of "be Beauty Shop", locating across Hong Kong, Kowloon and New Territories. More than 100 varieties of products are available for sale under different series of skincare service, including "Y.U.E", "Advanced Natural", "Bioline", "BeYu", "Malu Wilz" which can fulfill the needs of customers with different skin types.
Mainland China
During the FY2020, our Mainland China operations are conducted through two wholly owned foreign enterprises established in Shanghai and Guangzhou. These two wholly owned foreign enterprises operate a total of 3 service centres at the two cities referred to. During the year under review, our service income and receipts from prepaid beauty packages in Mainland China amounted to HK$11.1 million and HK$10.7 million respectively, representing a decrease of 29.6% and 17.1% respectively, as compared to the same period last year.
010 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
MANAGEMENT
DISCUSSION AND ANALYSIS
Singapore
During the FY2020, the Group operated a total of 10 beauty and wellness service centres in Singapore (FY2019: 11). During the FY2020, the revenue from operations in Singapore was HK$57.6 million, as compared with HK$60.8 million for the same period last year. Revenue recognised for provision of beauty and wellness services and receipts from sales of prepaid beauty packages in Singapore amounted to HK$52.2 million and HK$44.1 million respectively, as compared with HK$55.3 million and HK$54.4 million for the same period last year.
The Group will proceed with its Singapore business development in a prudent and steady manner. With relentless dedication to customer satisfaction, we will continue to focus on providing quality services that serve our customers well and enhance our brand awareness.
Financial Review
Revenue
Set out below is a breakdown on the revenue of the Group by service lines and product sales during FY2020 (with comparative figures for FY2019):
For the year ended 31 March | |||||
2020 | 2019 | ||||
Percentage | Percentage | ||||
Sales mix | HK$'000 | of revenue | HK$'000 | of revenue | Change |
Beauty & facial | 372,100 | 71.2% | 453,706 | 78.8% | -18.0% |
Slimming | 94,463 | 18.1% | 64,477 | 11.2% | +46.5% |
Spa and massage | 25,764 | 4.9% | 24,964 | 4.3% | +3.2% |
Beauty and wellness services | 492,327 | 94.2% | 543,147 | 94.3% | -9.4% |
Sales of skincare and wellness products | 30,279 | 5.8% | 32,870 | 5.7% | -7.9% |
Total | 522,606 | 100% | 576,017 | 100% | -9.3% |
Revenue of the Group was mainly contributed by the beauty, facial and slimming services. The Group's revenue from beauty and wellness services decreased by about 9.4% from approximately HK$543.1 million in FY2019 to approximately HK$492.3 million in FY2020.
The Group reported that the sales of new prepaid beauty packages of the Group amounted to HK$496.3 million, representing a decrease of 8.6% compared with HK$543.2 million for FY2019, while cash and cash equivalents in hand were maintained at a healthy level.
ANNUAL REPORT 2019/20 011
MANAGEMENT
DISCUSSION AND ANALYSIS
Set out below is an analysis on the deferred revenue:
For the year ended 31 March | ||||||||||
2020 | 2019 | |||||||||
Singapore | ||||||||||
Hong | and | |||||||||
Movement of deferred revenue | Kong | Mainland | Singapore | Total | Hong Kong | Mainland | Taiwan | Malaysia | Total | |
HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | ||
At beginning of the year | 261,211 | 5,850 | 30,560 | 297,621 | 370,697 | 10,315 | 832 | 46,875 | 428,719 | |
Impact of changes in accounting policy | - | - | - | - | (113,750) | - | - | (13,830) | (127,580) | |
Exchange differences | - | (118) | 389 | 271 | - | (690) | (33) | (1,003) | (1,726) | |
Gross receipts from sales of prepaid beauty packages | 441,457 | 10,713 | 44,087 | 496,257 | 475,420 | 12,930 | 253 | 54,578 | 543,181 | |
Revenue recognized for provision of beauty and wellness | ||||||||||
services and expiry of prepaid beauty package | (429,077) | (11,073) | (52,177) | (492,327) | (471,156) | (15,726) | (677) | (55,588) | (543,147) | |
Adjustment on disposal of subsidiaries | - | - | - | - | - | (979) | (375) | (472) | (1,826) | |
At the end of the year | 273,591 | 5,372 | 22,859 | 301,822 | 261,211 | 5,850 | - | 30,560 | 297,621 |
Employee benefit expenses
Employee benefit expenses (including staff's salaries and bonuses as well as directors' remunerations) represented the largest component of the Group's operating costs. During the year under review, employee benefit expenses decreased by about 2.3% from HK$319.1 million in FY2019 to approximately HK$311.7 million. Employee benefit expenses accounted for 59.6% of our revenue in FY2020, as compared to 55.4% for FY2019. The total headcount of the Group as at 31 March 2020 decreased by 6.9% to 1,087, as compared to a headcount of 1,167 for the FY2019. The decrease of the amount of employee benefits expenses and headcount is mainly due to the continuous cost efficiency that we endeavor to pursue. The Group's remuneration policies are in line with the prevailing market practices and are determined based on the individual performance and experience. For the purpose of motivating and rewarding our staff, discretionary bonus and share options may be granted to eligible employees based on individual performance and the Group's results. The Group introduced the elite system since the first quarter of 2010, whereby excellent staff with outstanding performance may receive discretionary bonus in recognition of their contribution.
Occupancy costs and depreciation charge of other properties leased for own use
During the year under review, the Group's occupancy costs and depreciation of other properties leases for own use were approximately HK$92.2 million (2019: HK$114.5 million), accounting for approximately 17.7% of our revenue (2019: 19.9%). As of 31 March 2020, the Group operated a total of 35 service centres in Mainland China and Hong Kong with a total weighted average gross floor area of 209,000 square feet, representing a decrease of 11.4% as compared to 236,000 square feet in FY2019. As of 31 March 2020, the Group had 10 centres in Singapore, with a total weighted average gross floor area of approximately 20,000 square feet (FY2019: approximately 21,000 square feet).
Bank charges, advertising costs and building management fees
Bank charges recorded changes in line with sales of new prepaid beauty packages, which decreased by 5.7% to HK$25.2 million. Advertising costs increased to HK$5.3 million from HK$4.4 million for the same period last year. Advertising cost as a percentage of revenue in FY2020 was 1.0% which remained stable compared with that of the same period last year. This reflected the Group's ability to enjoy cost advantage in advertising cost as it could spread such costs across an enlarged service centre network that covers Hong Kong, Mainland China and Singapore. Advertising cost is allocated in an effective way to raise brand awareness and capture a greater market share. Building management fees decreased by about 6.8% from HK$14.0 million in FY2019 to approximately HK$13.0 million during the year under review. It accounts for 2.5% of our revenue in FY2020, as compared to 2.4% for FY2019.
012 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
MANAGEMENT
DISCUSSION AND ANALYSIS
Other operating expenses
Set out below is a breakdown on the other operating expenses of the Group during FY2020 (with comparative figures for FY2019):
For the year ended 31 March | ||
2020 | 2019 | |
Audit Fee | 4,252 | 3,157 |
Administrative expenses (Note) | 6,592 | 7,377 |
Cleaning, sanitary and laundry | 6,269 | 5,981 |
Consultancy fee | 4,928 | 5,680 |
Government rent and rates | 4,587 | 5,382 |
Insurance | 3,502 | 3,917 |
Legal and professional fee | 3,402 | 2,079 |
Repair and maintenance expenses | 6,369 | 9,216 |
Utilities | 8,374 | 10,694 |
Other expenses | 8,464 | 9,749 |
56,739 | 63,232 | |
Note: The administrative expenses for each of the years ended 31 March 2019 and 2020 included motor vehicles expenses, postage and courier expenses, printing and stationary, telephone and fax and transportation expenses.
Net loss
The net loss attributable to equity shareholders of the Company was approximately HK$31.6 million in FY2020, as compared to the net loss attributable to equity shareholders of the Company of HK$13.3 million in FY2019. The Group will continue to expand its business when opportunities arise in order to achieve the long-term value added objective of maximising shareholders' returns.
Dividend per share
The Board did not recommend any final dividend to the shareholders of the Company for the year under review (FY2019: Nil). As no interim dividend had been approved by the Board for the six months ended 30 September 2019, the total dividend for the year ended 31 March 2020 will be nil (FY2019: Nil).
Liquidity, financial resources and capital structure
The Group generally finances its liquidity requirements through the receipts from sales of prepaid beauty packages and settlement of credit card prepayment transactions with banks. During the year under review, we maintained a strong financial position with abundant cash and bank balances of approximately HK$180.0 million (FY2019: HK$188.2 million) with no bank borrowings. Our cash is primarily used as working capital and to finance our normal operating expenses,
as well as to pay for the purchase of skincare and wellness products, materials and consumable used in the provision of beauty and wellness services. During the year under review, except for the fund required for operation, the majority of the Group's cash was held under fixed and savings deposits as in line with the Group's prudent treasury policies.
Capital expenditure
The total capital expenditure of the Group (excluding additions to right-of-use assets for leases of properties for own use) during the year under review was approximately HK$20.0 million, as compared to HK$32.6 million for the same period last year. The amount was mainly used for the additions of leasehold improvements, motor vehicles and equipment and machinery in connection with the expansion and integration of its service network in Hong Kong, Mainland China and Singapore.
Contingent liabilities and capital commitment
The Board considered that there was no material contingent liabilities as at 31 March 2020. The Group had capital commitment of HK$0.1 million as at 31 March 2020 (31 March 2019: HK$4.9 million), mainly for the acquisition of plant and equipment.
Charges on assets
As of 31 March 2020, the Group had pledged bank deposits of HK$54.1 million (31 March 2019: HK$53.2 million) in favour of certain banks to secure banking facilities granted to certain subsidiaries in the Group.
ANNUAL REPORT 2019/20 013
MANAGEMENT
DISCUSSION AND ANALYSIS
Foreign exchange risk exposures
The Group's transactions were mainly denominated in Hong Kong Dollars. However, the exchange rates of Hong Kong Dollars against Renminbi and Singapore Dollars also affected the operating costs as the Group expanded its business to Mainland China and Singapore. The management will closely monitor the risk exposures faced by the Group, and will take necessary actions to minimise potential risks and strike a balance between our exposure and return so as to properly hedge such exposures.
Human resources and training
The Group had a workforce of 1,087 staff as of 31 March 2020 (31 March 2019: 1,167 staff), including 900 front-line service centre staff in Hong Kong, 36 in Mainland China and 60 in Singapore. Back office staff totaled 69 in Hong Kong, 5 in Mainland China, 14 in Singapore and 3 in Australia. The Group reviews its remuneration policies on a regular basis with reference to the legal framework, market conditions and performance of the Group and individual staff. The Remuneration Committee also reviews the remuneration policies and packages of executive directors and the senior management.
Pursuant to the remuneration policies of the Group, employees' remunerations comply with the legal requirements of all jurisdictions in which we operate, and are in line with the market rates. During the year under review, total employee benefit expenses including directors' emoluments amounted to HK$311.7 million, representing a 2.3% decrease as compared to HK$319.1 million in FY2019. To enhance the service quality and core skills of our staff members, the Group regularly organises training programs designed by the Group's senior management for its staff. In addition, the seminars also facilitate the interaction and communication between the Group's management and the general staff.
Outlook
The negative economic outlook and trade tensions between the US and China, as well as the combined impact of the global COVID-19 outbreak, have had a profound impact on the retail and services sector in Hong Kong and Singapore. Our shops in Hong Kong and Singapore are closed from 10 April 2020 to 7 May 2020 and 7 April to 18 June 2020 respectively due to the anti-epidemic and circuit-breaker measures launched by the Hong Kong and Singapore governments. Our performance after the year end period
will inevitably be affected. Nonetheless, the Group was or would be granted subsidy under the Subsidy Scheme for Beauty Parlours under the Anti-epidemic Fund and subsidy under the Employment Support Scheme in Hong Kong. Both subsidies reduce the loss destined to incur during the shop closure period.
During the year under review, in order to provide the Group with a more appropriate corporate identity and strategic direction, we have changed the name of the Company to Modern Healthcare Technology Holdings Limited to better reflect and highlight the future strategic business plan to diversify into healthcare and high technological business segments. During the year under review, the Group has acquired the IconX electronic business card application software, which is used as a social networking platform for users to exchange their electronic business cards via QR codes.
In the future, the Group will continue to explore various business opportunities proactively and prudently in order to seek new sources of business income.
Looking ahead, while the road to recovery is challenging, the Group will remain cautious in opening new salons with a focus on improving the performance of services to our customers through our salon network. We will also endeavor to negotiate with the landlords for rent reduction so that the Group's rental cost will be decreased to a reasonably low level in face of the uncertain global and local business environment.
Environmental Policies and
Performance
The Group understands that its business has an impact on the environment and recognises the importance of sound environmental management practices and sustainable business operations. It is committed to comply with the relevant environmental standards and policies related to its business operations as set by the relevant governments. The Group has implemented a number of environment-friendly measures in its operations and workplaces including but not limited to retail shops, warehouses and offices. In its day-to-day operations, the Group advocates "paperless office" and actively promotes electronic management information system. It also sets up required equipment in order to arrange different kinds of meeting by using teleconference and video conference, resulting in savings
014 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
MANAGEMENT
DISCUSSION AND ANALYSIS
in time and resources. For retail shops, the Group has implemented energy saving practices by using some LED lighting fixtures.
Compliance with Laws and
Regulations
The Group recognises the importance of compliance with regulatory requirements and risks of non-compliance with such requirements. The Group has conducted on-going review of the newly enacted laws and regulations affecting the operations of the Group and provides relevant trainings and guidance to the staff. The Group has complied with the relevant laws and regulations of its places of operation that have significant impact on the operations of the Group for the year ended 31 March 2020.
Key Relationships
-
Employees
The Group believes that employees are a key element to the success of its business, so it strives to maintain a high staff retention rate by providing competitive remuneration package and developing harmonious workplace. To enhance capabilities and effectiveness of its employees in operation, the Group provides them with a comprehensive training program which includes quality service skills, product knowledge and language and interpersonal skills. In addition, the Group would organize regular retail staff gatherings to promote team spirits and award retail staff who had outstanding sales performance. - Consumers
The Group provides direct service to consumers in its retail and salon shops. To ensure continuous improvement of the quality of products and services, the Group regularly conducts internal and external market surveys to interact with consumers and to gain market insights and feedback. - Suppliers
The Group has established long standing cooperation relationship with certain suppliers. It selects its suppliers prudently. The relevant suppliers need to fulfill certain assessment criteria of the Group, including, among others, experience of financial capability, reputation and history of meeting our standards for raw materials or finished products.
- Shareholders and Investors
The Board believes effective communication and accurate and timely information disclosure builds the Shareholders' and investors' confidence, and also facilitates the flow of constructive feedback and ideas that are beneficial for investor relations and future corporate development.
Principal risks and uncertainties
- Macroeconomic changes - The Group's business is sensitive to the general economic conditions and other factors like consumer credit.
- Regulatory & political risk of business - This includes legal regulation update in Hong Kong, especially the Trade Description Ordinance Chapter 362, Law of Hong Kong, since the Group's business mainly operates in Hong Kong. In addition, the Group would develop markets in Mainland China further, which also bring more risk in relation to regulatory and political changes.
- Market competition - The Group is under intense pressure to compete on both price and service as large and small, regional or niche competitors attempt to increase market share.
- Foreign currency risk associated with the Group's investment - The Group may be exposed to transaction and translation (exchange rate) risks, particularly Renminbi, Singapore Dollars and Australian Dollars, and associated financial cost risks.
- Rising costs of Hong Kong business - This mainly refers to increasing operational cost resulting from uncertain economic environment.
- Reputation and performance risk of skincare and wellness products business of the Group - The Group's business is dependent on its reputation and quality of service and the Group may lose potential business if the quality of its products and service are called into question.
ANNUAL REPORT 2019/20 015
INVESTOR RELATIONS AND FINANCIAL CALENDAR
Upholding the principles of timeliness, fairness and openness, we continue to proactively expand our active and effective investor relations program during the year under review. We are committed to maintaining stable and smooth two-way communications with the shareholders, investors, financial media and potential investors, so as to ensure that the investors fully understand the current and future developments of the Group and make informed investment decisions, and allow the Group's shares price to fully reflect the long term value of the Company.
Investor Relations Strategy and Policy
We understand the importance of transparency and accountability to the Company and strongly believe that the best way to improve business transparency and accountability to shareholders is a sincere and active communication with investors, media and the public on an on-going basis so as to enhance the investment sector and the community's perception and understanding on the Group's business affairs, strategies and plans and financial positions. We also highly value investors' opinions and feedback as these will help us to formulate our development strategy for the enhancement of shareholder value.
Effective Two-way Communication
We have in place a dedicated investor relations team for handling investor relations and setting up a bridge between the Group and the investors. During the year under review, as arranged by the investor relations team, we held such investor relations events as the annual general meeting. The investment community is able to have a clearer insight on our business development and the shareholders are able to have latest information on the Group. Valuable opinions from investors on our business development will also be collected by the investor relations team through various channels to enable the Group to better understand the market's concern and formulate more effective future investor relations programs and business strategy and practices.
As our business continues to grow, we expect more access to the capital markets, and it will be more and more important to maintain timely and smooth communication with the investors. We shall continue to improve and enhance our investor relations system, and endeavor to maintain a high standard of investor relations.
Financial Calendar
Last day to register for 2020 | 24 August 2020 |
Annual General Meeting | |
Closure of Register of Members | 25 August 2020 to |
for 2020 Annual General | 28 August 2020, |
Meeting | both dates inclusive |
2020 Annual General Meeting | 28 August 2020 |
Share Information
Modern Healthcare Technology Holdings Limited has been listed on The Stock Exchange of Hong Kong Limited since 9 February 2006.
Issued ordinary shares as at | 904,483,942 | shares |
31 March 2020: | ||
Board lot: | 4,000 | shares |
Nominal value: | HK$0.10 per share | |
Market Capitalization as at | HK$116.7 | million |
31 March 2020: |
Stock Codes
Stock Exchange: | 919 |
Reuters: | 0919.HK |
Bloomberg: | 919 HK |
016 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
BIOGRAPHY OF DIRECTORS AND SENIOR MANAGEMENT
Executive Directors
Dr. Tsang Yue, Joyce
Aged 59, is Executive Director and the Chairperson of the Board, the Chief Executive Officer of the Group, and the Chairperson of the Nomination Committee and a member of the Remuneration Committee of the Company. She is the founder and substantial shareholder of the Company as well as a veteran in the beauty and wellness industry who has profound understanding and distinctive expertise on how to originate and capitalize on the trends and changes in the market. Her wealth of knowledge in the business and her unique vision in corporate management had enabled to spearhead business growth at the Group in a dynamic manner. She holds a Doctorate in Business Administration (Honoris Causa) from International American University and a MBA Degree from Glyndwr University U.K.. She is a Fellow of the Hong Kong Institute of Directors. She is the Honorary Fellow of The Professional Valuation Centre of Hong Kong. Dr. Tsang is also devoted to community and welfare activities. She is also the founder and chairperson of Grateful Heart Charitable Foundation Limited and the founder and dean of Beauty Expert International College. She was also awarded "The President's Volunteer Service Award", the "Congratulatory Letter of The White House Washington" and the "US President Volunteer Service Award Medal". In 2013, Dr. Tsang was appointed as a committee member of the 11th Chinese People's Political Consultative Conference in Hunan Province, China. Dr. Tsang was awarded the Medal of Honour (MH) by the Hong Kong Special Administrative Region Government in July 2015. She is the Founder and Chief President of Hong Kong Beauty & Wellness Association since 2016. She is also the Founding Chairlady and Founder of Hong Kong Beauty Industry Union since 2017. Dr. Tsang is the spouse of Dr. Lee Soo Ghee, a former Executive Director of the Company (resigned on 15 September 2010) and currently Chief Administrative Officer of the Company.
Mr. Yip Kai Wing
Aged 46, is the Chief Technology Officer and an Executive Director of the Company. Mr. Yip is responsible for all computer and information system matters of the Group. Mr. Yip brings with him about twelve years of experience in the system integration, information system, network operation and telecommunications industries. He graduated from the Chinese University of Hong Kong in 1997 with a Bachelor Degree in Social Science and was awarded a Microsoft Certified Professional Systems Engineer, as well as CheckPoint Certified Administrator and Turbolinux Engineer in 2002. Mr. Yip joined the Group in March 2002.
Ms. Yeung See Man
Aged 46, is an Executive Director and the Financial Controller of the Group. She is responsible for overseeing the accounting and financial reporting of the Group. Ms. Yeung graduated from The Hong Kong Polytechnic University with a Bachelor Degree of Arts in Accountancy in 1995. She is a member of the Hong Kong Institute of Certified Public Accountants. She is also a former fellow member of the Association of Chartered Certified Accountants. Ms. Yeung has over six years of audit experience with Deloitte Touche Tohmatsu. She joined the Group in March 2004.
ANNUAL REPORT 2019/20 017
BIOGRAPHY OF DIRECTORS
AND SENIOR MANAGEMENT
Independent Non-Executive Directors
Ms. Liu Mei Ling, Rhoda
Aged 58, was appointed as an Independent Non-executive Director in December 2009. Ms. Liu is a Member of the Canadian Chartered Professional Accountants, Fellow Practicing Member of the Hong Kong Institute of Certified Public Accountants, Fellow Member of the Taxation Institute of Hong Kong, and Fellow Member of the Hong Kong Institute of Directors. Ms. Liu holds a Bachelor of Art Degree in Finance and Commercial Studies from University of Western Ontario in Canada, Professional Degree in China Law from Tsing Hua University in China, and a Master of Business Administration Degree from McMaster University in Canada. Ms. Liu is a Practicing Certified Public Accountant in Hong Kong and sole proprietor of Liu & Wong, Certified Public Accountants. Ms. Liu is also an independent non- executive director, chairperson of audit committee and member of remuneration committee of Mirach Energy Limited, a company listed on the Singapore Stock Exchange. Ms. Liu is an independent director and chairperson of the Audit Committee of Ellipsiz Communications Ltd, a company listed on Toronto Stock Exchange (Venture Capital). Ms. Liu was appointed as an independent non-executive Director, the chairman of the audit committee, a member of the nomination committee and a member of the remuneration committee of Fujian Holdings Limited (stock code: 181), a company listed on the Main Board of the Stock Exchange, with effect from 1 January 2019. Save as disclosed above, Ms. Liu did not hold directorship in other listed public companies in the past three years.
Dr. Wong Man Hin, Raymond
Aged 54, was appointed as an Independent Non-executive Director in December 2009. Dr. Wong is a member of American Institute of Certified Public Accountants (CPA), a Chartered Global Management Accountant (CGMA), a Certified Management Accountant (CMA) and holds a certificate in financial management (CFM). Dr. Wong holds a bachelor degree in chemical engineering, a master degree in economics and a doctorate degree in business administration. Dr. Wong is an executive director and deputy chairman of Raymond Industrial Limited (stock code: 229), a company listed on the Main Board of the Stock Exchange. Dr. Wong is also an independent non-executive director of Nan Nan Resources Enterprise Limited (stock code: 1229), a company listed on the Main Board of the Stock Exchange. Dr. Wong is also an independent non-executive director of
Tak Lee Machinery Holdings Limited (stock code: 8142) and Zhejiang United Investment Holdings Group Limited (stock code: 8366), both companies listed on the GEM of the Stock Exchange. Dr. Wong is Vice President and council member of the Hong Kong Independent Non-Executive Directors Association and an independent manager of TWGHs Wong Fut Nam College.
Mr. Hong Po Kui, Martin
Aged 70, was appointed as an Independent Non-executive Director in December 2009. Mr. Hong has been practicing as a solicitor of the High Court of the Hong Kong Special Administrative Region for over 40 years. Mr. Hong is a Notary Public issued by Hong Kong Society of Notaries. Mr. Hong is now the senior partner of Messrs. Lau Chan & Ko, Solicitors & Notaries.
Senior Management
Dr. Lee Soo Ghee
Aged 45, is the Chief Administrative Officer of the Company. Dr. Lee is a former Executive Director of the Company (resigned on 15 September 2010). Dr. Lee is responsible for overseeing brand management, overseas business/ supply chain, marketing and sales, products research and development, property management, procurement and administration of the Group. He is also responsible for providing comprehensive, technical, programmatic guidance in the areas of facilities management, logistics management and creative design and engineering as well as overall planning and strategic development of the Group's operation. Dr. Lee holds a diploma in Electronics, Computer & Communication Engineering from Singapore Polytechnic, having extraordinary talent in the sphere of design. He also holds a Degree of Doctor from Business Administration by International American University. He is the spouse of Dr. Tsang Yue, Joyce, Executive Director and Chairperson of the Board.
018 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
CORPORATE GOVERNANCE REPORT
Corporate Governance Practices
The Company is committed to principles of good corporate governance consistent with prudent management and enhancement of shareholder value, which emphasise transparency, accountability and independence.
The Company has adopted the code provisions ("Code Provisions") set out in the Corporate Governance Code (taking effect from 1 April 2012) ("the Code") as set out in Appendix 14 to the Rules Governing The Listing of Securities on The Stock Exchange of Hong Kong Limited ("the Listing Rules").
During the year under review, the Company met the Code Provisions in the Code, except for the deviation from Code provision A.2.1, Code provision A.6.7 and Code provision E.1.2 as set out below.
Model Code for Securities
Transactions by Directors
The Company has adopted the Model Code for Securities Transactions by Directors of Listed Issuers ("Model Code") set out in Appendix 10 to the Listing Rules as the code of conduct regarding securities transactions by the directors of the Company ("the Directors").
Having made specific enquiry of all Directors, all Directors confirmed that they had complied with, and there had been no non-compliance with, the required standard set out in the Model Code and its code of conduct regarding the Directors' securities transactions during the year under review.
Board of Directors
Board Composition
Composition of the board of directors of the Company ("the Board") is as follows:
Executive Directors:
Dr. Tsang Yue, Joyce
(Chairperson of the Board & Chief Executive Officer) Mr. Yip Kai Wing
Ms. Yeung See Man
Independent Non-executive Directors:
Ms. Liu Mei Ling, Rhoda
Dr. Wong Man Hin, Raymond Mr. Hong Po Kui, Martin
Mr. Lam Tak Leung (resigned with effect from 1 March 2020)
The Board is currently composed of three Executive Directors (including Chairperson of the Board) and three Independent Non-executive Directors. The Board considers this composition to be balanced and to reinforce a stronger independent review and monitoring function on overall management practices. The policy concerning diversity of Board members of the Company is to maintain a balanced composition of Board members in terms of age, gender, skills, experience, education to reinforce a stronger independent review and monitoring function. A majority of the Independent Non-executive Directors have the appropriate professional or accounting qualifications required by Rule 3.10(2) of the Listing Rules. Directors' biographical details and relevant relationships are set out in the section headed "Biography of Directors and Senior Management" on pages 16 to 17 of this annual report.
Update on Directors' Information Under Rule 13.51B(1) of The Listing Rules
Lam Tak Leung ("Mr. Lam")
Mr. Lam resigned as an independent non-executive director of the Company with effect from 1 March 2020 due to his other business commitments which require more of his attention and dedication.
Board Meetings
The Board conducts meeting on a regular basis and also as and when required. Board meetings are scheduled in advance to facilitate maximum attendance by Directors. The Company Secretary assists the Chairperson in preparing the meeting agendas, and each Director may request inclusion of items in the agenda. Senior Management is invited to join all Board meetings to enhance the Board and management communication. Meeting agendas and other relevant information are provided to the Directors in advance of Board or Board committee meetings. During the year under review, save for executive Board meetings held between Executive Directors during the normal course of business of the Company, the Board held nine board meetings.
ANNUAL REPORT 2019/20 019
CORPORATE
GOVERNANCE REPORT
Directors' Attendance at Board/Board Committee/General Meetings
A summary of all Directors' attendance at the Board meetings, Board Committee meetings and general meetings held during the year under review is set out in the following table:
Audit | Remuneration | Extraordinary | 2019 Annual | ||
Board | Committee | Committee | General | General | |
Meetings | Meetings | Meeting | Meetings | Meeting | |
Executive Director | |||||
Ms. Tsang Yue, Joyce1 | 0/9 | N/A | 0/1 | 0/2 | 0/1 |
Mr. Yip Kai Wing | 9/9 | N/A | N/A | 2/2 | 1/1 |
Ms. Yeung See Man | 9/9 | N/A | N/A | 2/2 | 1/1 |
Independent Non-Executive | |||||
Director | |||||
Ms. Liu Mei Ling, Rhoda2 | 9/9 | 2/2 | 1/1 | 2/2 | 1/1 |
Mr. Wong Man Hin, Raymond3 | 9/9 | 2/2 | 1/1 | 0/2 | 1/1 |
Mr. Hong Po Kui, Martin | 9/9 | 2/2 | 1/1 | 0/2 | 1/1 |
Mr. Lam Tak Leung4 | 2/7 | N/A | N/A | N/A | 1/1 |
Notes:
- Chairperson of the Board and Chairperson of the Nomination Committee of the Company.
- Chairperson of the Audit Committee of the Company.
- Chairperson of the Remuneration Committee of the Company.
- Resigned with effect from 1 March 2020.
Respective Responsibilities, Accountabilities and Contributions of the Board and the Management
The Board is responsible for the leadership and control of the Group (comprising the Company and its subsidiaries) and oversees the Group's business, strategic decisions and performance. The Board has the functions of considering and approving the strategies, financial objectives, annual budget and investment proposals of the Group. The Independent Non-executive Directors, who combine to offer diverse industry expertise, serve the important function of advising the management on strategy and ensuring that the Board maintains high standards of financial and other mandatory reporting requirements as well as providing adequate checks and balances for safeguarding the interests of shareholders and the Company as a whole. Significant transactions shall be approved by the Board.
The members of the Board have no financial, business, family or other material/relevant relationship with each other.
The Board also takes up the corporate governance functions pursuant to the Code. During the year under review, the work performed by the Board on corporate governance function is summarised as follows:
- developed and reviewed policies and practices on corporate governance;
020 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
CORPORATE GOVERNANCE REPORT
- reviewed and monitored the training and continuous professional development of directors and senior management;
- reviewed and monitored the policies and practices on compliance with legal and regulatory requirements;
- reviewed and monitored the code of conduct and compliance manual (if any) applicable to employees and directors; and
- reviewed the Company's compliance with the Code and disclosure in the Corporate Governance Report.
Delegation to Management
Day-to-day operational responsibilities are specifically delegated by the Board to the management under the leadership of the Chief Executive Officer ("CEO"). Major matters include implementation of the strategies and decisions approved by the Board and the management assumes full responsibility to the Board for operations of the Group.
Directors' Participation in Continuous Professional Trainings
Code Provision A.6.5 of the Code provides that all directors should participate in continuous professional development to develop and refresh their knowledge and skills. This is to ensure that their contribution to the Board remains informed and relevant. The Company should be responsible for arranging and funding suitable training, placing an appropriate emphasis on the roles, functions and duties of a listed company director. All Directors have been required to provide the Company with their training records. During the year under review, the Company organised training courses to the Directors or provided written materials to develop and refresh their professional skills on the latest development of applicable laws, rules and regulations for the Directors to assist them in discharging their duties. Some Directors participated in continuous professional
development by attending other professional training courses or by reading relevant materials in relation to corporate governance matter. The Company has received from the relevant Directors the confirmations on taking continuous professional training course during the year under review as follows:
Dr. Tsang Yue, Joyce | Reading materials |
Mr. Yip Kai Wing | Reading materials |
Ms. Yeung See Man | Participation in training |
course | |
Ms. Liu Mei Ling, Rhoda | Participation in training |
courses | |
Dr. Wong Man Hin, Raymond | Participation in training |
courses | |
Mr. Hong Po Kui, Martin | Participation in training |
courses | |
Mr. Lam Tak Leung | Reading materials |
(resigned with effect from | |
1 March 2020) |
Chairperson and Chief Executive Officer ("CEO")
During the year under review, Dr. Tsang Yue, Joyce ("Dr. Tsang") was both the Chairperson and CEO of the Company. Code provision A.2.1 of the Code stipulates that the role of chairperson and chief executive should be separate and should not be performed by the same individual. After reviewing the management structure, the Board is of the opinion that Board decisions are collective decisions of all Directors made by way of voting and not decisions of the Chairperson of the Board alone. Further, there is a clear division of responsibilities between the management of the Board and the day-to-day management of the business of the Company, which relies on the support of the senior management. As such, the power of management of the Company is not concentrated in any one individual. The Board considers that the present structure will not impair the balance of power and authority between the Board and the senior management of the Group.
CORPORATE GOVERNANCE REPORT
Code Provision A.6.7
Code Provision A.6.7 provides that Independent Non- executive Directors and other Non-executive Directors of the Company should attend general meetings and develop a balanced understanding of the views of the shareholders.
Dr. Wong Man Hin, Raymond and Mr. Hong Po Kui, Martin, both Independent Non-executive Directors of the Company, were absent from the two Extraordinary General Meetings of the Company held on 27 March 2020 due to personal reason.
Code Provision E.1.2
Code Provision E.1.2 provides that the chairman of the board should attend the annual general meeting.
Dr. Tsang Yue, Joyce, the Chairperson of the Board, was absent from the Annual General Meeting of the Company held on 30 August 2019 due to personal reason.
Independence of Independent Non-executive Directors ("INEDs")
Ms. Liu Mei Ling, Rhoda, Dr. Wong Man Hin, Raymond and Mr. Hong Po Kui, Martin, INEDs, had each entered into a letter of appointment dated 27 August 2019 for a term of three years commencing from 27 August 2019, subject to, inter alia, retirement from office by rotation at least once every three years and re-election in accordance with the Company's Articles of Association.
Each INED is required to give a written annual confirmation of his/her independence and to inform the Company as soon as practicable if there is any change that may affect his/her independence. The Company confirms that it has received from each INED an annual confirmation of his/ her independence pursuant to Rule 3.13 of the Listing Rules and the Company still considers each INED to be independent.
ANNUAL REPORT 2019/20 021
Appointment and Re-election of the Directors
In accordance with the Articles of Association of the Company, the appointment of a new director must be approved by the Board. The Board has delegated the power to the Nomination Committee to select and recommend candidates for directorship including the consideration of referrals and engagement of external recruitment professionals when necessary. The responsibilities of Nomination Committee are set out in the subheading "Board Committees" below.
All Directors, including INEDs, elected at the annual general meeting are subject to retirement at annual general meeting of the Company by rotation at least once every three years in accordance with the Company's Articles of Association. All retiring Directors, including INEDs, shall be eligible for re-election. All Directors, including Non-executive Directors, appointed to fill a causal vacancy or as an addition to the existing Board, shall hold office only until the first annual general meeting after their appointment and shall then be eligible for re-election.
Board Committees
The Board has established the following committees with defined terms of reference, which are on no less exacting terms than those set out in the Code:
- Remuneration Committee
- Nomination Committee
- Audit Committee
Each Committee has authority to engage outside consultants or experts as it considers necessary to discharge the Committee's responsibilities. Minutes of all committees meetings are circulated to their members. To further reinforce independence and effectiveness, all Audit Committee members are INEDs, and the Nomination and Remuneration Committees have been structured with a majority of INEDs as members.
022 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
CORPORATE GOVERNANCE REPORT
Remuneration Committee
The composition of the Remuneration Committee is as follows:
Independent Non-executive Directors
Dr. Wong Man Hin, Raymond (Chairman)
Ms. Liu Mei Ling, Rhoda
Mr. Hong Po Kui, Martin
Executive Director
Dr. Tsang Yue, Joyce
The responsibilities of Remuneration Committee as set out in its written terms of reference include reviewing and determining the terms of remuneration packages, bonuses and other compensation payable to the Directors and senior management according to the policies as prescribed. Such policies (including Directors' remuneration policy) are to link total compensation for senior management with the achievement of annual and long term performance goals. By providing total compensation at competitive industry levels for delivering on-target performance, the Group seeks to attract, motivate and retain the key executives essential to its long term success.
During the year under review, the Remuneration Committee met one time. Details of the attendance of the members of the Remuneration Committee in the said meeting(s) are set out under the sub-heading "Directors' Attendance at Board/ Board Committee/General Meetings" above.
The work performed by the Remuneration Committee during the year under review is summarised as follows:
a. reviewed remuneration policy, organizational structure and human resources deployment;
- reviewed the performance, compensation and benefits for directors and senior management for the year under review.
Nomination Committee
The composition of the Nomination Committee is as follows:
Executive Director
Dr. Tsang Yue, Joyce (Chairman)
Independent Non-executive Directors
Ms. Liu Mei Ling, Rhoda
Dr. Wong Man Hin, Raymond
Mr. Hong Po Kui, Martin
The Board established the Nomination Committee with written terms of reference which cover recommendations to the Board on the appointment of Directors, evaluation of Board composition, assessment of the independence of INEDs and the management of Board succession.
The basis for the Nomination Committee to select and recommend candidates to the Board is set out in the Nomination Policy below.
During the year under review, the Nomination Committee did not hold any meeting.
Audit Committee
The composition of the Audit Committee is as follows:
Independent Non-executive Directors
Ms. Liu Mei Ling, Rhoda (Chairman)
Dr. Wong Man Hin, Raymond
Mr. Hong Po Kui, Martin
The Audit Committee reviews the Group's financial reporting, risk management, internal control and corporate governance issues and makes relevant recommendations to the Board. All Audit Committee members possess appropriate professional qualifications, accounting or related financial management expertise as required under the Listing Rules. During the year under review, the Audit Committee met twice. Details of the attendance of the members of the Audit Committee in the said meeting(s) are set out under the sub-heading "Directors' Attendance at Board/Board Committee/General Meetings" above.
CORPORATE GOVERNANCE REPORT
The work performed by the Audit Committee during the year under review is summarised as follows:
- approved the remuneration and terms of engagement of KPMG as the external auditor of the Company;
- reviewed the external auditor's independence and objectivity and the effectiveness of audit process in accordance with applicable standards;
- reviewed the audit planning for the annual results circulated to them;
- reviewed the interim and annual financial statements before submission to the Board; and
- reviewed the audit programme of the internal audit department and risk management and internal control systems.
The Audit Committee had reviewed and approved the Group's annual results for the year under review prior to their approval by the Board.
Auditors' Remuneration
During the year under review, the remuneration paid/ payable to the Company's external auditor, KPMG and its network firms, for providing the audit and other services were as follows:
Fee paid/payable | |
HK$'000 | |
Audit services | 3,382 |
Non-audit services | 280 |
ANNUAL REPORT 2019/20 023
Remuneration of Directors and Senior Management
The remuneration of the members of the senior management by band for the year under review is set out below:
Remuneration bands (HK$) | Number of persons |
HK$Nil to HK$1,000,000 | 6 |
HK$1,000,001 to HK$2,000,000 | 1 |
Over HK$2,000,000 | 1 |
Further particulars regarding Director's remuneration and the five highest paid employees are set out in notes 8 and 9 to the financial statements, respectively.
Directors' Responsibilities for preparing accounts and Auditor's Responsibilities
The Directors acknowledged their responsibility for preparing the accounts of the Company for the year under review and the auditor's reporting responsibilities is set out on page 43 of this annual report.
Internal Control and Risk
Management
The Board has conducted a review of the effectiveness of the risk management and internal control systems of the Company and its subsidiaries and considered the systems to be effective and adequate.
The Board is responsible for maintaining sound and effective systems of risk management and internal control in the Group and for reviewing its effectiveness through the Audit Committee. Such systems are designed to manage rather than eliminate the risk of failure to achieve corporate objectives. They aim to provide reasonable but not absolute assurance against material misstatement, loss or fraud.
The Company has set up an internal audit department. The risk management and internal control systems are reviewed at least once during the year under review.
024 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
CORPORATE GOVERNANCE REPORT
The Board has adopted a structure of enterprise risk management for the Company. Business units, support functions and individuals of the Group review, share experience and report to the senior management if any material risk is alerted during daily operation. Internal audit department communicates and assesses the Group's risk profile and material risk at Group level. The Board has delegated to executive management the design, implementation and ongoing assessment of such systems of risk management and internal control, while the Board through its Audit Committee oversees and reviews the adequacy and effectiveness of relevant financial, operational and compliance controls and risk management procedures that have been in place. Qualified personnel throughout the Group maintain and monitor these systems of controls on an ongoing basis. Inside information is handled by and disseminated to senior management on a need-to-know basis.
Based on the results of evaluations and representations made by the senior management, the Audit Committee is satisfied that:
- there is an ongoing process for identifying, evaluating and managing the significant risks faced by the Group that threaten the achievement of its business objectives; and
- appropriate systems of internal control and risk management have been in place for the year under review, and up to the date of approval of this annual report.
Company Secretary
Owing to the Covid-19 pandemic, the Company Secretary of the Company was unable to take not less than 15 hours of relevant professional training during the year under review as required under Rule 3.29 of the Listing Rules. The Company Secretary will take the outstanding hours of the relevant professional training as soon as possible.
Board Diversity Policy
The Board has adopted a policy concerning diversity of the Board members, which policy sets out the principles of, and the factors and rationale behind to be considered in order to achieve diversity in the board of directors the Company.
Principles
The Board believes in the benefits that diversity brings and it recognizes that diversity of thought makes prudent business sense. Having the Board composed of men and women with diverse skills, experience, backgrounds and perspectives means:
- competitive advantage;
- robust understanding of opportunities, issues and risks;
- inclusion of different concepts, ideas, and relationships;
- enhanced decision-making and dialogue; and
- heightened capacity for oversight of the Company and its governance.
Factors and rationale behind
For purposes of achieving diversity in the Board, the factors to be considered include, but are not limited to:
- business and industry experience;
- professional skills and expertise;
- gender;
- age; and
- cultural and educational background.
The principal activities of the Company and its subsidiaries ("the Group") are provision of beauty and wellness services and sales of skincare and wellness products, which are very competitive business and activities. Experience in such business or activities or other business or activities is essential to understand and run the business and activities of the Group. Professional (e.g. legal, accounting) skills and expertise are important to minimize risks in the business and activities of the Group. Gender and age diversity as well as cultural and educational diversity will give different perspectives in terms of customer requirements and feedback in provision of products and services of the Group and the needs of the shareholders and investors.
ANNUAL REPORT 2019/20 025
CORPORATE
GOVERNANCE REPORT
The Board will make good use of these differences and distinctions among individuals in determining the optimum composition of the Board.
Measureable Objectives
This Policy will be measurable on an objective review of the composition of the Board.
This policy will be reviewed from time to time.
- Experience or expertise in the field of beauty sector or beauty services;
- Understands and share the vision of the Company;
- Able to devote time and effort necessary for the good governance and betterment of the Company.
Nomination Policy
The Board has adopted a policy for Nomination of Directors setting out the criteria, procedure and process to select and recommend candidates for appointment as a member of the board of directors the Company.
Selection Criteria
A number of factors shall be considered in making selection and recommendation of candidates for directorship of the Company, including but not limited to:
- Personal Attributes: Every candidate must adhere to the highest ethical standards, display solid business judgment, and have strong interpersonal skills.
- Adherence to the Policy on Diversity of Members of Board of Directors of the Company.
- Compliance with the Memorandum and Articles of Association of the Company and the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
- Specific Skills and Experience:
- Leadership experience in an organization or company of the similar size and complexity of the Company;
- Previous board experience;
- Ability to read and interpret financial statements;
- Experience in legal matters;
Procedures and Process
- Any member of the Board may nominate candidates for new appointment as a director of the Company or re-appointment of any existing director.
- Nomination Committee may convene a meeting to consider the nomination of such candidate(s).
- The Nomination Committee shall make due diligence in respect of the nominated candidates and make recommendations for the Board's consideration and approval.
- Shareholders of the Company may by ordinary resolution elect any person to be a director of the Company. Please refer to the "The Way by Which Shareholders Can Convene Extraordinary General Meeting/Put Forward Proposal" available in the website of the Company for the relevant procedure.
This policy will be reviewed from time to time.
Dividend Policy
In deciding whether to propose the payment and the amount of the dividends, the Company will take into account the Group's future operations and strategies, financial results, cash flows, market situation, capital requirements and any other factors that the Board considers relevant.
The declaration and payment of dividends by the Company shall be determined at the sole discretion of the Board from time to time and shall be subject to any restrictions under the Companies Law of the Cayman Islands and the Articles of Association of the Company.
This policy will be reviewed from time to time.
026 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
CORPORATE GOVERNANCE REPORT
Shareholders' Rights
The Way by Which Shareholders Can Convene Extraordinary General Meeting/Put Forward Proposal
Pursuant to Article 79 of the Articles of Association of the Company, the Board may, whenever it thinks fit, convene an extraordinary general meeting. General meetings shall also be convened on the written requisition of any two or more members of the Company deposited at the principal office of the Company in Hong Kong or, in the event the Company ceases to have such a principal office, the registered office specifying the objects of the meeting and signed by the requisitionists, provided that such requisitionists held as at the date of deposit of the requisition not less than one tenth of the paid up capital of the Company which carries the right of voting at general meetings of the Company. General meeting may also be convened on the written requisition of any one member of the Company which is a recognised clearing house (or its nominee(s)) deposited at the principal office of the Company in Hong Kong or, in the event the Company ceases to have such a principal office, the registered office specifying the objects of the meeting and signed by the requisitionists, provided that such requisitionists held as at the date of deposit of the requisition not less than one-tenth of the paid up capital of the Company which carries the right of voting at general meetings of the Company. If the Board does not within 21 days from the date of deposit of the requisition proceed duly to convene the meeting to be held within a further 21 days, the requisitionist(s) themselves or any of them representing more than one half of the total voting rights of all of them, may convene the general meeting in the same manner, as nearly as possible, as that in which meetings may be convened by the Board provided that any meeting so convened shall not be held after the expiration of three months from the date of deposit of the requisition, and all reasonable expenses incurred by the requisitionist(s) as a result of the failure of the Board shall be reimbursed to them by the Company. And, if a shareholder wishes to make any proposal at any general meeting of the Company, the shareholder should deposit a written notice of the proposal to the Company Secretary of the Company within 7 days commencing from the date of the notice of the general meeting of the Company (or such other period as may be determined and announced by the Director from time to time).
The Procedures for Sending Enquiries to the Board
Any enquiries to be put to the Board are welcomed and can be addressed to the Investors Relation Department of the Company by email at ir@modernhealthcaretech.com or by mail to the following address:
Modern Healthcare Technology Holdings Limited Workshops Nos. 66-68, 6th Floor, Sino Industrial Plaza 9 Kai Cheung Road
Kowloon Bay Kowloon Hong Kong
Attn: Investor Relation Department
ANNUAL REPORT 2019/20 027
REPORT
OF THE DIRECTORS
The directors ("the Directors") of Modern Healthcare Technology Holdings Limited (formerly known as Modern Beauty Salon Holdings Limited) ("the Company") have pleasure in submitting their report together with the audited financial statements of the Company and its subsidiaries (collectively, "the Group") for the year ended 31 March 2020 ("FY2020" or "the year under review").
Principal Activities
The principal activity of the Company is investment holding and the principal activities of the Group continued throughout FY2020 were provision of beauty and wellness services and sales of skincare and wellness products. Details of the Company's principal subsidiaries as at 31 March 2020 are set out in note 15 to the financial statements.
Business Review
A review of the business of the Group during the year under review, including (a) a fair review of the Group's business; (b) a description of the principal risks and uncertainties facing the Group; (c) particulars of important events affecting the Group that have occurred since the end of the year under review; (d) an indication of likely future development in the Group's business; (e) an analysis of the Group's performance during the year under review using financial key performance indicators; (f) a discussion on the Group's environmental policies and performance and compliance with the relevant laws and regulations that have a significant impact on the Group (if any) and
- an account of the Group's key relationships with its employees, customers and suppliers and others that have a significant impact on the Group and on which the Group's success depends, is set out in "Management Discussion and Analysis" on page 8 to page 14 of this annual report, which constitutes part of this report of the directors.
Results and Appropriations
The results of the Group for FY2020 are set out in the consolidated statement of profit or loss on page 46.
The revenue and results of the Group are principally derived from the provision of beauty and wellness services in Hong Kong, Mainland China and Singapore. The Group's revenue and results by reportable segment are set out in note 3 to the financial statements. A detailed review of the development of the business of the Group during the year
under review, and likely future prospects, is set out in the section headed "Management Discussion and Analysis" of this annual report.
Declaration of Dividend
No interim dividend had been paid to shareholders of the Company ("Shareholders") during the year under review (FY2019: Nil interim dividend).
No final dividend had been approved by the board during the year under review (FY2019: Nil final dividend).
The Annual General Meeting ("AGM") is scheduled to be held on Friday, 28 August 2020. For determining the entitlement to attend and vote at the AGM, the register of members of the Company will be closed from Tuesday, 25 August 2020 to Friday, 28 August 2020, both days inclusive, during which period no transfer of Share will be effected. In order to be eligible to attend and vote at the AGM, all transfers of Shares, accompanied by the relevant share certificates, must be lodged with the Company's share registrar in Hong Kong, Tricor Investor Services Limited, Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong, for registration not later than 4:30 p.m. on Monday, 24 August 2020.
Reserves
Movements during the year under review in the reserves of the Group and the Company are set out in the consolidated statement of changes in equity on page 50 and note 24 to the financial statements respectively.
Distributable Reserves
As at 31 March 2020, the Company's reserve available for distribution amounted to approximately HK$11.5 million. Movements in reserves of the Company during the year under review and the distributable reserves of the Company as at 31 March 2020 are set out in note 24 to the financial statements.
028 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
REPORT
OF THE DIRECTORS
Financial Summary
A summary of the results and assets and liabilities of the Group for the last five financial years is set out on page 112, which does not form part of the financial statements.
Management Contracts
No contracts concerning the management and administration of the whole or any substantial part of the business of the Company and the Group were entered into or existed during the year under review.
Major Customers and Suppliers
During the year under review, the aggregate purchases attributable to the Group's largest supplier accounted for approximately 5% (FY2019: 8%) of the Group's total purchase for the year under review and the five largest suppliers taken together accounted for approximately 19% (FY2019: 22%) of the Group's total purchase for the year under review.
The five largest customers of the Group in aggregate accounted for less than 5% of the total sales.
None of the Directors, their associates, or any Shareholders (which to the knowledge of the Directors own more than 5% of the Company's issued share capital) had any interest in any of the Group's five largest suppliers and customers during the year under review.
Share Capital
Details of movements in the share capital of the Company during the year under review are set out in note 24 to the financial statements.
Pre-emptive Rights
There are no provisions for pre-emptive rights under the Company's Articles of Association or the laws of the Cayman Islands, which would oblige the Company to offer new Shares on a pro-rata basis to existing Shareholders.
Charitable Donations
Directors
The Directors during the year under review and up to the date of this report are:
Executive Directors
Dr. Tsang Yue, Joyce
(Chairperson and Chief Executive Officer)
Mr. Yip Kai Wing
Ms. Yeung See Man
Independent Non-executive Directors
Dr. Wong Man Hin, Raymond
Mr. Hong Po Kui, Martin
Ms. Liu Mei Ling, Rhoda
Mr. Lam Tak Leung (resigned with effect from 1 March 2020)
Pursuant to Article 130 of the Company's Articles of Association, Dr. Tsang Yue, Joyce and Ms. Liu Mei Ling, Rhoda will retire by rotation and, being eligible, offer themselves for re-election at the forthcoming AGM. Particulars of the aforesaid Directors seeking for re-election at the AGM are set out in the relevant circular to be sent to the Shareholders.
The Company had received from each Independent Non- executive Director ("INED") an annual confirmation of his or her independence as regard each of the factors referred to in Rule 3.13(1) to (8) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the Company considered all of them to be independent.
Directors' Service Contracts
None of the Directors has entered into any service contract which is not determinable by the Company and any of its subsidiaries within one year without payment of compensation, other than statutory compensation.
During the year under review, the Group made no donations to charitable and non-profit making organisations.
ANNUAL REPORT 2019/20 029
REPORT
OF THE DIRECTORS
Directors' Interests in Transaction, Arrangement or Contract
Save as disclosed in the sections headed "Connected Transactions" and "Continuing Connected Transactions" below and in note 29 to the financial statements and those exempted from the reporting, annual review, announcement and independent shareholders' approval requirements under the Listing Rules, no transaction, arrangement or contract of significance to the business of the Group to which the Company, its subsidiaries, its holding companies or any subsidiaries of its holding companies was a party and in which a Director or an entity connected with a Director had a material interest, whether directly or indirectly, subsisted at the end of the year under review or at any time during the year under review.
Competing Interest
Save as disclosed in the sections headed "Connected Transactions" and "Continuing Connected Transactions" below, none of the Directors or their respective associates (as defined in the Listing Rules) had an interest in a business, which competes or may compete with the business of the Group.
Directors' and Chief Executive's Interests and Short Positions in the Shares, Underlying Shares and Debentures
As at 31 March 2020, the interests and short positions of the Directors and chief executive of the Company in the shares, underlying shares and debentures of the Company or any of its associated corporations (within the meaning of Part XV of the Securities and Futures Ordinance ("the SFO") as recorded in the register kept by the Company pursuant to Section 352 of the SFO or otherwise notified to the Company and The Stock Exchange of Hong Kong Limited ("the Stock Exchange") pursuant to the Model Code for Securities Transactions by Directors of Listed Issuers ("Model Code") set out in Appendix 10 to the Listing Rules, were as follows:
Long positions in Shares, underlying Shares and Debentures of the Company
Approximate | ||||
Percentage of | ||||
Issued Voting | ||||
Capacity in which | Interests in | Total | Shares of the | |
Name | interests are held | Shares | Interests | Company1 |
Ms. Tsang Yue, Joyce | Founder of a discretionary trust | 677,247,942 | 677,247,942 | 74.88% |
Interest of spouse2 | 650,000 | 650,000 | 0.07% | |
Mr. Yip Kai Wing | Beneficial Owner | 185,000 | 185,000 | 0.02% |
Ms. Yeung See Man | Beneficial Owner | 172,000 | 172,000 | 0.02% |
Notes:
- The percentage has been compiled based on the total number of Shares of the Company in issue as at 31 March 2020 (i.e. 904,483,942 Shares).
- Dr. Tsang Yue, Joyce is the spouse of Dr. Lee Soo Ghee and is deemed to be interested in the Shares in which Dr. Lee Soo Ghee is deemed or taken to be interested for the purpose of the SFO.
030 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
REPORT
OF THE DIRECTORS
Save as disclosed above, as at 31 March 2020, none of the Directors and chief executive of the Company nor their respective associates had any interest or short position in the shares, underlying shares and debentures of the Company or any of its associated corporation (within the meaning of Part XV of the SFO) which were required to be notified to the Company and the Stock Exchange pursuant to Divisions 7 and 8 of Part XV of the SFO (including interests or short positions which they were taken or deemed to have under such provisions of the SFO), or pursuant to section 352 of the SFO, to be entered in the register referred to therein, or notified to the Company and the Stock Exchange pursuant to the Model Code.
Directors' Rights to Acquire Shares or Debentures
At no time during the year under review was the Company, any of its holding companies, subsidiaries or fellow subsidiaries a party to any arrangements to enable the Directors or Chief Executive of the Company or any of their respective spouses or children under 18 years of age to acquire benefits by means of the acquisition of shares in, or debentures of, the Company or any other body corporate.
Substantial Shareholders' and Other Persons' Interests and Short Positions in the Shares and Underlying Shares
As at 31 March 2020, the interests or short positions of substantial shareholders and other persons of the Company in the shares and underlying shares of the Company as recorded in the register required to be kept under section 336 of the SFO, or as otherwise notified to the Company, were as follows:
Long positions of substantial shareholders and other persons in the Shares and underlying Shares of the Company
Approximate | ||||
Percentage of | ||||
Issued Voting | ||||
Capacity in which | Interests in | Total | Shares of the | |
Name | interests are held | Shares | Interests | Company1 |
Ms. Tsang Yue, Joyce | Founder of a discretionary trust | 677,247,942 | 677,247,9424 | 74.88% |
Interest of spouse2 | 650,000 | 650,000 | 0.07% | |
Dr. Lee Soo Ghee | Beneficial owner | 650,000 | 650,000 | 0.07% |
Interest of spouse3 | 677,247,942 | 677,247,9424 | 74.88% | |
TMF (Cayman) Ltd5 | Trustee (other than a bare | |||
trustee) | 677,247,942 | 677,247,9424 | 74.88% | |
Kelday International Limited5 | Nominee for another person | |||
(other than a bare trustee) | 677,247,942 | 677,247,9424 | 74.88% | |
Allied Chance Management | Interest of corporation controlled | |||
Limited5 | by it | 677,247,942 | 677,247,9424 | 74.88% |
Allied Wealth Limited5 | Beneficial owner | 209,247,942 | 209,247,9426 | 23.13% |
Silver Compass Holdings | Beneficial owner | |||
Corp5 | 367,200,000 | 367,200,0006 | 40.60% | |
Silver Hendon Enterprises | Beneficial owner | |||
Corp5 | 100,800,000 | 100,800,0006 | 11.14% |
REPORT
OF THE DIRECTORS
Notes:
- The percentage has been compiled based on the total number of Shares of the Company in issue as at 31 March 2020 (i.e. 904,483,942 Shares).
- Dr. Tsang Yue, Joyce is the spouse of Dr. Lee Soo Ghee and is deemed to be interested in the Shares in which Dr. Lee Soo Ghee is deemed or taken to be interested for the purpose of the SFO.
- Dr. Lee Soo Ghee is the spouse of Dr. Tsang Yue, Joyce and is deemed to be interested in the Shares in which Dr. Tsang Yue, Joyce is deemed or taken to be interested for the purpose of the SFO.
- These Shares were the same parcel of Shares held by a trust of which Dr. Tsang Yue, Joyce was the founder. TMF (Cayman) Ltd. was the trustee of the trust. See Note 5.
- Allied Wealth Limited, Silver Compass Holdings Corp. and Silver Hendon Enterprises Corp. are indirect wholly- owned subsidiaries of Allied Chance Management Limited. Allied Chance Management Limited is in turn a direct wholly-owned subsidiary of Kelday International Limited. TMF (Cayman) Ltd. is the ultimate holding company of Allied Chance Management Limited and Kelday International Limited.
- These Shares were included in the above-mentioned number of Shares of 677,247,942. See note 4 and note 5.
Apart from the above, no other interest or short position in the shares or underlying shares of the Company was recorded in the register required to be kept under section 336 of the SFO as at 31 March 2020.
Connected Transactions
The related party transactions or continuing related party transactions (as the case may be) ("the Note 29 Transactions") included in note 29 to the financial statements in accordance with the Hong Kong Accounting Standards fell under the definition of "connected transactions" or "continuing connected transactions" (as the case may be) in Chapter 14A of the Listing Rules. It is confirmed that the Company has, to the extent required, complied with the applicable shareholder's approval, annual review and disclosure requirements in accordance with Chapter 14A of the Listing Rules in relation to the Note 29 Transactions.
ANNUAL REPORT 2019/20 031
Continuing Connected Transactions
Certain transactions entered into by the Group constituted continuing connected transactions under the Listing Rules during the year under review, in respect of which the Company confirms that it has complied with the disclosure requirements in accordance with Chapter 14A of the Listing Rules. Details of these transactions required to be disclosed are set out below:
- The following transactions have been approved by independent shareholders at an Extraordinary General Meeting held on 29 March 2017.
Since the Group intends to continue to lease certain existing premises and may lease certain new premises and, if appropriate, other new premises from subsidiaries ("Owners") of Asia Power Global Limited ("Lessor"), a company wholly owned by a family trust set up by Dr. Tsang Yue, Joyce, as its operating facilities (including but not limited to offices, retail shops, service centres and warehouses) and staff quarters and anticipates that it will enter into new leases during the ordinary and usual course of the Group's business during the three years ended 31 March 2020, the Company and the Lessor entered into a Master Lease Agreement on 23 February 2017 ("2017 Master Lease Agreement") to set out the principal terms and conditions governing the leasing of premises by the Group from the Owners pursuant to the 2017 Master Lease Agreement by entering into a tenancy or lease agreement in respect of such premises between the Group and the relevant Owner ("2017-2020 Leasing Arrangements") in the future.
The 2017 Master Lease Agreement shall be for a term commencing from 1 April 2017 and ended on 31 March 2020. In addition, the 2017 Master Lease Agreement may be terminated by the Company by giving the Lessor at least sixty days' written notice of termination.
032 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
REPORT
OF THE DIRECTORS
Each of the 2017-2020 Leasing Arrangements to be entered into between the Company and the relevant Owner pursuant to the 2017 Master Lease Agreement will have a term commencing on or after 1 April 2017 and expiring on or before 31 March 2020.
Pursuant to the 2017 Master Lease Agreement, each 2017-2020 Leasing Arrangement shall be on normal commercial terms and shall be on terms which are no less favourable than those offered by the Owners to other independent third parties and the amount of rental (exclusive of rates, land rent and management fees) under each 2017-2020 Leasing Arrangement shall be determined by the parties to each 2017-2020 Leasing Arrangement with reference to the then prevailing market rents on premises comparable in location, area and permitted use ("Comparable Premises") provided that before each 2017-2020 Leasing Arrangement is entered into, the Group shall, at its own cost and expenses, obtain a confirmation from an independent property valuer providing its opinion of the then prevailing market rent of the premises with reference to the market rent of the Comparable Premises and the rent to be set out in the relating 2017-2020 Leasing Arrangement shall be no more than such prevailing market rent and the effective date of the opinion shall not be more than three months. In light of such safeguard, there will not be a situation where the actual rent payable by the Group under any individual lease to be entered into pursuant to the 2017 Master Lease Agreement will be higher than the prevailing market rent of the relevant Comparable Premises.
The government rent, rates and management fee under each 2017-2020 Leasing Arrangement will be paid to the government or, as the case may be, the management companies by the relevant tenant directly.
It is expected that the maximum consideration payable by the Group to the Lessor and/or the Owners (as the case may be) in respect of the 2017- 2020 Leasing Arrangements as contemplated under the 2017 Master Lease Agreement for the year ended 31 March 2018, the year ended 31 March 2019 and the year ended 31 March 2020 will not exceed HK$79 million, HK$79 million and HK$79 million, respectively ("2017-2020 Annual Caps").
Under the Company's internal policy, the independent non-executive Directors will review the proposed 2017-2020 Leasing Arrangements in respect of any additional new premises in light of the then prevailing market rent of such new premises and other terms of the leases to ensure that the proposed 2017- 2020 Leasing Arrangements are (i) entered into in the ordinary and usual course of business of the Company; (ii) on normal commercial terms and on terms that are no less favourable than those offered by the Owners to other independent third parties; and (iii) in accordance with the provisions of the 2017 Master Lease Agreement. The interested parties, i.e. Dr. Tsang Yue, Joyce and her associates, will not be involved in such reviewing process.
Pursuant to the 2017 Master Lease Agreement, the Group (as tenant) and the Owners (as landlord) has entered into the following tenancy agreements:
- tenancy agreement dated 12 April 2017 in respect of 18th Floor, Hou Feng Industrial Building, Nos. 1-5 Wing Kin Road, Kwai Chung, New Territories, Hong Kong at the monthly rent of HK$62,050 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 36 months from 1 April 2017;
- tenancy agreement dated 12 April 2017 in respect of Workshops Nos. 11-31, 32B, 33B, 41-78 and Store Room No. 10 on 6th Floor and Lorry Car Parking Space Nos. L8, L10, L14 and L15 on Basement, Sino Industrial Plaza, No. 9 Kai Cheung Road, Kowloon Bay, Kowloon, Hong Kong at the monthly rent of HK$501,500 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 36 months from 1 April 2017. The monthly rent of HK$501,500 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) was reduced to HK$272,525 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water,
ANNUAL REPORT 2019/20 033
REPORT
OF THE DIRECTORS
gas and electricity charges) for 20 months from 1 August 2018 to 31 March 2020, and was further reduced to HK$136,451 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for two months commencing from 1st day of February, 2020 to 31st day of March, 2020. By a Partial Surrender Agreement dated 1 February 2020, Workshop Nos. 14-31,41-49 and 72-78 on 6th Floor and Lorry Car Parking Space No. L10 on Basement, Sino Industrial Plaza, No. 9 Kai Cheung Road, Kowloon Bay, Kowloon, Hong Kong ("the Outgoing Property") were surrendered to the landlord on 1 February 2020, only Workshops Nos. 11-13, 32B, 33B, 50-71 and Store Room No.10 on 6th Floor and Lorry Car Parking Space Nos. L8, L14 and L15 on Basement, Sino Industrial Plaza, No. 9 Kai Cheung Road, Kowloon Bay, Kowloon, Hong Kong ("the Retaining Property") were retained under the said tenancy agreement;
- tenancy agreement dated 12 April 2017 in respect of Shop and Toilet Area on 1st Floor, Shop and Toilet Area on 2nd Floor, Lift and Staircase (No.3) and Grease Trap Room on 1st Floor, 1st Floor Staircase for 2nd Floor, Lift and Staircase on 2nd Floor, Lift Machine Room for 1st to 2nd Floors on 3rd Floor, Signage Units Nos. 1 to 8 on Ground Floor, Signage Units Nos. 9 to 14 on 1st Floor, Store and Open Store on Ground Floor, The Grandeur, 47 Jardine's Bazaar, Causeway Bay, Hong Kong at the monthly rent of HK$620,500 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 36 months from 1 April 2017. The said monthly rent of HK$620,500 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) was reduced to HK$371,353 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for 20 months from 1 August 2018 to 31 March 2020;
- tenancy agreement dated 12 April 2017 in respect of Shop 1 on Ground Floor and 1st Floor (with flat roof adjacent thereto) including the staircases and landings treatment on and leading from the Ground Floor to the First Floor and Covered Air-Conditioned Plant Shelter on 2nd Floor, Len Fat Mansion, Nos. 56-60,64-86 Kin Yip Street, Yuen Long, New Territories, Hong Kong at the monthly rent of HK$161,500 exclusive of rates, Government rent, management fee and other outgoings(including but not limited to water, gas and electricity charges) for a term of 36 months from 1 April 2017;
- tenancy agreement dated 12 April 2017 in respect of Units B74-B90,B99-B116,B132-B136, 1/F., The Commercial Accommodation of Well On Garden, No. 9 Yuk Nga Lane, Tseung Kwan O, New Territories, Hong Kong at the monthly rent of HK$161,500 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 36 months from 1 April 2017;
- tenancy agreement dated 12 April 2017 in respect of 1/F (including its Flat Roof and Stair-Entrance on Ground Floor), King Kwong Mansion, No. 8 King Kwong Street, Happy Valley, Hong Kong at the monthly rent of HK$65,450 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 36 months from 1 April 2017;
- tenancy agreement dated 12 April 2017 in respect of 1st Floor and 2nd Floor Commercial Unit with 1st Floor and 2nd Floor Advertising Space of Paradise Square, 3 Kwong Wa Street, Kowloon, Hong Kong at the monthly rent of HK$514,802 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 36 months from 1 April 2017. The said monthly rent of HK$514,802 exclusive of rates, Government
034 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
REPORT
OF THE DIRECTORS
rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) was reduced to HK$257,129 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for 20 months from 1 August 2018 to 31 March 2020; and was further reduced to HK$150,000.00 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for nine months commencing from 1st day of July, 2019 to 31st day of March, 2020. By a Partial Surrender Agreement dated 15 July 2019, 1st Floor Commercial Unit with 1st Floor Advertising Space of Paradise Square, 3 Kwong Wa Street, Kowloon, Hong Kong ("the 1st Floor Property") were surrendered to the landlord on 14 July 2019, only 2nd Floor Commercial Unit with 2nd Floor Advertising Space of Paradise Square, 3 Kwong Wa Street, Kowloon, Hong Kong ("the 2nd Floor Property") were retained under the said tenancy agreement;
- tenancy agreement dated 12 April 2017 in respect of Shop No. 5 on Ground Floor, Paradise Square, 3 Kwong Wa Street, Kowloon, Hong Kong at the monthly rent of HK$12,198 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 36 months from 1 April 2017;
- tenancy agreement dated 12 April 2017 in respect of 3rd and 4th Floor, (including Flat Roof) BCC Building, Nos 25-31 Carnarvon Road, Kowloon, Hong Kong at the monthly rent of HK$323,000 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 36 months from 1 April 2017;
- tenancy agreement dated 12 April 2017 in respect of Portion B of Shop C on Ground Floor and Shop E on Basement, King's View Court, 901-907 King's Road, Quarry Bay, Hong Kong at the monthly rent of HK$212,500 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 36 months from 1 April 2017;
- tenancy agreement dated 12 April 2017 in respect of 3/F, Causeway Bay Commercial Building, No. 3 Sugar Street, Causeway Bay, Hong Kong at the monthly rent of HK$212,500 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 36 months from 1 April 2017;
- tenancy agreement dated 12 April 2017 in respect of Units C1, C2, D1, D2, E1 & E2, 16/F., TG Place, No. 10 Shing Yip Street, Kowloon at the monthly rent of HK$136,000 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 36 months from 1 April 2017;
- tenancy agreement dated 28 May 2018 in respect of Room 301-305, 3/F., On Lok Yuen Building, Nos. 25, 27 & 27A Des Voeux Road Central, Hong Kong at the monthly rent of HK$122,400 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 22 months from 1 June 2018;
- tenancy agreement dated 28 May 2018 in respect of Room 1201-1203, 12/F., Silver Fortune Plaza, No.1 Wellington Street, Central, Hong Kong at the monthly rent of HK$164,050 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 22 months from 1 June 2018;
ANNUAL REPORT 2019/20 035
REPORT
OF THE DIRECTORS
- tenancy agreement dated 31 July 2018 in respect of 5/F., World Trust Tower, Nos. 50 Stanley Street, Central, Hong Kong at the monthly rent of HK$103,700 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 20 months from 1 August 2018;
- tenancy agreement dated 3 April 2019 in respect of 16/F & Lavatories, Oriental Central Nos. 67- 71 Chatham Road South, Kowloon Hong Kong at the monthly rent of HK$118,150 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 15 months from 1 January 2019;
- tenancy agreement dated 3 April 2019 in respect of Portion B of Basement of Hang Ying House, Nos. 318-328 King's Road, Hong Kong at the monthly rent of HK$111,350 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 12 months from 1 April 2019; and
- tenancy agreement dated 13 January 2020 in respect of Unit 2A, 2/F, Winner House, Nos. 310 King's Road, Hong Kong at the monthly rent of HK$125,000 exclusive of rates, Government rent, management fee and other outgoings (including but not limited to water, gas and electricity charges) for a term of 4 months from 1 December 2019
(collectively, the transactions in this sub-paragraph (A) are referred to as "2017-2020 Continuing Connected Transactions").
-
The following transactions have been approved by independent shareholders at an Extraordinary General Meeting held on 27 March 2020.
Since the Group intends to continue to lease certain existing premises and may lease certain new premises and, if appropriate, other new premises from the subsidiaries ("Owners") of Asia Power Global Limited
("Lessor"), a company wholly owned by a family trust set up by Dr. Tsang, as its operating facilities (including but not limited to offices, retail shops, service centres and warehouses) and anticipates that it will enter into new leases during the ordinary and usual course of the Group's business during the three years ending 31 March 2023, the Company and the Lessor entered into an agreement on 20 February 2020 (as varied and modified by a supplemental agreement entered into between the Company and the Lessor dated 28 February 2020) ("2020 Master Lease Agreement") to set out the principal terms and conditions governing the leasing of premises by the Group from the Owners pursuant to the 2020 Master Lease Agreement by the entering into a tenancy or lease agreement in respect of such premises between the Group and the relevant Owner ("2020-2023 Leasing Arrangements") in the future.
The 2020 Master Lease Agreement shall be for a term commencing from 1 April 2020 and ending on 31 March 2023. In addition, the 2020 Master Lease Agreement may be terminated by the Company by giving the Lessor at least sixty days' written notice of termination. Such right allows the Group the flexibility to terminate the 2020 Master Lease Agreement at any time during its term. According to the terms of the 2020 Master Lease Agreement, the Lessor shall not have any right to terminate the 2020 Master Lease Agreement.
Each of the 2020-2023 Leasing Arrangements to be entered into between the Group and the relevant Owners pursuant to the 2020 Master Lease Agreement will have a term commencing on or after 1 April 2020 and expiring on or before (i) the expiration or earlier termination of its own term, or (ii) 31 March 2023, whichever is earlier.
Pursuant to the 2020 Master Lease Agreement, each 2020-2023 Leasing Arrangement shall be on normal commercial terms or better (within the meaning of Chapter 14A of the Listing Rules) and the amount of rental (exclusive of rates, government rent and management fees) under each 2020-2023 Leasing Arrangement shall be determined by the parties to each 2020-2023 Leasing Arrangement with reference to the then prevailing market rents on premises
036 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
REPORT
OF THE DIRECTORS
comparable in location, area and permitted use ("Comparable Premises") provided that before each 2020-2023 Leasing Arrangement is entered into, the Group shall, at its own cost and expenses, obtain a confirmation from an independent property valuer providing its opinion of the then prevailing market rent of the premises with reference to the market rents of the Comparable Premises and the rent to be set out in the relating 2020-2023 Leasing Arrangement shall be no more than such prevailing market rent and the valuation date of the opinion shall not be more than three months.
Pursuant to the agreed form of the individual tenancy agreement to be entered into by the Group and the relevant Owner(s) appended to the 2020 Master Lease Agreement, the Lessee shall pay the rent to the relevant Owner(s) in Hong Kong dollars in advance on the first day of each and every calendar month during the term of the relevant lease.
The rates, government rent and management fee under each 2020-2023 Leasing Arrangement will be paid to the government or, as the case may be, the management companies.
The Hong Kong Financial Reporting Standards issued by the Hong Kong Institute of Certified Public Accountants ("HKFRS") applicable to the Group include HKFRS 16 "Leases" which has come into effect on 1 January 2019 and is applicable to financial years starting on or after 1 January 2019. Under HKFRS 16, the Group, as the lessee, shall recognise the total rental payments payable to the relevant Owners under the 2020 Master Lease Agreement as a right-of-use asset and a lease liability in the consolidated statement of the financial position of the Group.
The annual caps under the 2020 Master Lease Agreement, which are determined with reference to the total value of the right-of-use assets relating to the 2020-2023 Leasing Arrangements to be or expected to be entered into by the Group, for the year ending 31 March 2021, the year ending 31 March 2022 and the year ending 31 March 2023 were adjusted to HK$115.2 million, HK$7.1 million and HK$3.6 million, respectively ("2020-2023 Annual Caps").
The Independent Non-executive Directors have reviewed the 2017-2020 Continuing Connected Transactions and confirmed that these transactions have been entered into:
- in the ordinary and usual course of business of the Group;
- either on normal commercial terms or on terms no less favourable to the Group than terms available to or from independent third parties; and
- in accordance with the relevant agreement governing them on terms that are fair and reasonable and in the interests of the Shareholders as a whole.
Pursuant to the Listing Rules, the Company has engaged the auditor of the Company to report on the 2017-2020 Continuing Connected Transactions in accordance with the Hong Kong Standard on Assurance Engagements 3000 (Revised) "Assurance Engagements Other Than Audits or Reviews of Historical Financial Information" and with reference to Practice Note 740 "Auditor's Letter on Continuing Connected Transactions under the Hong Kong Listing Rules" issued by the Hong Kong Institute of Certified Public Accountants. The auditor has confirmed in writing to the Board of Directors that in respect of the 2017-2020 Continuing Connected Transactions:
- nothing has come to their attention that causes them to believe that the 2017-2020 Continuing Connected Transactions ("the disclosed continuing transactions") have not been approved by the Company's board of directors.
- for transactions involving the provision of goods or services by the Group, nothing has come to their attention that causes them to believe that the disclosed continuing transactions were not, in all material respects, in accordance with the pricing policies of the Group.
- nothing has come to their attention that causes them to believe that the disclosed continuing transactions were not entered into, in all material respects, in accordance with the relevant agreements governing such transactions.
ANNUAL REPORT 2019/20 037
REPORT
OF THE DIRECTORS
- with respect to the aggregate amount of the 2017- 2020 Continuing Connected Transactions, nothing has come to their attention that causes them to believe that the disclosed continuing transactions have exceeded the annual cap disclosed in the previous announcement dated 23 February 2017 made by the Company in respect of the disclosed continuing transactions.
The Company confirms that it has complied with the disclosure requirements, where appropriate, in accordance with Chapter 14A of the Listing Rules.
Public Float
Based on the information that is publicly available to the Company and within the knowledge of its Directors, as at the date of this annual report, there is sufficient public float of not less than 25% of the Company's issued shares as required under the Listing Rules.
During the year under review, the Company took out and kept in force insurance for directors and officers of the Company against liability for certain claims for certain wrongful acts.
Purchase, Sale or Redemption of the Company's Listed Securities
During the year under review, the Company did not redeem, and neither the Company nor any of its subsidiaries purchased or sold, any of the Company's listed securities.
Audit Committee
The Audit Committee had reviewed and approved the Group's annual results for the year ended 31 March 2020 prior to their approval by the Board. Information on the work of the Audit Committee and its composition are set out in the Corporate Governance Report on page 22 of this annual report.
Permitted Indemnity Provision
Article 225 of the Articles of Association of the Company provides, inter alia, that every director of the Company shall be entitled to be indemnified out of the assets of the Company against all losses or liabilities incurred or sustained by him as a director of the Company in defending any proceedings, whether civil or criminal, in which judgment is given in his favour, or in which he is acquitted.
Article 226 of the Articles of Association of the Company provides, inter alia, that subject to Companies Law (2004 Revision), Cap. 22 of the Cayman Islands and any amendments thereto or re-enactments thereof for the time being in force and includes every other law incorporated therewith or substituted therefor, if any director of the Company shall become personally liable for the payment of any sum primarily due from the Company, the majority of the directors of the Company present and voting at a meeting of the directors of the Company at which a quorum is present, may execute or cause to be executed any mortgage, charge, or security over or affecting the whole or any part of the assets of the Company by way of indemnity to secure the director so becoming liable as aforesaid from any loss in respect of such liability.
Corporate Governance
The Company's corporate governance practices are set out in Corporate Governance Report on page 18 of this annual report.
Environmental, Social and
Governance Report
The Company will publish a separate Environmental, Social and Governance Report as close as possible to, and in any event no later than three months after, the publication of this annual report.
Auditor
The financial statements for FY2020 had been audited by KPMG who will retire and, being eligible, offer itself for reappointment at the AGM. A resolution for the reappointment of KPMG as auditor of the Company will be proposed at the forthcoming AGM.
By order of the Board
Dr. Tsang Yue, Joyce
Chairperson and Chief Executive Officer
Hong Kong, 29 June 2020
038 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
INDEPENDENT
AUDITOR'S REPORT
Independent auditor's report to the shareholders of Modern Healthcare Technology Holdings Limited (formerly known as Modern Beauty Salon Holdings Limited) (Incorporated in the Cayman Islands with limited liability)
Opinion
We have audited the consolidated financial statements of Modern Healthcare Technology Holdings Limited (formerly known as Modern Beauty Salon Holdings Limited) ("the Company") and its subsidiaries ("the Group") set out on pages 46 to 110, which comprise the consolidated statement of financial position as at 31 March 2020, the consolidated statement of profit or loss, the consolidated statement of profit or loss and other comprehensive income, the consolidated statement of changes in equity and the consolidated cash flow statement for the year then ended and notes to the consolidated financial statements, including a summary of significant accounting policies.
In our opinion, the consolidated financial statements give a true and fair view of the consolidated financial position of the Group as at 31 March 2020 and of its consolidated financial performance and its consolidated cash flows for the year then ended in accordance with Hong Kong Financial Reporting Standards ("HKFRSs") issued by the Hong Kong Institute of Certified Public Accountants ("HKICPA") and have been properly prepared in compliance with the disclosure requirements of the Hong Kong Companies Ordinance.
Basis for opinion
We conducted our audit in accordance with Hong Kong Standards on Auditing ("HKSAs") issued by the HKICPA. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the consolidated financial statements section of our report. We are independent of the Group in accordance with the HKICPA's Code of Ethics for Professional Accountants ("the Code") together with any ethical requirements that are relevant to our audit of the consolidated financial statements in the Cayman Islands, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
ANNUAL REPORT 2019/20 039
INDEPENDENT
AUDITOR'S REPORT
Key audit matters
Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the consolidated financial statements of the current period. These matters were addressed in the context of our audit of the consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.
Recognition of revenue
Refer to notes 4 and 22 to the consolidated financial statements and the accounting policies in note 2(r)(ii).
The Key Audit Matter | How the matter was addressed in our audit |
The Group's revenue mainly comprises income from beauty and wellness services, which contributed approximately 94% of the Group's total revenue for the year ended 31 March 2020.
The Group sells prepaid packages for beauty and wellness services which comprise multiple numbers of treatments. When prepaid packages are sold, the Group receives upfront payment of the treatment fees, which are recorded as revenue initially.
Prepaid packages sold are non-refundable and customers may not exercise all of their contractual rights within the contract period of one year. Those unexercised contractual rights are referred to as "breakage" and, at the end of the reporting period, management estimates an expected amount of breakage based on historical experience.
In respect of the value of the prepaid beauty and wellness services for which the related services have not yet been provided and have not yet expired, adjusted for breakage, is recorded as deferred revenue in the consolidated financial statements.
Our audit procedures to assess the recognition of revenue in respect of the provision of beauty and wellness services included the following:
- with the assistance of our internal IT specialists, identifying and evaluating the relevant IT systems and the design, implementation and operating effectiveness of key internal controls over the recognition of revenue, with particular emphasis on the capturing and recording of beauty and wellness services transactions;
- utilising our internal IT specialists to assist us in assessing the calculation logic of deferred revenue for beauty and wellness services;
- analysing the Group's historical data in respect of the unexercised contractual rights of the prepaid packages to determine an expectation of the breakage amount for the current year; comparing our expectation with the actual figures recorded by the Group and investigating unusual items or trends; and assessing whether or not there was an indication of management bias;
040 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
INDEPENDENT
AUDITOR'S REPORT
Key audit matters (continued)
Recognition of revenue
Refer to notes 4 and 22 to the consolidated financial statements and the accounting policies in note 2(r)(ii).
The Key Audit Matter
The Group automatically tracks beauty and wellness services transaction details, including receipts of treatment fees from sales of prepaid packages, subsequent delivery of the related services and the calculation of the expected amount of breakage estimated by management.
At the end of the reporting period, the Group generates a "deferred revenue report", representing the prepaid services for which the related services have not yet been provided and have not yet expired, to determine the amount of revenue to be deferred at the end of the reporting period.
Based on this deferred revenue report, manual journal entries are prepared to adjust revenue and the balance of deferred revenue at the end of the reporting period.
We identified the recognition of revenue from the provision of beauty and wellness services as a key audit matter because revenue is a key performance indicator of the Group and therefore there is a risk that revenue could be manipulated to meet specific targets or expectations..
How the matter was addressed in our audit
- comparing the details in the deferred revenue report generated by the IT system, on a sample basis, with relevant underlying documentation, including original invoices and customer acknowledgement records for beauty and wellness services provided to assess whether or not revenue and deferred revenue are
- completely and accurately recorded based on the deferred revenue report and (b) whether they are accounted for in the correct accounting period;
- for the invoices tested in the preceding paragraph, also comparing details therein with transaction statements received from credit card companies; and
- inspecting underlying documentation for other manual journal entries relating to revenue which met specific risk-based criteria.
ANNUAL REPORT 2019/20 041
INDEPENDENT
AUDITOR'S REPORT
Key audit matters (continued)
Assessing potential impairment of property, plant and equipment ("PPE") including right-of-use assets
Refer to note 11 to the consolidated financial statements and the accounting policies in note 2(j)).
The Key Audit Matter | How the matter was addressed in our audit |
As at 31 March 2020, management identified indicators of potential impairment of the Group's PPE including right- of-use assets attributable to certain beauty and wellness services segment which has sustained operating losses for the year ended 31 March 2020.
The Group recognised impairment loss on PPE, including right-of-use assets, during the year ended 31 March 2020 amounting to HK$9.9 million.
Management determined the recoverable amount of the smallest cash-generating unit ("CGU") to which these assets were allocated where indicators of impairment were identified. The recoverable amount of a CGU is the greater of its value in use and the fair value less costs of disposal of the related assets.
In determining the value in use amount of each CGU for which there are impairment indications, a discounted cash flow forecast is prepared by management.
The preparation of a discounted cash flow forecast involves the exercise of significant management judgement, particularly in forecasting the future revenue and future costs of each concerned CGUs and the discount rate applied.
Our audit procedures to assess potential impairment of PPE including right-of-use assets included the following:
- evaluating management's identification of the CGUs and the allocation of assets to the CGUs and assessing the methodology adopted by management in its preparation of the discounted cash flow forecast with reference to the requirements of the prevailing accounting standards;
- comparing forecast revenue, forecast cost of sales and forecast other operating expenses in the discounted cash flow forecast with the relevant data included in the annual financial budget which was approved by management;
- comparing the revenue growth rate and net profit margin adopted in the discounted cash flow forecast with the past growth rates and the net profit margin achieved by the CGU as well as with those of comparable companies and other available external market data, taking into account recent developments in the beauty and wellness industry and the Group's future operating plans;
042 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
INDEPENDENT
AUDITOR'S REPORT
Key audit matters (continued)
Assessing potential impairment of property, plant and equipment ("PPE") including right-of-use assets
Refer to note 11 to the consolidated financial statements and the accounting policies in note 2(j)).
The Key Audit Matter
We identified potential impairment of PPE including right-of-use assets as a key audit matter because identifying impairment indicators and determining the level of impairment, if any, involves certain judgemental assumptions, which may be inherently uncertain and could be subject to management bias.
How the matter was addressed in our audit
- involving our internal valuation specialists to assist us in assessing the methodology applied by management in its discounted cash flow forecast with reference to the requirements of the prevailing accounting standards;
- involving our internal valuation specialists to assist us in assessing whether the discount rate applied in the discounted cash flow forecast is within the range adopted by other companies in the same industry;
- comparing the revenue, cost of sales and other operating expenses included in the discounted cash flow forecast prepared in the prior year with the current year's performance to assess the reliability of management's budgeting and forecasting processes; and
- performing sensitivity analyses of the key assumptions adopted in the discounted cash flow forecast and assessing the impact of changes in the key assumptions, including the revenue growth rate, the net profit margin and the discount rate applied, to evaluate the impact on the conclusions reached in the impairment assessment and considering whether there were any indicators of management bias.
ANNUAL REPORT 2019/20 043
INDEPENDENT
AUDITOR'S REPORT
Information other than the consolidated financial statements and auditor's report thereon
The directors are responsible for the other information. The other information comprises all the information included in the annual report, other than the consolidated financial statements and our auditor's report thereon.
Our opinion on the consolidated financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.
In connection with our audit of the consolidated financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the consolidated financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated.
If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Responsibilities of the directors for the consolidated financial statements
The directors are responsible for the preparation of the consolidated financial statements that give a true and fair view in accordance with HKFRSs issued by the HKICPA and the disclosure requirements of the Hong Kong Companies Ordinance and for such internal control as the directors determine is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, the directors are responsible for assessing the Group's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Group or to cease operations, or have no realistic alternative but to do so.
The directors are assisted by the Audit Committee in discharging their responsibilities for overseeing the Group's financial reporting process.
Auditor's responsibilities for the audit of the consolidated financial statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. This report is made solely to you, as a body, and for no other purpose. We do not assume responsibility towards or accept liability to any other person for the contents of this report.
Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with HKSAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.
044 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
INDEPENDENT
AUDITOR'S REPORT
Auditor's responsibilities for the audit of the consolidated financial statements (continued)
As part of an audit in accordance with HKSAs, we exercise professional judgement and maintain professional scepticism throughout the audit. We also:
- Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
- Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group's internal control.
- Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors.
- Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Group to cease to continue as a going concern.
- Evaluate the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
- Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of the group audit. We remain solely responsible for our audit opinion.
We communicate with the Audit Committee regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide the Audit Committee with a statement that we have complied with relevant ethical requirements regarding independence and communicate with them all relationships and other matters that may reasonably be thought to bear on our independence and, where applicable, related safeguards.
ANNUAL REPORT 2019/20 045
INDEPENDENT
AUDITOR'S REPORT
Auditor's responsibilities for the audit of the consolidated financial statements (continued)
From the matters communicated with the Audit Committee, we determine those matters that were of most significance in the audit of the consolidated financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor's report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.
The engagement partner on the audit resulting in this independent auditor's report is Yip Ka Ming, Alice.
KPMG
Certified Public Accountants 8th Floor, Prince's Building 10 Chater Road
Central, Hong Kong
29 June 2020
046 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
CONSOLIDATED STATEMENT OF PROFIT OR LOSS
For the year ended 31 March 2020 | |||||
Note | 2020 | 2019 | |||
(Note) | |||||
HK$'000 | HK$'000 | ||||
Revenue | 4 | 522,606 | 576,017 | ||
Other income | 5 | 6,858 | 3,067 | ||
Cost of inventories sold | (18,917) | (24,112) | |||
Advertising costs | (5,346) | (4,382) | |||
Building management fees | (13,046) | (13,993) | |||
Bank charges | (25,182) | (26,717) | |||
Employee benefit expenses | 6(a) | (311,732) | (319,087) | ||
Depreciation and amortisation | 11&14 | (71,930) | (15,264) | ||
Occupancy costs | 6(b) | (43,843) | (114,450) | ||
Other operating expenses | (56,739) | (63,232) | |||
Loss from operations | (17,271) | (2,153) | |||
Finance costs | 6(b) | (2,896) | - | ||
Interest income | 1,541 | 688 | |||
Fair value change on investment properties | 12 | 110 | (90) | ||
Impairment loss on property, plant and equipment | 11 | (9,933) | (5,103) | ||
Net gain/(loss) on disposal of subsidiaries | 809 | (306) | |||
Loss before taxation | 6 | (27,640) | (6,964) | ||
Income tax expense | 7(a) | (4,389) | (5,833) | ||
Loss for the year | (32,029) | (12,797) | |||
Attributable to: | |||||
Equity shareholders of the Company | (31,590) | (13,289) | |||
Non-controlling interests | (439) | 492 | |||
Loss for the year | (32,029) | (12,797) | |||
Loss per share (HK cents) | 10 | ||||
Basic | (3.49) | (1.47) | |||
Diluted | (3.49) | (1.47) | |||
Note: The Group has initially applied HKFRS 16 at 1 April 2019 using the modified retrospective approach. Under this approach, comparative information is not restated. See note 2(c).
The notes on pages 53 to 110 form part of these financial statements.
ANNUAL REPORT 2019/20 047
CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
For the year ended 31 March 2020 | |||
Note | 2020 | 2019 | |
(Note) | |||
HK$'000 | HK$'000 | ||
Loss for the year | (32,029) | (12,797) | |
Other comprehensive income for the year (after tax and | |||
reclassification adjustments): | |||
Items that may be reclassified subsequently to profit or loss: | |||
- Exchange differences on translation of foreign operations, net | |||
of Nil tax | (2,867) | 1,706 | |
- Reserves released upon disposal of subsidiaries | - | 511 | |
Other comprehensive income for the year | (2,867) | 2,217 | |
Total comprehensive income for the year | (34,896) | (10,580) | |
Attributable to: | |||
Equity shareholders of the Company | (34,457) | (11,072) | |
Non-controlling interests | (439) | 492 | |
Total comprehensive income for the year | (34,896) | (10,580) | |
Note: The Group has initially applied HKFRS 16 at 1 April 2019 using the modified retrospective approach. Under this approach, comparative information is not restated. See note 2(c).
The notes on pages 53 to 110 form part of these financial statements.
048 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
As at 31 March 2020 | |||
Note | 31 March 2020 | 31 March 2019 | |
(Note) | |||
HK$'000 | HK$'000 | ||
Non-current assets | |||
Property, plant and equipment | 11 | 144,374 | 80,452 |
Investment properties | 12 | 13,920 | 13,810 |
Intangible assets | 14 | 1,343 | 1,776 |
Goodwill | 13 | 1,070 | 1,070 |
Deposits and prepayments | 16 | 10,264 | 22,256 |
Deferred tax assets | 17(a) | 3,863 | 3,874 |
174,834 | 123,238 | ||
Current assets | |||
Inventories | 18 | 15,131 | 18,881 |
Trade and other receivables, deposits and prepayments | 16 | 188,081 | 190,077 |
Tax recoverable | 7,929 | 5,860 | |
Pledged bank deposits | 19 | 54,092 | 53,206 |
Bank deposits with original maturity over three months | 5,151 | 5,469 | |
Cash and bank balances | 20(a) | 174,779 | 182,766 |
445,163 | 456,259 | ||
Current liabilities | |||
Trade and other payables, deposits received and accrued expenses | 21 | 79,702 | 86,832 |
Deferred revenue | 22 | 301,822 | 297,621 |
Lease liabilities | 23 | 48,602 | - |
Tax payable | 4,910 | 7,690 | |
435,036 | 392,143 | ||
Net current assets | 10,127 | 64,116 | |
ANNUAL REPORT 2019/20 049
CONSOLIDATED STATEMENT
OF FINANCIAL POSITION
As at 31 March 2020 | |||
Note | 31 March 2020 | 31 March 2019 | |
(Note) | |||
HK$'000 | HK$'000 | ||
Total assets less current liabilities | 184,961 | 187,354 | |
Non-current liabilities | |||
Lease liabilities | 23 | 32,281 | - |
Deferred tax liabilities | 17(a) | 570 | 458 |
32,851 | 458 | ||
NET ASSETS | 152,110 | 186,896 | |
CAPITAL AND RESERVES | |||
Share capital | 24(c) | 90,448 | 90,448 |
Reserves | 56,345 | 90,802 | |
Total equity attributable to equity shareholders of the | |||
Company | 146,793 | 181,250 | |
Non-controlling interests | 5,317 | 5,646 | |
TOTAL EQUITY | 152,110 | 186,896 |
Approved and authorised for issue by the Board of Directors on 29 June 2020
Ms. Yeung See Man | Mr. Yip Kai Wing |
Director | Director |
Note: The Group has initially applied HKFRS 16 at 1 April 2019 using the modified retrospective approach. Under this approach, comparative information is not restated. See note 2(c).
The notes on pages 53 to 110 form part of these financial statements.
050 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For the year ended 31 March 2020
Property | Non- | |||||||||
Share | Share | Merger | Exchange | revaluation | Retained | controlling | Total | |||
Note | capital | premium | reserve | reserve | reserve | earnings | Total | interests | equity | |
HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | ||
Balance at 1 April 2018 | 90,448 | 318,791 | (373,253) | (2,968) | 3,552 | 155,752 | 192,322 | 2,635 | 194,957 | |
Changes in equity for 2019: | ||||||||||
Loss for the year | - | - | - | - | - | (13,289) | (13,289) | 492 | (12,797) | |
Other comprehensive income | ||||||||||
- Exchange differences on translation of | ||||||||||
subsidiaries | - | - | - | 1,706 | - | - | 1,706 | - | 1,706 | |
- Reserves released upon disposal of | ||||||||||
subsidiaries | - | - | - | 511 | - | - | 511 | - | 511 | |
Total comprehensive income | - | - | - | 2,217 | - | (13,289) | (11,072) | 492 | (10,580) | |
Addition of a subsidiary | - | - | - | - | - | - | - | 480 | 480 | |
Disposal of subsidiaries | - | - | - | - | - | - | - | 2,039 | 2,039 | |
- | - | - | - | - | - | - | 2,519 | 2,519 | ||
Balance at 31 March 2019 | 90,448 | 318,791 | (373,253) | (751) | 3,552 | 142,463 | 181,250 | 5,646 | 186,896 | |
Balance at 1 April 2019 | 90,448 | 318,791 | (373,253) | (751) | 3,552 | 142,463 | 181,250 | 5,646 | 186,896 | |
Changes in equity for 2020: |
Loss for the year
Other comprehensive income
- Exchange differences on translation of subsidiaries
- | - | - | - | - | (31,590) | (31,590) | (439) | (32,029) |
- | - | - | (2,867) | - | - | (2,867) | - | (2,867) |
Total comprehensive income | - | - | - | (2,867) | - | (31,590) | (34,457) | (439) | (34,896) | |
Addition of a subsidiary | - | - | - | - | - | - | - | 31 | 31 | |
Disposal of a subsidiary | - | - | - | - | - | - | - | 79 | 79 | |
Balance at 31 March 2020 | 90,448 | 318,791 | (373,253) | (3,618) | 3,552 | 110,873 | 146,793 | 5,317 | 152,110 |
Note: The Group has initially applied HKFRS 16 at 1 April 2019 using the modified retrospective approach. Under this approach, comparative information is not restated. See note 2(c).
The notes on pages 53 to 110 form part of these financial statements.
ANNUAL REPORT 2019/20 051
CONSOLIDATED CASH
FLOW STATEMENT
For the year ended 31 March 2020 | ||||
Note | 2020 | 2019 | ||
(Note) | ||||
HK$'000 | HK$'000 | |||
Operating activities | ||||
Loss before taxation | (27,640) | (6,964) | ||
Adjustments for: | ||||
Depreciation and amortisation | 11&14 | 71,930 | 15,264 | |
Interest income | (1,541) | (688) | ||
Finance costs | 2,896 | - | ||
Rent concessions | (1,200) | - | ||
Net gain on disposals of property, plant and equipment | 5 | (560) | (107) | |
Fair value change on investment properties | 12 | (110) | 90 | |
Impairment loss on property, plant and equipment | 11 | 9,933 | 5,103 | |
Impairment loss on other receivables | - | 3,193 | ||
Exchange adjustment | 1,242 | - | ||
Net (gain)/loss on disposal of subsidiaries | (809) | 306 | ||
Operating profit before changes in working capital | 54,141 | 16,197 | ||
Decrease in inventories | 3,032 | 3,019 | ||
Decrease in trade and other receivables, deposits and prepayments | 12,882 | 28,451 | ||
Decrease in trade and other payables, deposits received and | ||||
accrued expenses | (2,158) | (6,704) | ||
Increase/(decrease) in deferred revenue | 3,930 | (1,792) | ||
Cash generated from operations | 71,827 | 39,171 | ||
Interest received | 1,541 | 688 | ||
Tax paid | (9,463) | (6,325) | ||
Net cash generated from operating activities | 63,905 | 33,534 |
052 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
CONSOLIDATED CASH
FLOW STATEMENT
For the year ended 31 March 2020 | ||||
Note | 2020 | 2019 | ||
(Note) | ||||
HK$'000 | HK$'000 | |||
Investing activities | ||||
Decrease in bank deposits with original maturity over three months | 318 | 87 | ||
Payment for purchase of property, plant and equipment | (19,996) | (32,597) | ||
Proceeds from disposals of property, plant and equipment | 560 | 107 | ||
Disposal of a subsidiary | (765) | - | ||
(Increase)/decrease in pledged bank deposits | (886) | 1,265 | ||
Net cash used in investing activities | (20,769) | (31,138) | ||
Financing activities | ||||
Capital element of lease rentals paid | 20(b) | (2,896) | - | |
Interest element of lease rentals paid | 20(b) | (45,908) | - | |
Net cash used in financing activities | (48,804) | - | ||
Net (decrease)/increase in cash and cash equivalents | (5,668) | 2,396 | ||
Effect of foreign exchange rates changes | (2,319) | (1,313) | ||
Cash and cash equivalents at beginning of year | 182,766 | 181,683 | ||
Cash and cash equivalents at end of year | 20(a) | 174,779 | 182,766 |
Note: The Group has initially applied HKFRS 16 using the modified retrospective approach and adjusted the opening balances at 1 April 2019 to recognise right-of-use assets and lease liabilities relating to leases which were previously classified as operating leases under HKAS 17. Previously, cash payments under operating leases made by the Group as a lessee of HK$114,450,000 were classified as operating activities in the consolidated cash flow statement. Under HKFRS 16, except for short-term lease payments not included in the measurement of lease liabilities, all other rentals paid on leases are now split into capital element and interest element (see note 20(b)) and classified as financing cash outflows. Under the modified retrospective approach, the comparative information is not restated. Further details on the impact of the transition to HKFRS 16 are set out in note 2(c).
The notes on pages 53 to 110 form part of these financial statements.
ANNUAL REPORT 2019/20 053
NOTES TO
THE FINANCIAL STATEMENTS
1 General information
Modern Healthcare Technology Holdings Limited (formerly known as Modern Beauty Salon Holdings Limited) ("the Company") was incorporated in the Cayman Islands with limited liability. The address of its registered office is PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. The address of its principal place of business is Workshops Nos. 66-68, 6th Floor, Sino Industrial Plaza, 9 Kai Cheung Road, Kowloon Bay, Kowloon, Hong Kong. The Company's shares are listed on the Main Board of The Stock Exchange of Hong Kong Limited ("the Stock Exchange").
The Company is an investment holding company. The principal activities of its subsidiaries are provision of beauty and wellness services and the sales of skincare and wellness products. In the opinion of the directors of the Company, Dr. Tsang Yue, Joyce ("Dr. Tsang"), who is a director of the Company, is the ultimate controlling party of the Company.
2 Significant accounting policies
-
Statement of compliance
These financial statements have been prepared in accordance with all applicable Hong Kong Financial Reporting Standards ("HKFRSs"), which collective term includes all applicable individual Hong Kong Financial Reporting Standards, Hong Kong Accounting Standards ("HKASs") and Interpretations issued by the Hong Kong Institute of Certified Public Accountants ("HKICPA"), accounting principles generally accepted in Hong Kong and the disclosure requirements of the Hong Kong Companies Ordinance. These financial statements also comply with the applicable disclosure provisions of the Rules Governing the Listing of Securities on the Stock Exchange. Significant accounting policies adopted by the Company and its subsidiaries ("the Group") are disclosed below.
The HKICPA has issued certain new and revised HKFRSs that are first effective or available for early adoption for the current accounting period of the Group. Note 2(c) provides information on any changes in accounting policies resulting from initial application of these developments to the extent that they are relevant to the Group for the current and prior accounting periods reflected in these financial statements. - Basis of preparation of the financial statements
The consolidated financial statements for the year ended 31 March 2020 comprise the Company and its subsidiaries.
The measurement basis used in the preparation of the financial statements is the historical cost basis except that the investment properties (see note 2(f)) are stated at their fair values as explained in the accounting policies set out below.
The preparation of financial statements in conformity with HKFRSs requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.
054 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
-
Basis of preparation of the financial statements (continued)
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
Judgements made by management in the application of HKFRSs that have significant effect on the financial statements and major sources of estimation uncertainty are discussed in note 31. - Changes in accounting policies
The HKICPA has issued a new HKFRS, HKFRS 16, Leases, and a number of amendments to HKFRSs that are first effective or available for early adoption for the current accounting period of the Group.
Except for HKFRS 16, Leases, early adoption of amendment to HKFRS 16-COVID-19-Related Rent Concessions and amendments to HKFRS 3, Definition of a business, none of the developments have had a material effect on how the Group's results and financial position for the current or prior periods have been prepared or presented.
HKFRS 16, Leases and early adoption of amendment to HKFRS 16-COVID-19-Related Rent Concessions
HKFRS 16 replaces HKAS 17, Leases, and the related interpretations, HK(IFRIC) 4, Determining whether an arrangement contains a lease, HK(SIC) 15, Operating leases - incentives, and HK(SIC) 27, Evaluating the substance of transactions involving the legal form of a lease. It introduces a single accounting model for lessees, which requires a lessee to recognise a right-of-use asset and a lease liability for all leases, except for leases that have a lease term of 12 months or less ("short-term leases") and leases of low-value assets. The lessor accounting requirements are brought forward from HKAS 17 which remain substantially unchanged.
HKFRS 16 also introduces additional qualitative and quantitative disclosure requirements which aim to enable users of the financial statements to assess the effect that leases have on the financial position, financial performance and cash flows of an entity.
The Group has initially applied HKFRS 16 as from 1 April 2019. The Group has elected to use the modified retrospective approach and has therefore recognised the cumulative effect of initial application as an adjustment to the opening balance of equity at 1 April 2019. Comparative information has not been restated and continues to be reported under HKAS 17.
ANNUAL REPORT 2019/20 055
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
-
Changes in accounting policies (continued)
Further details of the nature and effect of the changes to previous accounting policies and the transition options applied are set out below: - New definition of a lease
The change in the definition of a lease mainly relates to the concept of control. HKFRS 16 defines a lease on the basis of whether a customer controls the use of an identified asset for a period of time, which may be determined by a defined amount of use. Control is conveyed where the customer has both the right to direct the use of the identified asset and to obtain substantially all of the economic benefits from that use.
The Group applies the new definition of a lease in HKFRS 16 only to contracts that were entered into or changed on or after 1 April 2019. For contracts entered into before 1 April 2019, the Group has used the transitional practical expedient to grandfather the previous assessment of which existing arrangements are or contain leases. Accordingly, contracts that were previously assessed as leases under HKAS 17 continue to be accounted for as leases under HKFRS 16 and contracts previously assessed as non-lease service arrangements continue to be accounted for as executory contracts. - Lessee accounting and transitional impact
HKFRS 16 eliminates the requirement for a lessee to classify leases as either operating leases or finance leases, as was previously required by HKAS 17. Instead, the Group is required to capitalise all leases when it is the lessee, including leases previously classified as operating leases under HKAS 17, other than those short-term leases and leases of low-value assets which are exempt. As far as the Group is concerned, these newly capitalised leases are primarily in relation to property, plant and equipment as disclosed in note 11(c). For an explanation of how the Group applies lessee accounting, see note 2(i)(i).
At the date of transition to HKFRS 16 (i.e. 1 April 2019), the Group determined the length of the remaining lease terms and measured the lease liabilities for the leases previously classified as operating leases at the present value of the remaining lease payments, discounted using the relevant incremental borrowing rates at 1 April 2019. The weighted average of the incremental borrowing rates used for determination of the present value of the remaining lease payments was 3.45%.
To ease the transition to HKFRS 16, the Group applied the following recognition exemption and practical expedients at the date of initial application of HKFRS 16: - the Group elected not to apply the requirements of HKFRS 16 in respect of the recognition of lease liabilities and right-of-use assets to leases for which the remaining lease term ends within 12 months from the date of initial application of HKFRS 16, i.e. where the lease term ends on or before 31 March 2020; and
- when measuring the lease liabilities at the date of initial application of HKFRS 16, the Group applied a single discount rate to a portfolio of leases with reasonably similar characteristics (such as leases with a similar remaining lease term for a similar class of underlying asset in a similar economic environment).
- New definition of a lease
056 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
- Changes in accounting policies (continued)
-
Lessee accounting and transitional impact (continued)
As a practical expedient on the early adoption of amendment relating to the issuance of COVID-19- Related Rent Concessions, the Group elected not to assess whether a rent concession that meets the following condition is a lease modification: - the change in lease payments results in revised consideration for the lease immediately preceding the change;
- any reduction in lease payments affects only payments originally due on or before 30 June 2021; and
- there is no substantive change in other terms and conditions of the lease.
-
Lessee accounting and transitional impact (continued)
The Group has accounted for any change in lease payment resulting from these rental concessions the same way it had accounted for the change in applying HKFRS 16, as if the change were not a modification.
The following table reconciles the operating lease commitments as disclosed in note 27(a) as at
31 March 2019 to the opening balance for lease liabilities recognised as at 1 April 2019:
1 April 2019 | ||
HK$'000 | ||
Operating lease commitments at 31 March 2019 | 128,393 | |
Less: commitments relating to leases exempt from capitalisation: | ||
- short-term leases and other leases with remaining lease term | ||
ending on or before 31 March 2020 | (35,494) | |
92,899 | ||
Less: total future interest expenses | (3,470) | |
Present value of remaining lease payments, discounted using the incremental | ||
borrowing rate at 1 April 2019 | 89,429 |
The right-of-use assets in relation to leases previously classified as operating leases have been recognised at an amount equal to the amount recognised for the remaining lease liabilities, adjusted by the amount of any prepaid or accrued lease payments relating to that lease recognised in the statement of financial position at 31 March 2019.
ANNUAL REPORT 2019/20 057
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
- Changes in accounting policies (continued)
-
Lessee accounting and transitional impact (continued)
The following table summarises the impacts of the adoption of HKFRS 16 on the Group's consolidated statement of financial position:
-
Lessee accounting and transitional impact (continued)
Carrying amount | Capitalisation of | Carrying amount | |
at 31 March | operating lease | at 1 April | |
2019 | contracts | 2019 | |
HK$'000 | HK$'000 | HK$'000 | |
Line items in the consolidated | |||
statement of financial position | |||
impacted by the adoption of | |||
HKFRS 16: | |||
Property, plant and equipment | 80,452 | 87,327 | 167,779 |
Total non-current assets | 123,238 | 87,327 | 210,565 |
Trade and other payables, deposits | |||
received and accrued expenses | 86,832 | (2,102) | 84,730 |
Lease liabilities (current) | - | 44,324 | 44,324 |
Total current liabilities | 392,143 | 42,222 | 434,365 |
Net current assets | 64,116 | (42,222) | 21,894 |
Total assets less current liabilities | 187,354 | 45,105 | 232,459 |
Lease liabilities (non-current) | - | 45,105 | 45,105 |
Total non-current liabilities | 458 | 45,105 | 45,563 |
Net assets | 186,896 | - | 186,896 |
058 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
- Changes in accounting policies (continued)
-
Leasehold investment property
Under HKFRS 16, the Group is required to account for all leasehold properties as investment properties when these properties are held to earn rental income and/or for capital appreciation ("leasehold investment properties"). The adoption of HKFRS 16 does not have a significant impact on the Group's financial statements as the Group previously elected to apply HKAS 40, Investment properties, to account for all of its leasehold properties that were held for investment purposes as at 31 March 2019. Consequentially, these leasehold investment properties continue to be carried at fair value. - Lessor accounting
In addition to leasing out the investment property referred to in paragraph c above, the Group leases out a number of building units as the lessor of operating leases. The accounting policies applicable to the Group as a lessor remain substantially unchanged from those under HKAS17.
-
Leasehold investment property
Amendments to HKFRS 3, Definition of a business
The Group had early adopted the amendments to HKFRS 3, Definition of business, in the current accounting period. The amendment clarifies and simplifies the assessment on whether an acquired set of activities and assets is not a business. The Group has applied the amendment to transactions for which the acquisition date is on or after 1 April 2019.
-
Subsidiaries and non-controlling interests
Subsidiaries are entities controlled by the Group. The Group controls an entity when it is exposed, or has rights, to variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. When assessing whether the Group has power, only substantive rights (held by the Group and other parties) are considered.
An investment in a subsidiary is consolidated into the consolidated financial statements from the date that control commences until the date that control ceases. Intra-group balances, transactions and cash flows and any unrealised profits arising from intra-group transactions are eliminated in full in preparing the consolidated financial statements. Unrealised losses resulting from intra-group transactions are eliminated in the same way as unrealised gains but only to the extent that there is no evidence of impairment.
Non-controlling interests represent the equity in a subsidiary not attributable directly or indirectly to the Company, and in respect of which the Group has not agreed any additional terms with the holders of those interests which would result in the Group as a whole having a contractual obligation in respect of those interests that meets the definition of a financial liability. For each business combination, the Group can elect to measure any non-controlling interests either at fair value or at the non-controlling interests' proportionate share of the subsidiary's net identifiable assets.
ANNUAL REPORT 2019/20 059
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
-
Subsidiaries and non-controlling interests (continued)
Non-controlling interests are presented in the consolidated statement of financial position within equity, separately from equity attributable to the equity shareholders of the Company. Non-controlling interests in the results of the Group are presented on the face of the consolidated statement of profit or loss and the consolidated statement of profit or loss and other comprehensive income as an allocation of the total profit or loss and total comprehensive income for the year between non-controlling interests and the equity shareholders of the Company. Loans from holders of non-controlling interests and other contractual obligations towards these holders are presented as financial liabilities in the consolidated statement of financial position in accordance with note 2(m) depending on the nature of the liability.
Changes in the Group's interests in a subsidiary that do not result in a loss of control are accounted for as equity transactions, whereby adjustments are made to the amounts of controlling and non-controlling interests within consolidated equity to reflect the change in relative interests, but no adjustments are made to goodwill and no gain or loss is recognised.
When the Group loses control of a subsidiary, it is accounted for as a disposal of the entire interest in that subsidiary, with a resulting gain or loss being recognised in profit or loss. Any interest retained in that former subsidiary at the date when control is lost is recognised at fair value and this amount is regarded as the fair value on initial recognition of a financial asset or, when appropriate, the cost on initial recognition of an investment in an associate or a joint venture.
In the Company's statement of financial position, an investment in a subsidiary is stated at cost less impairment losses (see note 2(j)), unless the investment is classified as held for sale (or included in a disposal group that is classified as held for sale). - Goodwill
Goodwill represents the excess of - the aggregate of the fair value of the consideration transferred, the amount of any non-controlling interest in the acquiree and the fair value of the Group's previously held equity interest in the acquiree; over
- the net fair value of the acquiree identifiable assets and liabilities measured as at the acquisition date.
When (ii) is greater than (i), then this excess is recognised immediately in profit or loss as a gain on a bargain purchase.
Goodwill is stated at cost less accumulated impairment losses. Goodwill arising on a business combination is allocated to each cash-generating unit, or groups of cash generating units, that is expected to benefit from the synergies of the combination and is tested annually for impairment (see note 2(j)).
On disposal of a cash generating unit during the year, any attributable amount of purchased goodwill is included in the calculation of the profit or loss on disposal.
060 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
-
Investment properties
Investment properties are land and/or buildings which are owned or held under a leasehold interest to earn rental income and/or for capital appreciation. These include land held for a currently undetermined future use and property that is being constructed or developed for future use as investment property.
Investment properties are stated at fair value, unless they are still in the course of construction or development at the end of the reporting period and their fair value cannot be reliably measured at that time. Any gain or loss arising from a change in fair value or from the retirement or disposal of an investment property is recognised in profit or loss. Rental income from investment properties is accounted for as described in note 2(r)(iii).
In the comparative period, when the Group held a property interest under an operating lease and used the property to earn rental income and/or for capital appreciation, the Group could elect on a property- by-property basis to classify and account for such interest as an investment property. Any such property interest which had been classified as an investment property was accounted for as if it were held under a finance lease (see note 2(i)), and the same accounting policies were applied to that interest as were applied to other investment properties leased under finance leases. Lease payments were accounted for as described in note 2(i). - Property, plant and equipment
Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses (see note 2(j)).
Gains or losses arising from the retirement or disposal of an item of property, plant and equipment are determined as the difference between the net disposal proceeds and the carrying amount of the item and are recognised in profit or loss on the date of retirement or disposal.
Depreciation is calculated to write off the cost of items of property, plant and equipment and other properties leased for own use less their estimated residual value, if any, using the straight line method over their estimated useful lives as follows: - Leasehold land is depreciated over the unexpired term of lease.
- The Group's interest in buildings situated on leasehold land and other properties leased for
own use are depreciated over the shorter of the unexpired term of lease and the buildings' estimated useful lives.
- Leasehold improvements
- Equipment and machinery
- Furniture and fixtures
- Motor vehicles
- Computers
Where parts of an item of property, plant and equipment have different useful lives, the cost of the item is allocated on a reasonable basis between the parts and each part is depreciated separately. Both the useful life of an asset and its residual value, if any, are reviewed annually.
ANNUAL REPORT 2019/20 061
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
-
Intangible assets (other than goodwill)
Intangible assets that are acquired by the Group are stated at cost less accumulated amortisation (where the estimated useful life is finite) and impairment losses (see note 2(j)). Intangible assets, if acquired in a business combination, are measured at fair value at acquisition date.
Amortisation of intangible assets with finite useful lives is charged to profit or loss on a straight-line basis over the assets' estimated useful lives. The following intangible assets with finite useful lives are amortised from the date they are available for use and their estimated useful lives are as follows:
- | Customer relationship | 6 years |
Both the period and method of amortisation are reviewed annually.
Intangible assets are not amortised while their useful lives are assessed to be indefinite. Any conclusion that the useful life of an intangible asset is indefinite is reviewed annually to determine whether events and circumstances continue to support the indefinite useful life assessment for that asset. If they do not, the change in the useful life assessment from indefinite to finite is accounted for prospectively from the date of change and in accordance with the policy for amortisation of intangible assets with finite lives as set out above.
-
Leased assets
At inception of a contract, the Group assesses whether the contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Control is conveyed where the customer has both the right to direct the use of the identified asset and to obtain substantially all of the economic benefits from that use. - As a lessee
-
Policy applicable from 1 April 2019
At the lease commencement date, the Group recognises a right-of-use asset and a lease liability, except for short-term leases that have a lease term of 12 months. The lease payments associated with those leases which are not capitalised are recognised as an expense on a systematic basis over the lease term.
Where the lease is capitalised, the lease liability is initially recognised at the present value of the lease payments payable over the lease term, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, using a relevant incremental borrowing rate. After initial recognition, the lease liability is measured at amortised cost and interest expense is calculated using the effective interest method. Variable lease payments that do not depend on an index or rate are not included in the measurement of the lease liability and hence are charged to profit or loss in the accounting period in which they are incurred.
-
Policy applicable from 1 April 2019
062 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
- Leased assets (continued)
- As a lessee (continued)
-
Policy applicable from 1 April 2019 (continued)
The right-of-use asset recognised when a lease is capitalised is initially measured at cost, which comprises the initial amount of the lease liability plus any lease payments made at or before the commencement date, and any initial direct costs incurred. Where applicable, the cost of the right-of-use assets also includes an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, discounted to their present value, less any lease incentives received. The right-of-use asset is subsequently stated at cost less accumulated depreciation and impairment losses (see notes 2(g) and 2(j)(ii)), except for the following types of right-of-use asset:
-
Policy applicable from 1 April 2019 (continued)
- right-of-useassets that meet the definition of investment property are carried at fair value in accordance with note 2(f).
The lease liability is remeasured when there is a change in future lease payments arising from a change in an index or rate, or there is a change in the Group's estimate of the amount expected to be payable under a residual value guarantee, or there is a change arising from the reassessment of whether the Group will be reasonably certain to exercise a purchase, extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.
The Groups presents right-of-use assets that do not meet the definition of an investment property in property, plant and equipment and presents lease liabilities separately.
-
Policy applicable prior to 1 April 2019
In the comparative period, as a lessee the Group classified leases as finance leases if the leases transferred substantially all the risks and rewards of ownership to the Group. Leases which did not transfer substantially all the risks and rewards of ownership to the Group were classified as operating leases.
Where the Group had the use of assets held under operating leases, payments made under the leases were charged to profit or loss in equal instalments over the accounting periods covered by the lease term, except where an alternative basis was more representative of the pattern of benefits to be derived from the leased asset. Lease incentives received were recognised in profit or loss as an integral part of the aggregate net lease payments made. Contingent rentals were charged to profit or loss in the accounting period in which they were incurred.
ANNUAL REPORT 2019/20 063
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
- Leased assets (continued)
-
As a lessor
When the Group acts as a lessor, it determines at lease inception whether each lease is a finance lease or an operating lease. A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to the ownership of an underlying assets to the lessee. If this is not the case, the lease is classified as an operating lease.
-
As a lessor
When a contract contains lease and non-lease components, the Group allocates the consideration in the contract to each component on a relative stand-alone selling price basis. The rental income from operating leases is recognised in accordance with note 2(r)(iii).
- Credit losses and impairment of assets
-
Credit losses from financial instruments and lease receivables
The Group recognises a loss allowance for expected credit losses ("ECLs") on financial assets measured at amortised cost (including cash and cash equivalents, trade and other receivables) and lease receivables.
Measurement of ECLs
ECLs are a probability-weighted estimate of credit losses. Credit losses are measured as the present value of all expected cash shortfalls (i.e. the difference between the cash flows due to the Group in accordance with the contract and the cash flows that the Group expects to receive).
Expected cash shortfalls of trade and other receivables are discounted using the effective interest rate determined at initial recognition or an approximation thereof, while lease receivables are discounted using the discount rate used in the measurement of the lease receivable.
The maximum period considered when estimating ECLs is the maximum contractual period over which the Group is exposed to credit risk.
In measuring ECLs, the Group takes into account reasonable and supportable information that is available without undue cost or effort. This includes information about past events, current conditions and forecasts of future economic conditions.
-
Credit losses from financial instruments and lease receivables
064 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
- Credit losses and impairment of assets (continued)
-
Credit losses from financial instruments and lease receivables (continued) Measurement of ECLs (continued)
ECLs are measured on either of the following bases: - 12-monthECLs: these are losses that are expected to result from possible default events within the 12 months after the reporting date; and
- lifetime ECLs: these are losses that are expected to result from all possible default events over the expected lives of the items to which the ECL model applies.
-
Credit losses from financial instruments and lease receivables (continued) Measurement of ECLs (continued)
Loss allowances for trade receivables and lease receivables are always measured at an amount equal to lifetime ECLs. ECLs on these financial assets are estimated using a provision matrix based on the Group's historical credit loss experience, adjusted for factors that are specific to the debtors and an assessment of both the current and forecast general economic conditions at the reporting date.
Significant increases in credit risk
In assessing whether the credit risk of a financial instrument (including a loan commitment) has increased significantly since initial recognition, the Group compares the risk of default occurring on the financial instrument assessed at the reporting date with that assessed at the date of initial recognition. In making this reassessment, the Group considers that a default event occurs when (i) the borrower is unlikely to pay its credit obligations to the Group in full, without recourse by the Group to actions such as realising security (if any is held); or (ii) the financial asset is 90 days past due. The Group considers both quantitative and qualitative information that is reasonable and supportable, including historical experience and forward-looking information that is available without undue cost or effort.
In particular, the following information is taken into account when assessing whether credit risk has increased significantly since initial recognition:
- failure to make payments of principal or interest on their contractually due dates;
- an actual or expected significant deterioration in a financial instrument's external or internal credit rating (if available);
- an actual or expected significant deterioration in the operating results of the debtor; and
- existing or forecast changes in the technological, market, economic or legal environment that have a significant adverse effect on the debtor's ability to meet its obligation to the Group.
Depending on the nature of the financial instruments, the assessment of a significant increase in credit risk is performed on either an individual basis or a collective basis. When the assessment is performed on a collective basis, the financial instruments are grouped based on shared credit risk characteristics, such as past due status and credit risk ratings.
ANNUAL REPORT 2019/20 065
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
- Credit losses and impairment of assets (continued)
-
Credit losses from financial instruments and lease receivables (continued) Significant increases in credit risk (continued)
ECLs are remeasured at each reporting date to reflect changes in the financial instrument's credit risk since initial recognition. Any change in the ECL amount is recognised as an impairment gain or loss in profit or loss. The Group recognises an impairment gain or loss for all financial instruments with a corresponding adjustment to their carrying amount through a loss allowance account.
Basis of calculation of interest income
Interest income recognised in accordance with note 2(r)(iv) is calculated based on the gross carrying amount of the financial asset unless the financial asset is credit-impaired, in which case interest income is calculated based on the amortised cost (i.e. the gross carrying amount less loss allowance) of the financial asset.
At each reporting date, the Group assesses whether a financial asset is credit-impaired. A financial asset is credit-impaired when one or more events that have a detrimental impact on the estimated future cash flows of the financial asset have occurred.
Evidence that a financial asset is credit-impaired includes the following observable events: - significant financial difficulties of the debtor;
- a breach of contract, such as a default or past due event;
- it becoming probable that the borrower will enter into bankruptcy or other financial reorganisation;
- significant changes in the technological, market, economic or legal environment that have an adverse effect on the debtor; or
- the disappearance of an active market for a security because of financial difficulties of the issuer.
-
Credit losses from financial instruments and lease receivables (continued) Significant increases in credit risk (continued)
Write-off policy
The gross carrying amount of a financial asset or lease receivable is written off (either partially or in full) to the extent that there is no realistic prospect of recovery. This is generally the case when the Group determines that the debtor does not have assets or sources of income that could generate sufficient cash flows to repay the amounts subject to the write-off.
Subsequent recoveries of an asset that was previously written off are recognised as a reversal of impairment in profit or loss in the period in which the recovery occurs.
066 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
- Credit losses and impairment of assets (continued)
-
Impairment of other non-current assets
Internal and external sources of information are reviewed at the end of each reporting period to identify indications that the following assets may be impaired or, except in the case of goodwill, an impairment loss previously recognised no longer exists or may have decreased: - property, plant and equipment;
- intangible assets;
- goodwill; and
- investments in subsidiaries in the Company's statement of financial position.
-
Impairment of other non-current assets
If any such indication exists, the asset's recoverable amount is estimated. In addition, for goodwill, intangible assets that are not yet available for use and intangible assets that have indefinite useful lives, the recoverable amount is estimated annually whether or not there is any indication of impairment.
-
Calculation of recoverable amount
The recoverable amount of an asset is the greater of its fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. Where an asset does not generate cash inflows largely independent of those from other assets, the recoverable amount is determined for the smallest group of assets that generates cash inflows independently (i.e. a cash-generating unit). - Recognition of impairment losses
An impairment loss is recognised in profit or loss if the carrying amount of an asset, or the cash-generating unit to which it belongs, exceeds its recoverable amount. Impairment losses recognised in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to the cash-generating unit (or group of units) and then, to reduce the carrying amount of the other assets in the unit (or group of units) on a pro rata basis, except that the carrying value of an asset will not be reduced below its individual fair value less costs of disposal (if measurable) or value in use (if determinable). - Reversals of impairment losses
In respect of assets other than goodwill, an impairment loss is reversed if there has been a favourable change in the estimates used to determine the recoverable amount. An impairment loss in respect of goodwill is not reversed.
A reversal of an impairment loss is limited to the asset's carrying amount that would have been determined had no impairment loss been recognised in prior years. Reversals of impairment losses are credited to profit or loss in the year in which the reversals are recognised.
ANNUAL REPORT 2019/20 067
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
-
Inventories
Inventories are assets which are held for sale in the ordinary course of business, or in the form of materials or supplies to be consumed in the rendering of services.
Inventories are carried at the lower of cost and net realisable value.
Cost is calculated using the weighted average cost formula and comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition.
Net realisable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale.
When inventories are sold, the carrying amount of those inventories is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of inventories to net realisable value and all losses of inventories are recognised as an expense in the period the write-down or loss occurs. The amount of any reversal of any write-down of inventories is recognised as a reduction in the amount of inventories recognised as an expense in the period in which the reversal occurs. - Trade and other receivables
A receivable is recognised when the Group has an unconditional right to receive consideration. A right to receive consideration is unconditional if only the passage of time is required before payment of that consideration is due.
Receivables are stated at amortised cost using the effective interest method less allowance for credit losses (see note 2(j)(i)). - Trade and other payables
Trade and other payables are initially recognised at fair value and are subsequently stated at amortised cost unless the effect of discounting would be immaterial, in which case they are stated at cost. - Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other financial institutions, and short-term, highly liquid investments that are readily convertible into known amounts of cash and which are subject to an insignificant risk of changes in value, having been within three months of maturity at acquisition. Cash and cash equivalents are assessed for ECL in accordance with the policy set out in note 2(j)(i).
068 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
- Employee benefits
-
Short term employee benefits and contributions to defined contribution retirement plans
Salaries, annual bonuses, paid annual leave, contributions to defined contribution retirement plans, including those payables in Australia, Hong Kong, Singapore, Malaysia, the People's Republic of China (the "PRC") and Taiwan, and the cost of non-monetary benefits are accrued in the year in which the associated services are rendered by employees. Where payment or settlement is deferred and the effect would be material, these amounts are stated at their present values. - Defined contribution retirement plans
The Group operates a mandatory provident fund scheme (the "MPF Scheme") under the Hong Kong Mandatory Provident Fund Schemes Ordinance for all qualifying employees in Hong Kong. The Group's contributions to the MPF Scheme are calculated at 5% of the salaries and wages subject to a monthly maximum amount of contribution of HK$1,500 per employee and vest fully with employees when contributed into the MPF Scheme.
The Group's subsidiaries established in Singapore are required to make contributions to defined contribution retirement benefit plans are recognised as an expense as they fall due. The entity's legal or constructive obligation is limited to the amount that it agrees to contribute to an independently administered fund which is the Central Provident Fund in Singapore (a government managed retirement benefit plan).
The Group's subsidiaries established in Australia and Malaysia are required to make contributions to respective defined contribution plans, which are charged to profit or loss in the financial year to which they relate.
The employees of the Group's subsidiaries established in the PRC are members of a central pension scheme operated by the local municipal government. These subsidiaries are required to contribute certain percentage of the employees' basic salaries and wages to the central pension scheme to fund the retirement benefits. The local municipal government undertakes to assume the retirement benefits obligations of all existing and future retired employees of these subsidiaries. The only obligation of these subsidiaries with respect to the central pension scheme is to meet the required contributions under the scheme.
A subsidiary company and branches of subsidiary companies of the Group in Taiwan have a defined contribution scheme governed by the Taiwan Labor Pension Act. Under the scheme, a subsidiary company and branches of subsidiary companies of the Group in Taiwan contribute monthly to the Bureau of Labor Insurance 6% of the payroll of the employees who choose to participate in the scheme. Contributions to the scheme vest immediately. - Termination benefits
-
Short term employee benefits and contributions to defined contribution retirement plans
Termination benefits are recognised at the earlier of when the Group can no longer withdraw the offer of those benefits and when it recognises restructuring costs involving the payment of termination benefits.
ANNUAL REPORT 2019/20 069
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
-
Income tax
Income tax for the year comprises current tax and movements in deferred tax assets and liabilities. Current tax and movements in deferred tax assets and liabilities are recognised in profit or loss except to the extent that they relate to items recognised in other comprehensive income or directly in equity, in which case the relevant amounts of tax are recognised in other comprehensive income or directly in equity, respectively.
Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the end of the reporting period, and any adjustment to tax payable in respect of previous years.
Deferred tax assets and liabilities arise from deductible and taxable temporary differences respectively, being the differences between the carrying amounts of assets and liabilities for financial reporting purposes and their tax bases. Deferred tax assets also arise from unused tax losses and unused tax credits.
Apart from certain limited exceptions, all deferred tax liabilities, and all deferred tax assets to the extent that it is probable that future taxable profits will be available against which the asset can be utilised, are recognised. Future taxable profits that may support the recognition of deferred tax assets arising from deductible temporary differences include those that will arise from the reversal of existing taxable temporary differences, provided those differences relate to the same taxation authority and the same taxable entity, and are expected to reverse either in the same period as the expected reversal of the deductible temporary difference or in periods into which a tax loss arising from the deferred tax asset can be carried back or forward. The same criteria are adopted when determining whether existing taxable temporary differences support the recognition of deferred tax assets arising from unused tax losses and credits, that is, those differences are taken into account if they relate to the same taxation authority and the same taxable entity, and are expected to reverse in a period, or periods, in which the tax loss or credit can be utilised.
The limited exceptions to recognition of deferred tax assets and liabilities are those temporary differences arising from goodwill not deductible for tax purposes, the initial recognition of assets or liabilities that affect neither accounting nor taxable profit (provided they are not part of a business combination), and temporary differences relating to investments in subsidiaries to the extent that, in the case of taxable differences, the Group controls the timing of the reversal and it is probable that the differences will not reverse in the foreseeable future, or in the case of deductible differences, unless it is probable that they will reverse in the future.
Where investment properties are carried at their fair value in accordance with the accounting policy set out in note 2(f), the amount of deferred tax recognised is measured using the tax rates that would apply on sales of those assets at their carrying value at the reporting date unless the property is depreciable and is held within a business model whose objective is to consume substantially all of the economic benefits embodied in the property over time, rather than through sale. In all other cases, the amount of deferred tax recognised is measured based on the expected manner of realisation or settlement of the carrying amount of the assets and liabilities, using tax rates enacted or substantively enacted at the end of the reporting period. Deferred tax assets and liabilities are not discounted.
The carrying amount of a deferred tax asset is reviewed at the end of each reporting period and is reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow the related tax benefit to be utilised. Any such reduction is reversed to the extent that it becomes probable that sufficient taxable profits will be available.
070 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
-
Income tax (continued)
Additional income taxes that arise from the distribution of dividends are recognised when the liability to pay the related dividends is recognised.
Current tax balances and deferred tax balances, and movements therein, are presented separately from each other and are not offset. Current tax assets are offset against current tax liabilities, and deferred tax assets against deferred tax liabilities, if the Company or the Group has the legally enforceable right to set off current tax assets against current tax liabilities and the following additional conditions are met: - in the case of current tax assets and liabilities, the Company or the Group intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously; or
- in the case of deferred tax assets and liabilities, if they relate to income taxes levied by the same taxation authority on either:
- the same taxable entity; or
- different taxable entities, which, in each future period in which significant amounts of deferred tax liabilities or assets are expected to be settled or recovered, intend to realise the current tax assets and settle the current tax liabilities on a net basis or realise and settle simultaneously.
-
Provisions and contingent liabilities
Provisions are recognised when the Group or the Company has a legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. Where the time value of money is material, provisions are stated at the present value of the expenditure expected to settle the obligation.
Where it is not probable that an outflow of economic benefits will be required, or the amount cannot be estimated reliably, the obligation is disclosed as a contingent liability, unless the probability of outflow of economic benefits is remote. Possible obligations, whose existence will only be confirmed by the occurrence or non-occurrence of one or more future events are also disclosed as contingent liabilities unless the probability of outflow of economic benefits is remote. - Revenue and other income
Income is classified by the Group as revenue when it arises from the sale of goods, the provision of services or the use by others of the Group's assets under leases in the ordinary course of the Group's business.
Revenue is recognised when control over a product or service is transferred to the customer, or the lessee has the right to use the asset, at the amount of promised consideration to which the Group is expected to be entitled, excluding those amounts collected on behalf of third parties. Revenue excludes value added tax or other sales taxes and is after deduction of any trade discounts.
ANNUAL REPORT 2019/20 071
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
-
Revenue and other income (continued)
Further details of the Group's revenue and other income recognition policies are as follows: - Sale of skincare and wellness products
Revenue is recognised when goods are delivered to the customers which is taken to be the point in time when the customer takes possession of and accepts the products. - Provision of beauty and wellness services
The Group sells prepaid packages for beauty and wellness services which comprise multiple numbers of treatments.
Revenue from the rendering of services is recognised when the services have been rendered to customers.
Prepaid packages sold are non-refundable and customers may not exercise all of their contractual rights within the contract period of one year. Those unexercised contractual rights are referred to as "breakage". An expected breakage amount is determined by historical experience and is recognised as revenue in proportion to the pattern of rights exercised by the customers.
In respect of the value of the prepaid beauty and wellness services for which the related services have not yet been rendered and have not yet expired, adjusted for breakage, is recorded as deferred revenue in the consolidated financial statements.
Any residual deferred revenue at the end of the contractual service period is fully recognised in profit or loss. - Rental income from operating leases
Rental income receivable under operating leases is recognised in profit or loss in equal instalments over the periods covered by the lease term, except where an alternative basis is more representative of the pattern of benefits to be derived from the use of the leased asset. Lease incentives granted are recognised in profit or loss as an integral part of the aggregate net lease payments receivable. Variable lease payments that do not depend on an index or a rate are recognised as income in the accounting period in which they are earned. - Interest income
Interest income is recognised as it accrues using the effective interest method. For financial assets measured at amortised cost or fair value through other comprehensive income (recycling) that are not credit-impaired, the effective interest rate is applied to the gross carrying amount of the asset. For credit-impaired financial assets, the effective interest rate is applied to the amortised cost (i.e. gross carrying amount net of loss allowance) of the asset (see note 2(j)(i)).
- Sale of skincare and wellness products
072 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
- Revenue and other income (continued)
-
Government grants
Government grants are recognised in the statement of financial position initially when there is reasonable assurance that they will be received and that the Group will comply with the conditions attaching to them. Grants that compensate the Group for expenses incurred are recognised as income in profit or loss on a systematic basis in the same periods in which the expenses are incurred. Grants that compensate the Group for the cost of an asset are deducted from the carrying amount of the asset and consequently are effectively recognised in profit or loss over the useful life of the asset by way of reduced depreciation expense. - Commission income
Commission income is recognised when services are rendered.
-
Government grants
- Translation of foreign currencies
Foreign currency transactions during the year are translated into Hong Kong dollars at the foreign exchange rates ruling at the transaction dates. Monetary assets and liabilities denominated in foreign currencies are translated into Hong Kong dollars at the foreign exchange rates ruling at the end of the reporting period. Exchange gains and losses are recognised in profit or loss.
Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated into Hong Kong dollars using the foreign exchange rates ruling at the transaction dates. Non- monetary assets and liabilities denominated in foreign currencies that are stated at fair value are translated into Hong Kong dollars using the foreign exchange rates ruling at the dates the fair value was measured.
The results of foreign operations are translated into Hong Kong dollars at the exchange rates approximating the foreign exchange rates ruling at the dates of the transactions. Statement of financial position items, including goodwill arising on consolidation of foreign operations acquired, are translated into Hong Kong dollars at the closing foreign exchange rates at the end of the reporting period. The resulting exchange differences are recognised in other comprehensive income and accumulated separately in equity in the exchange reserve.
On disposal of a foreign operation, the cumulative amount of the exchange differences relating to that foreign operation is reclassified from equity to profit or loss when the profit or loss on disposal is recognised. - Related parties
- A person, or a close member of that person's family, is related to the Group if that person:
- has control or joint control over the Group;
- has significant influence over the Group; or
- is a member of the key management personnel of the Group or the Group's parent.
ANNUAL REPORT 2019/20 073
NOTES TO THE
FINANCIAL STATEMENTS
2 Significant accounting policies (continued)
- Related parties (continued)
- An entity is related to the Group if any of the following conditions applies:
- The entity and the Group are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others).
- One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member).
- Both entities are joint ventures of the same third party.
- One entity is a joint venture of a third entity and the other entity is an associate of the third entity.
- The entity is a post-employment benefit plan for the benefit of employees of either the Group or an entity related to the Group.
- The entity is controlled or jointly controlled by a person identified in (a).
- A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity).
- The entity, or any member of a group of which it is a part, provides key management personnel services to the Group or to the Group's parent.
Close members of the family of a person are those family members who may be expected to influence, or be influenced by, that person in their dealings with the entity.
-
Segment reporting
Operating segments, and the amounts of each segment item reported in the financial statements, are identified from the financial information provided regularly to the Group's most senior executive management for the purposes of allocating resources to, and assessing the performance of, the Group's various lines of business and geographical locations.
Individually material operating segments are not aggregated for financial reporting purposes unless the segments have similar economic characteristics and are similar in respect of the nature of products and services, the nature of production processes, the type or class of customers, the methods used to distribute the products or provide the services, and the nature of the regulatory environment. Operating segments which are not individually material may be aggregated if they share a majority of these criteria.
3 Segment information
The Group has two reportable segments as follows:
Beauty and wellness services | - | Provision of beauty and wellness services |
Skincare and wellness products | - | Sales of skincare and wellness products |
074 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
3 Segment information (continued)
The Group's reportable segments are strategic business units that offer different products and services. They are managed separately because each business requires different technology and marketing strategies. Segment profits do not include other income, interest income and fair value changes on investment properties, unallocated costs, which comprise corporate administrative expenses, and income tax credit/expense. Segment assets do not include properties held for corporate uses, investment properties, deferred tax assets and tax recoverable. Segment liabilities do not include tax payable, deferred tax liabilities and amounts due to related companies and the ultimate controlling party.
- Information regarding the Group's reportable segments as provided to the Group's most senior executive management for the purposes of resource allocation and assessment of segment performance for the years ended 31 March 2020 and 2019 is set out below.
Beauty and | Skincare and | |||
wellness services | wellness products | Total | ||
HK$'000 | HK$'000 | HK$'000 | ||
Year ended 31 March 2020 | ||||
Revenue from external customers | 492,327 | 30,279 | 522,606 | |
Reportable segment (loss)/profit | (20,168) | 11,518 | (8,650) | |
Other segment information: | ||||
Additions to property, plant and equipment | 55,093 | 6,423 | 61,516 | |
Depreciation and amortisation | 68,200 | 3,730 | 71,930 | |
As at 31 March 2020 | ||||
Reportable segment assets | 561,132 | 19,485 | 580,617 | |
Reportable segment liabilities | 441,374 | 20,944 | 462,318 | |
Beauty and | Skincare and | |||
wellness services | wellness products | Total | ||
HK$'000 | HK$'000 | HK$'000 | ||
Year ended 31 March 2019 (Note) | ||||
Revenue from external customers | 543,147 | 32,870 | 576,017 | |
Reportable segment profit | 9,772 | 10,143 | 19,915 | |
Other segment information: | ||||
Additions to property, plant and equipment | 32,051 | 546 | 32,597 | |
Depreciation and amortisation | 14,116 | 1,148 | 15,264 | |
As at 31 March 2019 | ||||
Reportable segment assets | 532,553 | 9,462 | 542,015 | |
Reportable segment liabilities | 372,694 | 11,670 | 384,364 |
Note: The Group has initially applied HKFRS 16 at 1 April 2019 using the modified retrospective approach. Under this approach, comparative information is not restated. See note 2(c).
ANNUAL REPORT 2019/20 075
NOTES TO THE
FINANCIAL STATEMENTS
3 Segment information (continued)
- Reconciliations of reportable segment profit/(loss), assets and liabilities
2020 | 2019 | ||
(Note) | |||
HK$'000 | HK$'000 | ||
(Loss)/profit | |||
Reportable segment (loss)/profit | (8,650) | 19,915 | |
Other income | 6,858 | 3,067 | |
Interest income | 1,541 | 688 | |
Fair value change on investment properties | 110 | (90) | |
Unallocated costs | (27,499) | (30,544) | |
Income tax expense | (4,389) | (5,833) | |
Consolidated loss for the year | (32,029) | (12,797) | |
Assets | |||
Reportable segment assets | 580,617 | 542,015 | |
Properties held for corporate use | 13,668 | 13,938 | |
Investment properties | 13,920 | 13,810 | |
Deferred tax assets | 3,863 | 3,874 | |
Tax recoverable | 7,929 | 5,860 | |
Consolidated total assets | 619,997 | 579,497 | |
Liabilities | |||
Reportable segment liabilities | 462,318 | 384,364 | |
Tax payable | 4,910 | 7,690 | |
Deferred tax liabilities | 570 | 458 | |
Amounts due to related companies | 87 | 87 | |
Amount due to the ultimate controlling party | 2 | 2 | |
Consolidated total liabilities | 467,887 | 392,601 |
Note: The Group has initially applied HKFRS 16 at 1 April 2019 using the modified retrospective approach. Under this approach, comparative information is not restated. See note 2(c).
076 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
3 Segment information (continued)
-
Geographic information
The following table sets out information about the geographical location of (i) the Group's revenue from external customers and (ii) the Group's property, plant and equipment ("specified non-current assets"). The geographical location of customers is based on the location at which the services were provided or the goods delivered. The geographical location of the specified non-current asset is based on the physical location of the asset, in the case of property, plant and equipment. Specified non-current assets do not include investment properties, intangible assets, goodwill, deferred tax assets and deposits.
Revenue from | Specified | |||
external customers | non-current assets | |||
2020 | 2019 | 2020 | 2019 | |
(Note) | (Note) | |||
HK$'000 | HK$'000 | HK$'000 | HK$'000 | |
Hong Kong (place of domicile) | 451,329 | 491,232 | 121,904 | 76,633 |
PRC | 11,281 | 19,439 | 4,169 | 814 |
Singapore | 57,588 | 60,802 | 18,065 | 2,604 |
Malaysia | - | 285 | - | - |
Taiwan | - | 678 | - | - |
Australia | 2,408 | 3,581 | 236 | 401 |
522,606 | 576,017 | 144,374 | 80,452 |
Note: The Group has initially applied HKFRS 16 at 1 April 2019 using the modified retrospective approach. Under this approach, comparative information is not restated. See note 2(c).
4 Revenue
The principal activities of the Group are the provision of beauty and wellness services and sales of skincare and wellness products.
The amount of each significant category of revenue is as follows: | ||
2020 | 2019 | |
HK$'000 | HK$'000 | |
Revenue from contracts with customers within the scope of | ||
HKFRS 15 | ||
Revenue recognised from provision of beauty and wellness services and | ||
expiry of prepaid beauty packages | 492,327 | 543,147 |
Sales of skincare and wellness products | 30,279 | 32,870 |
522,606 | 576,017 |
Since all the revenue comprises revenue recognised from provision of beauty and wellness services and expiry of prepaid beauty packages and sales of skincare and wellness products transferred to customers at a point in time, no revenue derived from services transferred over time.
ANNUAL REPORT 2019/20 077
NOTES TO THE
FINANCIAL STATEMENTS
4 Revenue (continued)
Disaggregation of revenue from contracts with customers by geographical segment is disclosed in note 3(c).
5 | Other income | ||
2020 | 2019 | ||
HK$'000 | HK$'000 | ||
Income from provision of domestic helper agency services | 2,152 | - | |
Rent concessions received* | 1,200 | - | |
Net gain on disposals of property, plant and equipment | 560 | 107 | |
Rental income | 423 | 1,015 | |
Government grants | 167 | 234 | |
Compensation received | - | 932 | |
Others | 2,356 | 779 | |
6,858 | 3,067 |
- The Group has early adopted the amendment to HKFRS 16 relating to COVID-19-Related Rent Concessions to all rent concessions that meet the conditions set out in note 2(c).
6 | Loss before taxation | |||
Loss before taxation is arrived at after charging: | ||||
(a) | Employee benefit expenses | |||
2020 | 2019 | |||
HK$'000 | HK$'000 | |||
Salaries, wages and other benefits | 295,466 | 301,534 | ||
Contributions to defined contribution retirement plans | 16,266 | 17,553 | ||
311,732 | 319,087 | |||
(b) | Other items | |||
2020 | 2019 | |||
HK$'000 | (Note) | |||
HK$'000 | ||||
Finance costs - interest on lease liabilities (note 20(b)) | 2,896 | - | ||
Auditor's remuneration | 4,252 | 3,157 | ||
Occupancy costs | ||||
- Total minimum lease payments for leases previously | - | |||
classified as operating leases under HKAS 17 | 114,450 | |||
- Short-term lease payments not included in the measurement | 43,843 | - | ||
of lease liabilities |
Note: The Group has initially applied HKFRS 16 at 1 April 2019 using the modified retrospective approach. Under this approach, comparative information is not restated. See note 2(c).
078 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
7 Income tax in the consolidated statement of profit or loss
- Taxation in the consolidated statement of profit or loss represents:
2020 | 2019 | ||
HK$'000 | HK$'000 | ||
Current tax - Hong Kong Profits Tax | |||
Provision for the year | 1,499 | 4,010 | |
Under/(over)-provision in respect of prior years | 1,063 | (130) | |
2,562 | 3,880 | ||
Current tax - Overseas | |||
Provision for the year | 1,768 | 2,007 | |
Under/(over)-provision in respect of prior years | 59 | (54) | |
1,827 | 1,953 | ||
4,389 | 5,833 |
The provision for Hong Kong Profits Tax for 2020 is calculated at 16.5% (2019: 16.5%) of the estimated assessable profits for the year, except for one subsidiary of the Group which is a qualifying corporation under the two-tiered Profits Tax rate regime.
For this subsidiary, the first HK$2 millions of assessable profits are taxed at 8.25% and the remaining assessable profits are taxed at 16.5%.
The provision for Hong Kong Profits Tax for 2020 is taken into account a reduction granted by the Hong Kong SAR Government of 75% of the tax payable for the year of assessment 2018-19 subject to a maximum reduction of HK$30,000 for each business (2019: a maximum reduction of HK$30,000 was granted for the year of assessment 2017-18 and was taken into account in calculating the provision for 2019).
Taxation for overseas subsidiaries is charged at the appropriate current rates of taxation ruling in the relevant countries.
ANNUAL REPORT 2019/20 079
NOTES TO THE
FINANCIAL STATEMENTS
7 Income tax in the consolidated statement of profit or loss (continued)
- Reconciliation between the tax expenses and accounting loss at applicable tax rates:
2020 | 2019 | |||
HK$'000 | HK$'000 | |||
Loss before taxation | (27,640) | (6,964) | ||
Notional tax on loss before taxation | (4,560) | (1,149) | ||
Effect of different tax rates of subsidiaries | (232) | 116 | ||
Tax effect of tax exemption | (697) | (405) | ||
Tax effect of non-taxable income | (299) | (685) | ||
Tax effect of non-deductible expenses | 2,454 | 762 | ||
Tax effect of utilisation of tax losses previously not recognised | (20) | (22) | ||
Tax effect of tax losses not recognised | 5,975 | 8,333 | ||
Tax effect of temporary differences not recognised | (792) | (286) | ||
Under/(over)-provision in respect of prior years | 1,122 | (184) | ||
Others | 1,438 | (647) | ||
Actual tax expenses | 4,389 | 5,833 | ||
8 Directors' emoluments
Directors' emoluments disclosed with reference to section 383(1) of the Hong Kong Companies Ordinance and Part
2 of the Companies (Disclosure of Information about Benefits of Directors) Regulation are as follows:
2020 | |||||
Contributions | |||||
to defined | |||||
Salaries and | contributions | ||||
Directors' | other benefits | retirement | |||
Name of Director | fees | in kind | plan | Total | |
HK$'000 | HK$'000 | HK$'000 | HK$'000 | ||
Tsang Yue, Joyce | - | 9,822 | 73 | 9,895 | |
Yip Kai Wing | - | 634 | 18 | 652 | |
Yeung See Man | - | 750 | 18 | 768 | |
Liu Mei Ling, Rhoda | 324 | - | - | 324 | |
Wong Man Hin, Raymond | 264 | - | - | 264 | |
Hong Po Kui, Martin | 264 | - | - | 264 | |
Lam Tak Leung | |||||
(resigned on 1 March 2020) | 242 | - | - | 242 | |
1,094 | 11,206 | 109 | 12,409 |
080 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
8 | Directors' emoluments (continued) | ||||
2019 | |||||
Contributions | |||||
to defined | |||||
Salaries and | contributions | ||||
Directors' | other benefits | retirement | |||
Name of Director | fees | in kind | plan | Total | |
HK$'000 | HK$'000 | HK$'000 | HK$'000 | ||
Tsang Yue, Joyce | - | 9,785 | 74 | 9,859 | |
Yip Kai Wing | - | 632 | 18 | 650 | |
Yeung See Man | - | 756 | 18 | 774 | |
Liu Mei Ling, Rhoda | 324 | - | - | 324 | |
Wong Man Hin, Raymond | 264 | - | - | 264 | |
Hong Po Kui, Martin | 264 | - | - | 264 | |
Lam Tak Leung | 264 | - | - | 264 | |
1,116 | 11,173 | 110 | 12,399 |
9 Individuals with highest emoluments
Of the five individuals with the highest emoluments, one (2019: one) is the director whose emolument is disclosed
in note 8. The aggregate of the emoluments in respect of the other four (2019: four) individuals are as follows:
2020 | 2019 | |
HK$'000 | HK$'000 | |
Salaries and other benefits in kind | 5,895 | 5,882 |
Contributions to defined contribution retirement plan | 137 | 152 |
6,032 | 6,034 |
The emoluments of the four (2019: four) individuals with the highest emoluments are within the following bands:
Number of individuals | |||
2020 | 2019 | ||
Nil-HK$1,000,000 | 2 | 2 | |
HK$1,000,001-HK$1,500,000 | - | - | |
HK$1,500,001-HK$2,000,000 | 1 | 1 | |
HK$2,000,001-HK$2,500,000 | 1 | 1 | |
4 | 4 |
During the year, no emoluments were paid by the Group to any of the directors or the highest paid individuals as an inducement to join or upon joining the Group or as compensation for loss of office (2019: Nil).
ANNUAL REPORT 2019/20 081
NOTES TO THE
FINANCIAL STATEMENTS
10 Loss per share
The calculation of basic loss per share is based on the loss attributable to ordinary equity shareholders of the Company of HK$31,590,000 (2019: loss attributable to ordinary equity shareholders of the Company of HK$13,289,000) and the weighted average number of 904,483,942 ordinary shares (2019: weighted average number of 904,483,942 ordinary shares) in issue during the year. Diluted loss per share is the same as basic loss per share as there were no dilutive potential shares in issue throughout the years ended 31 March 2019 and 2020.
11 Property, plant and equipment and right-of-use assets
Ownership | |||||||||
interests in | Other | ||||||||
leasehold land | properties | ||||||||
and buildings held | Leasehold | Equipment | Furniture | Motor | leased for | ||||
for own use | improvements | and machinery | and fixtures | vehicles | Computers | own use | Total | ||
HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | ||
Cost: | |||||||||
At 1 April 2018 | 15,886 | 184,636 | 94,745 | 4,494 | 17,720 | 12,068 | - | 329,549 | |
Additions | - | 24,323 | 8,074 | - | - | 200 | - | 32,597 | |
Disposals/written off | - | (26,074) | (4,505) | (39) | (304) | (249) | - | (31,171) | |
Exchange differences | - | (1,019) | (712) | (37) | (40) | (27) | - | (1,835) | |
At 31 March 2019 | 15,886 | 181,866 | 97,602 | 4,418 | 17,376 | 11,992 | - | 329,140 | |
Impact on initial application of | |||||||||
HKFRS 16 (Note) | - | - | - | - | - | - | 87,327 | 87,327 | |
At 1 April 2019 | 15,886 | 181,866 | 97,602 | 4,418 | 17,376 | 11,992 | 87,327 | 416,467 | |
Additions | - | 12,045 | 6,782 | 11 | 1,091 | 67 | 41,520 | 61,516 | |
Disposals/written off | - | - | (144) | - | (1,799) | - | (2,103) | (4,046) | |
Exchange differences | - | (1,855) | (1,271) | (113) | (178) | (36) | (1,607) | (5,060) | |
At 31 March 2020 | 15,886 | 192,056 | 102,969 | 4,316 | 16,490 | 12,023 | 125,137 | 468,877 | |
Accumulated depreciation and | |||||||||
impairment losses: | |||||||||
At 1 April 2018 | 1,214 | 141,714 | 86,402 | 4,366 | 17,459 | 9,634 | - | 260,789 | |
Charge for the year | 502 | 8,364 | 5,189 | 26 | 194 | 777 | - | 15,052 | |
Written back on disposals/written off | - | (26,074) | (3,855) | (39) | (304) | (179) | - | (30,451) | |
Impairment loss | - | 5,103 | - | - | - | - | - | 5,103 | |
Exchange differences | - | (1,092) | (619) | (36) | (37) | (21) | - | (1,805) | |
At 31 March 2019 and 1 April 2019 | 1,716 | 128,015 | 87,117 | 4,317 | 17,312 | 10,211 | - | 248,688 | |
Charge for the year | 502 | 16,737 | 5,442 | 16 | 90 | 529 | 48,417 | 71,733 | |
Written back on disposals/written off | - | - | (144) | - | (1,799) | - | (386) | (2,329) | |
Impairment loss | - | 7,823 | - | - | - | - | 2,110 | 9,933 | |
Exchange differences | - | (1,701) | (1,165) | (111) | (131) | (33) | (381) | (3,522) | |
At 31 March 2020 | 2,218 | 150,874 | 91,250 | 4,222 | 15,472 | 10,707 | 49,760 | 324,503 | |
Carrying amount: | |||||||||
At 31 March 2020 | 13,668 | 41,182 | 11,719 | 94 | 1,018 | 1,316 | 75,377 | 144,374 | |
At 31 March 2019 | 14,170 | 53,851 | 10,485 | 101 | 64 | 1,781 | - | 80,452 |
Note: The Group has initially applied HKFRS 16 using the modified retrospective method and adjusted the opening balances at 1 April 2019 to recognise right-of-use assets relating to leases which were previously classified as operating leases under HKAS 17. See note 2(c).
082 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
11 Property, plant and equipment and right-of-use assets (continued)
- As of 31 March 2020 and 2019 the Group's land and buildings at their carrying amounts are situated in Hong Kong under medium-term leases.
- Impairment loss on property, plant and equipment
During the year ended 31 March 2020, the Group conducted a review of its property, plant and equipment and determined that the recoverable amount of certain property, plant and equipment and right-of-use assets are estimated to be less than its carrying amount. Based on the results of the review, an impairment loss of HK$9,933,000 (2019: HK$5,103,000) was recognised in "impairment loss on property, plant and equipment" in the Group's consolidated statement of profit or loss. The recoverable amount of the property, plant and equipment is estimated based on value in use calculation. - Right-of-useassets
The analysis of the net book value of right-of use assets by class of underlying asset is as follows:
2020 | 2019 | |
(Note) | ||
HK$'000 | HK$'000 | |
Ownership interests in leasehold land and buildings held for own | ||
use, carried at depreciated cost in Hong Kong with remaining | ||
lease term of between 10 and 30 years | 13,668 | - |
Other properties leased for own use | 75,377 | - |
The analysis of expense items in relation to leases recognised in profit or loss is as follows:
2020 | 2019 | |
(Note) | ||
HK$'000 | HK$'000 | |
Depreciation charge of right-of-use assets by class of underlying | ||
asset: | ||
Ownership interest in leasehold land and building | ||
held for own use | 502 | - |
Other properties leased for own use | 48,417 | - |
Interest on lease liabilities (note 6(b)) | 2,896 | - |
Expense relating to short-term leases and other leases with | ||
remaining lease term ending on or before 31 March 2020 | 43,843 | - |
Total minimum lease payments for leases previously classified as | ||
operating leases under HKAS 17 | - | 114,450 |
ANNUAL REPORT 2019/20 083
NOTES TO THE
FINANCIAL STATEMENTS
11 Property, plant and equipment and right-of-use assets (continued)
- Right-of-useassets (continued)
Note: The Group has initially applied HKFRS 16 using the modified retrospective approach and adjusted the opening balances at 1 April 2019 to recognise right-of-use assets relating to leases which were previously classified as operating leases under HKAS 17. After initial recognition of right-of-use assets at 1 April 2019, the Group as a lessee is required to recognise the depreciation of right-of-use assets, instead of the previous policy of recognising rental expenses incurred under operating leases on a straight-line basis over the lease term. Under this approach, the comparative information is not restated. See note 2(c).
During the year, additions to right-of-use assets were HK$41,520,000 which related to the capitalised lease payments payable under new tenancy agreements.
Details of total cash outflow for leases and the maturity analysis of lease liabilities are set out in notes 20(c) and 23, respectively.
-
Ownership interests in leasehold land and buildings held for own use
The Group holds several buildings units for provision of beauty and wellness services and sales of skincare and wellness. The Group is the registered owner of these property interests, including the whole or part of undivided share in the underlying land. Lump sum payments were made upfront to acquire these property interests from their previous registered owners, and there are no ongoing payments to be made under the terms of the land lease, other than payments based on rateable values set by the relevant government authorities. These payments vary from time to time and are payable to the relevant government authorities. - Other properties leased for own use
The Group has obtained the right to use other properties as its warehouses and beauty centres through tenancy agreements. The leases typically run for an initial period of 1 to 3 years. Lease payments are adjusted periodically to reflect market rentals.
During the year ended 31 March 2020, the Group leased a number of beauty centres which contain variable lease payment terms that are based on sales generated from the beauty centres and minimum annual lease payment terms that are fixed. These payment terms are common in beauty centres in Hong Kong where the Group operates. No variable lease payment was incurred for the year as the thresholds were not met.
084 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
12 Investment properties
2020 | 2019 | ||
HK$'000 | HK$'000 | ||
At 1 April | 13,810 | 13,900 | |
Fair value change | 110 | (90) | |
At 31 March | 13,920 | 13,810 |
Investment properties were revalued as at 31 March 2020. Details of the fair value measurement are disclosed in note 12(a)(i).
As of 31 March 2020, all the Group's investment properties are situated in Hong Kong, with remaining lease term between 10 and 30 years.
- Fair value measurement of investment properties
-
Fair value hierarchy
The following table presents the fair value of the Group's investment properties measured at the end of the reporting period on a recurring basis, categorised into the three-level fair value hierarchy as defined in HKFRS 13, Fair value measurement. The level into which a fair value measurement is classified is determined with reference to the observability and significance of the inputs used in the valuation technique as follows: - Level 1 valuations: Fair value measured using only Level 1 inputs i.e. unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date
- Level 2 valuations: Fair value measured using Level 2 inputs i.e. observable inputs which fail to meet Level 1, and not using significant unobservable inputs. Unobservable inputs are inputs for which market data are not available
- Level 3 valuations: Fair value measured using significant unobservable inputs
-
Fair value hierarchy
Fair value measurements as at | |||||
31 March 2020 categorised into | |||||
Fair value at | |||||
31 March | |||||
2020 | Level 1 | Level 2 | Level 3 | ||
HK$'000 | HK$'000 | HK$'000 | HK$'000 | ||
Recurring fair value measurements | |||||
Investment properties | |||||
- Commercial - Hong Kong | 13,920 | - | - | 13,920 | |
ANNUAL REPORT 2019/20 085
NOTES TO THE
FINANCIAL STATEMENTS
12 Investment properties (continued)
- Fair value measurement of investment properties (continued)
- Fair value hierarchy (continued)
Fair value measurements as at | ||||
31 March 2019 categorised into | ||||
Fair value at | ||||
31 March 2019 | Level 1 | Level 2 | Level 3 | |
HK$'000 | HK$'000 | HK$'000 | HK$'000 | |
Recurring fair value measurements | ||||
Investment properties | ||||
- Commercial - Hong Kong | 13,810 | - | - | 13,810 |
All of the Group's investment properties measured at fair value on a recurring basis are categorised as Level 3 of the fair value hierarchy.
During the year ended 31 March 2020, there were no transfers between Level 1 and Level 2, or transfers into or out of Level 3 in respect of the Group's investment properties (2019: Nil). The Group's policy is to recognise transfers between levels of fair value hierarchy as at the end of the reporting period in which they occur.
All the Group's investment properties were revalued as at 31 March 2020. The valuations were carried out by an independent firm of surveyors, Roma Appraisal Limited, who have among their staff Members of the Hong Kong Institute of Surveyors with recent experience in the location and category of property being valued. The Group's senior management have discussion with the surveyors on the valuation assumptions and valuation results when the valuation is performed at each interim and annual reporting date.
-
Information about Level 3 fair value measurements
The fair value of the Group's investment properties located in Hong Kong is determined on a recurring basis using the market comparable approach assuming sale of properties in their existing state with vacant possession and by reference to recent comparable sales transactions as available in the market.
Valuation techniques | Unobservable inputs | Range |
Market Comparable Approach | Unit rate/square feet (for saleable area) | HK$9,280 to |
HK$11,800 |
Fair value adjustment of investment properties is recognised as a separate line item "fair value change on investment properties" in the Group's consolidated statement of profit or loss.
086 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
12 Investment properties (continued)
-
Investment properties leased out under operating leases
Undiscounted lease payments under non-cancellable operating leases in place at the reporting date will be receivable by the Group in future periods as follows:
20202019
HK$'000HK$'000
Within 1 year | - | 1,015 |
13 Goodwill and business combination
Goodwill arose from business combination is as follows:
20202019
HK$'000HK$'000
At 1 April and 31 March | 1,070 | 1,070 |
- Care Plus International Pty Limited
In July 2014, Main Deal Limited, a wholly owned subsidiary of the Group, acquired 49% equity interest in Care Plus International Pty Limited ("Care Plus"), which is incorporated in Australia, with a subsequent acquisition of an additional 2% equity interest in Care Plus in 2016. In May 2016, the Group completed the acquisition of the 2% equity interest in Care Plus, which has given the Group control over Care Plus. Care Plus has become a subsidiary of the Group since then. The acquisitions in July 2014 and May 2016 have been treated as "step acquisitions" under HKFRS 3 (Revised) Business Combinations ("HKFRS 3"). The principal activities of Care Plus is manufacturing and trading of beauty and wellness products.
According to HKFRS 3, a step acquisition is accounted for using the acquisition method of accounting. Therefore the initial equity investments are remeasured to fair value as at the acquisition date and any gain or loss arising from the acquisition is recognised in the statement of profit or loss. The initial equity investments are deemed to have been disposed of, in return, with the consideration transferred for the total 51% equity interest in Care Plus. The fair values of the initial equity investments form one of the components to calculate goodwill, along with the consideration transferred and non-controlling interests, if any, less the fair value of the identifiable net assets of Care Plus.
As at 31 March 2020, the carrying amount of goodwill of HK$1,070,000 (2019: HK$1,070,000) represented the future economic benefits arising from assets acquired that are not currently individually identified and separately recognised. None of the goodwill recognised is expected to be deductible for income tax purposes.
ANNUAL REPORT 2019/20 087
NOTES TO THE
FINANCIAL STATEMENTS
13 Goodwill and business combination (continued)
-
Elegant Trend Limited
In January 2017, Topluck International Holdings Limited, a wholly owned subsidiary of the Group, acquired 51% equity interest in Elegant Trend Limited ("Elegant Trend"), a Hong Kong incorporated company with a factory in the PRC named 廣州市美研達化妝品有限公司 ("美研達"). Elegant Trend is an unlisted corporate entity whose quoted market price is unavailable. The principal activities of Elegant Trend and 美研達 are investment holding and manufacturing of beauty and wellness products, respectively.
During the year ended 31 March 2019, the Group disposed of the equity interest in Elegant Trend back to the vendor at a consideration of HK$1, resulting in a gain on disposal of HK$2,122,000 included in "net gain/ (loss) on disposal of subsidiaries" in the consolidated statement of profit or loss. - Hoi Pak Cosmetics Trading Limited ("Hoi Pak")
During the year ended 31 March 2020, the Group disposed of its equity interest in Hoi Pak to the non- controlling shareholder at a consideration of HK$1, resulting in a gain on disposal of HK$809,000 included in "net gain/(loss) on disposal of subsidiaries" in the consolidated statement of profit or loss. - Impairment tests for cash-generating units containing goodwill
Goodwill is allocated to the Group's cash-generating units ("CGU") identified according to country of operation and operating segment as follows:
20202019
HK$'000HK$'000
Skincare and wellness - Australia | 1,070 | 1,070 |
The recoverable amount of the CGUs are determined based on value-in-use calculations. These calculations use cash flow projections based on financial budgets approved by management covering a five-year period. Cash flows beyond the five-year period are extrapolated using an estimated weighted average growth rate of 10%-27% (2019: 7-8%) and terminal capitalisation rate of 3% (2019: 3%) which are consistent with the forecasts included in industry reports. The growth rates used do not exceed the long-term average growth rates for the business in which the CGU operates. The cash flows are discounted using a discount rate of 20.3% (2019: 20.3%) for Australia CGU. The discount rates used are pre-tax and reflect specific risks relating to the relevant segments.
088 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
14 Intangible assets
Customer | ||||
relationships | Trademarks | Total | ||
HK$'000 | HK$'000 | HK$'000 | ||
Cost: | ||||
At 1 April 2018 | 1,345 | 1,218 | 2,563 | |
Exchange differences | (103) | (93) | (196) | |
At 31 March 2019 and 1 April 2019 | 1,242 | 1,125 | 2,367 | |
Exchange differences | (179) | (162) | (341) | |
At 31 March 2020 | 1,063 | 963 | 2,026 | |
Accumulated amortisation: | ||||
At 1 April 2018 | 416 | - | 416 | |
Charge for the year | 212 | - | 212 | |
Exchange differences | (37) | - | (37) | |
At 31 March 2019 and 1 April 2019 | 591 | - | 591 | |
Charge for the year | 197 | - | 197 | |
Exchange differences | (105) | - | (105) | |
At 31 March 2020 | 683 | - | 683 | |
Net book value: | ||||
At 31 March 2020 | 380 | 963 | 1,343 | |
At 31 March 2019 | 651 | 1,125 | 1,776 |
The amortisation charge for the year is included in "Depreciation and amortisation" in the consolidated statement of profit or loss.
ANNUAL REPORT 2019/20 089
NOTES TO THE
FINANCIAL STATEMENTS
15 Investments in subsidiaries
The following list contains only the particulars of subsidiaries which principally affected the results, assets or liabilities of the Group.
Place of | Particulars of | ||||
incorporation/ | issued and | Percentage of | Principal activities and place | ||
Name of company | registration | paid up capital | ownership interest | of business | |
Direct | Indirect | ||||
Care Plus International Pty | Australia | 1 ordinary share of | - | 51% | Sales of skincare and wellness |
Limited* | AU$1 | products, Australia | |||
Beauty Expert (B.V.I.) Limited | British Virgin | 1,000 ordinary | - | 100% | Provision of franchise and |
Islands | shares of US$1 | trademark services in | |||
each | relation to the provision of | ||||
beautification and gymnastic | |||||
services, Hong Kong |
Koladen Enterprises Inc.* | British Virgin | 100 ordinary shares | 100% | |
Islands | of US$1 each | |||
Modern Beauty Holdings | British Virgin | 1,000 | ordinary | - |
Limited* | Islands | shares of US$1 | ||
each | ||||
Modern Beauty Salon | British Virgin | 450,000 preferred | - | |
(International) Limited | Islands | shares of US$0.1 | ||
each and 50,000 | ||||
ordinary shares of | ||||
US$0.1 each | ||||
Nice Sound Investments | British Virgin | 1 ordinary share of | - | |
Limited* | Islands | US$1 | ||
Advanced Natural (Hong Kong) | Hong Kong | 10,000 | ordinary | - |
Limited | shares | |||
Artemis Beauty Supplies | Hong Kong | 650,000 | ordinary | - |
Limited | shares | |||
BE Universal Limited | Hong Kong | 1,000 | ordinary | - |
shares |
- Investment holding, Hong Kong
100% Investment holding, Hong Kong
100% Provision of sub-franchising services in relation to the provision of beautification and gymnastic services, Hong Kong
100% Investment holding, Hong Kong
51% Sales of skincare and wellness products, Hong Kong
100% Sales of skincare and wellness products, Hong Kong
100% Provision of beauty and wellness services and sales of skincare and wellness products, Hong Kong
Beauty Expert (International) | Hong Kong | 10,000 ordinary | - | 100% Provision of management services, |
Limited | shares | Hong Kong |
090 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
15 Investments in subsidiaries (continued)
Place of | Particulars of | ||||
incorporation/ | issued and | Percentage of | Principal activities and place | ||
Name of company | registration | paid up capital | ownership interest | of business | |
Direct | Indirect | ||||
Beauty Expert (Logistics) | Hong Kong | 10,000 ordinary | - | 100% | Sales of skincare and wellness |
Limited | shares | products and leasing of | |||
property, plant and equipment, | |||||
Hong Kong | |||||
Kin Yik Biomedical Technology | Hong Kong | 2 ordinary shares | - | 100% | Provision of beauty and wellness |
Limited | services and sales of skincare | ||||
and wellness products, Hong | |||||
Kong | |||||
Main Deal Limited | Hong Kong | 1 ordinary share | - | 100% | Investment holding, Hong Kong |
Modern (Human Resource) | Hong Kong | 10,000 ordinary | - | 100% | Provision of management services, |
Limited | shares | Hong Kong | |||
Modern Beauty Management | Hong Kong | 1,000 ordinary | - | 100% | Investment holding, Hong Kong |
Company Limited | shares | ||||
Modern Beauty Salon (HK) | Hong Kong | 2 ordinary shares | - | 100% | Provision of beauty and wellness |
Limited | services and sales of skincare | ||||
and wellness products, Hong | |||||
Kong | |||||
Modern Beauty Saloon Limited | Hong Kong | 10,000 ordinary | - | 100% | Provision of sub-franchising |
shares | services in relation to the | ||||
provision of beautification and | |||||
gymnastic services, Hong Kong | |||||
Moral Management Limited | Hong Kong | 1 ordinary share | - | 100% | Investment holding, Hong Kong |
Rise Star Asia Pacific Limited | Hong Kong | 1 ordinary share | - | 100% | Property holding, Hong Kong |
Sino Kingdom Trading Limited | Hong Kong | 1 ordinary share | - | 100% | Sales of skincare and wellness |
products, Hong Kong | |||||
Spread Full Limited | Hong Kong | 1 ordinary share | - | 100% | Provision of beauty and wellness |
services, Hong Kong | |||||
Zegna Management Limited | Hong Kong | 1 ordinary share | - | 100% | Investment holding, Hong Kong |
ANNUAL REPORT 2019/20 091
NOTES TO THE
FINANCIAL STATEMENTS
15 Investments in subsidiaries (continued)
Place of | Particulars of | |||||
incorporation/ | issued and | Percentage of | Principal activities and place | |||
Name of company | registration | paid up capital | ownership interest | of business | ||
Direct | Indirect | |||||
Zi Advertising (HK) Limited | Hong Kong | 10,000 | ordinary | - | 100% | Provision of advertising services, |
shares | Hong Kong | |||||
Splendid Overseas Pte. Limited | Singapore | 150,000 | ordinary | - | 100% | Provision of beauty and wellness |
shares of S$1 each | services, Singapore | |||||
Modern Beauty Salon (S) Pte. | Singapore | 150,000 | ordinary | - | 100% | Provision of beauty and wellness |
Limited | shares of S$1 each | services, Singapore | ||||
Lucky Marketing Management | Singapore | 100,000 | ordinary | - | 100% | Provision of beauty consultancy, |
Company Pte. Limited | shares of S$1 each | marketing and management | ||||
services, Singapore | ||||||
Modern Beauty Wellness Pte. | Singapore | 150,000 | ordinary | - | 100% | Provision of beauty and wellness |
Limited | shares of S$1 each | services, Singapore | ||||
Guangzhou Be Beauty Salon | PRC | Registered capital of | - | 100% | Provision of beauty and wellness | |
and Fitness Company | HK$15,000,000 | services, PRC | ||||
Limited* 廣州貝倚美容健身 | ||||||
有限公司 ("GZBS") (Note) | ||||||
Shanghai Be Beauty Salon and | PRC | Registered capital of | - | 100% | Provision of beauty and wellness | |
Fitness Company Limited* | HK$10,000,000 | services, PRC | ||||
上海貝倚美容健身有限公司 | ||||||
("SHBS") (Note) | ||||||
Golden Sense (Hong Kong) | Hong Kong | 99 ordinary shares | - | 70% | Provision of dental services, Hong | |
Limited | Kong | |||||
Hoi Pak Cosmetics Trading | Hong Kong | 10,000 | ordinary | - | 91% | Sales of beauty and wellness |
Limited# | shares | products, Hong Kong |
- Companies not audited by KPMG.
- Disposed during the year ended 31 March 2020.
Note: SHBS and GZBS are wholly foreign owned enterprises established in the PRC. These subsidiaries have financial reporting year end date on 31 December in accordance with the local statutory requirements, which is not coterminous with the Group. The consolidated financial statements of the Group were prepared based on the management accounts of these subsidiaries for the year ended 31 March 2020.
092 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
15 Investments in subsidiaries (continued)
The following table lists out the information relating to Care Plus, the subsidiary of the Group acquired in May 2016 which has a material non-controlling interest ("NCI"). The summarised financial information presented below represents the amounts before any inter-company elimination.
2020 | 2019 | ||
HK$'000 | HK$'000 | ||
NCI percentage | 49% | 49% | |
Current assets | 4,720 | 5,279 | |
Non-current assets | 2,893 | 3,389 | |
Current liabilities | (956) | (1,012) | |
Non-current liabilities | - | - | |
Net assets | 6,657 | 7,656 | |
Carrying amount of NCI | 3,262 | 3,751 | |
Revenue | 2,408 | 3,581 | |
Profit for the period | 144 | 687 | |
Total comprehensive income | 144 | 687 | |
Profit allocated to NCI | 71 | 337 | |
Dividend paid to NCI | - | - | |
Cash flows from operating activities | 9 | (518) | |
Cash flows from investing activities | - | - | |
Cash flows from financing activities | - | - |
16 Trade and other receivables, deposits and prepayments
2020 | 2019 | |
HK$'000 | HK$'000 | |
Non-current assets | ||
Deposits and prepayments | 10,264 | 22,256 |
Current assets | ||
Trade receivables, net of loss allowance for expected credit loss | 21,929 | 31,033 |
Trade deposits retained by banks/credit card companies (Note) | 133,490 | 133,959 |
Rental and other deposits, prepayments and other receivables | 32,599 | 24,501 |
Amounts due from related companies (note 29(c)) | 63 | 584 |
188,081 | 190,077 | |
198,345 | 212,333 |
Note: Trade deposits represent trade receivables that were retained by the banks/credit card companies in reserve accounts to secure the Group's performance of services to customers who paid for the services by credit cards, in accordance with the merchant agreements entered into between the Group and the banks/credit card companies.
ANNUAL REPORT 2019/20 093
NOTES TO THE
FINANCIAL STATEMENTS
16 Trade and other receivables, deposits and prepayments (continued)
-
Ageing analysis
As of the end of the reporting period, the ageing analysis of trade receivables, based on the invoice date and net of allowance for expected credit loss, is as follows:
2020 | 2019 | ||
HK$'000 | HK$'000 | ||
0-30 days | 9,504 | 15,678 | |
31-60 | days | 3,395 | 5,332 |
61-90 | days | 3,693 | 4,779 |
91-180 days | 5,337 | 4,853 | |
Over 180 days | - | 391 | |
21,929 | 31,033 |
Trade receivables are due within 7-180 days (2019: 7-180 days) from the date of billing. Further details on the Group's credit policy are set out in note 26(a).
The ageing analysis of the trade receivables based on the payment due date and net of allowance for expected credit losses is as follows:
2020 | 2019 | ||
HK$'000 | HK$'000 | ||
Neither past due nor impaired | 21,070 | 25,763 | |
Less than 30 days past due | 574 | 4,596 | |
31-60 | days past due | 264 | 271 |
61-90 | days past due | 17 | 3 |
91-150 days past due | 4 | 380 | |
Over 150 days past due | - | 20 | |
21,929 | 31,033 |
- Impairment of trade receivables
The movement in the expected credit loss allowance in respect of trade receivables during the year is as follows:
20202019
HK$'000HK$'000
At 1 April and 31 March | 828 | 828 |
094 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
17 Deferred tax in the consolidated statement of financial position
- The components of deferred tax (liabilities)/assets recognised in the consolidated statement of financial position and the movements during the year are as follows:
Depreciation | |||||
allowances | |||||
in excess of | |||||
the related | |||||
depreciation | Tax losses | Others | Total | ||
HK$'000 | HK$'000 | HK$'000 | HK$'000 | ||
Deferred tax arising from: | |||||
At 1 April 2018 | (457) | 3,611 | 259 | 3,413 | |
Exchange differences | (1) | (20) | 24 | 3 | |
At 31 March 2019 and 1 April 2019 | (458) | 3,591 | 283 | 3,416 | |
Exchange differences | (112) | (20) | 9 | (123) | |
At 31 March 2020 | (570) | 3,571 | 292 | 3,293 |
2020 | 2019 | ||
HK$'000 | HK$'000 | ||
Represent by: | |||
Deferred tax assets | 3,863 | 3,874 | |
Deferred tax liabilities | (570) | (458) | |
3,293 | 3,416 |
- At the end of the reporting period, the Group has total tax losses of HK$149,440,000 (2019: HK$114,089,000).
Deferred tax assets have been recognised in respect of HK$21,642,000 (2019: HK$22,503,000) of such losses as it is probable that future taxable profits will be generated against which the losses can be utilised. No deferred tax asset has been recognised in respect of the remaining tax losses of HK$127,798,000 (2019: HK$91,586,000) due to the unpredictability of future profit streams.
Included in unrecognised tax losses are (a) losses of HK$6,974,000 (2019: HK$6,974,000) from the PRC operations that will expire in five years, from the year the losses were incurred, and (b) losses of HK$120,824,000 (2019: HK$84,612,000) from other jurisdictions that can be carried forward indefinitely.
18 Inventories
As at 31 March 2020 and 2019, inventories represented finished goods of skincare and wellness products. The carrying amount of inventories recognised as an expense and included in profit or loss is HK$18,917,000 (2019: HK$24,112,000) which is recognised as "cost of inventories sold".
ANNUAL REPORT 2019/20 095
NOTES TO THE
FINANCIAL STATEMENTS
19 Pledged bank deposits
The Group's pledged bank deposits represented deposits pledged to banks to secure banking facilities of HK$6,000,000 (2019: HK$6,000,000) and credit card instalment programme granted to the Group. The deposits are denominated in United States dollars and Hong Kong dollars at floating interest rate, with effective interest rate during the year of 0.42% (2019: 0.08%) and 0.1%-1.2% (2019: 0.1%-0.16%) per annum respectively and therefore are subject to foreign currency risk and cash flow interest rate risk.
The Group had undrawn facilities of HK$6,000,000 (2019: HK$6,000,000) in form of documentary credit and trust receipt loan at 31 March 2020.
20 Cash and bank balances and other cash flow information
- Cash and bank balances comprise:
2020 | 2019 | |||||
HK$'000 | HK$'000 | |||||
Cash at bank and in hand | 111,169 | 118,217 | ||||
Short-term bank deposits with maturity less than three months | 63,610 | 64,549 | ||||
Cash and bank balances in the consolidated statement of financial | ||||||
position and cash and cash equivalents in the consolidated | ||||||
cash flow statement | 174,779 | 182,766 | ||||
(b) Reconciliation of liabilities arising from financing activities | ||||||
Lease liabilities | ||||||
HK$'000 | ||||||
(Note 23) | ||||||
At 1 April 2019 | ||||||
Impact on initial application of HKFRS 16 | 89,429 | |||||
Changes from financing cash flows: | ||||||
Capital element of lease rentals paid | (2,896) | |||||
Interest element of lease rentals paid | (45,908) | |||||
Total changes from financing cash flows | (48,804) | |||||
Exchange adjustments | (1,232) | |||||
Other changes: | ||||||
Increase in lease liabilities from entering into new leases during the year | 41,520 | |||||
Decrease in lease liabilities from early termination of a lease during the year | (1,726) | |||||
Finance costs (note 6(b)) | 2,896 | |||||
Rent concessions received | (1,200) | |||||
At 31 March 2020 | 80,883 |
096 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
20 Cash and bank balances and other cash flow information (continued)
-
Total cash outflow for leases
Amounts included in the cash flow statement for leases comprise the following:
2020 | 2019 | ||
(Note) | |||
HK$'000 | HK$'000 | ||
Within operating cash flows | (43,843) | (114,450) | |
Within financing cash flows | (48,804) | - | |
(92,647) | (114,450) | ||
Note: As explained in the note to the consolidated cash flow statement, the adoption of HKFRS 16 introduces a change in classification of cash flows of certain rentals paid on leases. The comparative amounts have not been restated.
These amounts relate to the following: | ||||||||
2020 | 2019 | |||||||
HK$'000 | HK$'000 | |||||||
Lease rentals paid | (92,647) | (114,450) | ||||||
21 Trade and other payables, deposits received and accrued expenses | ||||||||
31 March | 1 April | 31 March | ||||||
2020 | 2019 | 2019 | ||||||
HK$'000 | HK$'000 | HK$'000 | ||||||
Trade payables | 442 | 861 | 861 | |||||
Other payables, deposits received and accrued expenses (Note) | 79,171 | 83,780 | 85,882 | |||||
Amount due to the ultimate controlling party (note 29(c)) | 2 | 2 | 2 | |||||
Amounts due to related companies (note 29(c)) | 87 | 87 | 87 | |||||
79,702 | 84,730 | 86,832 |
Note: On the date of transition to HKFRS 16, accrued lease payments of HK$2,102,000 previously included in "Other payables, deposits received and accrued expenses" were adjusted to right-of-use assets recognised at 1 April 2019. See note 2(c).
All of the trade and other payables, deposit received and accrued expenses are expected to be settled or recognised as income within one year or are repayable on demand.
ANNUAL REPORT 2019/20 097
NOTES TO THE
FINANCIAL STATEMENTS
21 Trade and other payables, deposits received and accrued expenses (continued)
As of the end of the reporting period, the ageing analysis of trade payables, based on the invoice date, is as follows:
2020 | 2019 | |
HK$'000 | HK$'000 | |
Within 90 days | 442 | 851 |
Over 90 days | - | 10 |
442 | 861 |
22 Deferred revenue
- An ageing analysis of deferred revenue, based on invoice date, is as follows:
2020 | 2019 | |||
HK$'000 | HK$'000 | |||
Within 1 year | 301,822 | 297,621 | ||
(b) Movement of deferred revenue: | ||||
2020 | 2019 | |||
HK$'000 | HK$'000 | |||
At the beginning of the year | 297,621 | 301,139 | ||
Gross receipts from sales of prepaid beauty packages | 496,257 | 543,181 | ||
Revenue recognised for provision of beauty and wellness services | ||||
and expiry of prepaid beauty packages | (492,327) | (543,147) | ||
Adjustment on disposal of subsidiaries | - | (1,826) | ||
Exchange differences | 271 | (1,726) | ||
At the end of the year | 301,822 | 297,621 |
098 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
23 Lease liabilities
The following table shows the remaining contractual maturities of the Group's lease liabilities at the end of the current and previous reporting periods and at the date of transition to HKFRS 16:
31 March 2020 | 1 April 2019 (Note) | ||||
Present value | Present value | ||||
of the minimum | Total minimum | of the minimum | Total minimum | ||
lease payments | lease payments | lease payments | lease payments | ||
HK$'000 | HK$'000 | HK$'000 | HK$'000 | ||
Within 1 year | 48,602 | 50,393 | 44,324 | 46,637 | |
After 1 year but within 2 years | 25,687 | 26,297 | 32,640 | 33,569 | |
After 2 years but within 5 years | 6,594 | 6,664 | 12,465 | 12,693 | |
32,281 | 32,961 | 45,105 | 46,262 | ||
Less: total future interest expenses | 80,883 | 83,354 | 89,429 | 92,899 | |
(2,471) | (3,470) | ||||
Present value of lease liabilities | 80,883 | 89,429 |
Note: The Group has initially applied HKFRS 16 using the modified retrospective approach and adjusted the opening balances at 1 April 2019 to recognise lease liabilities relating to leases which were previously classified as operating leases under HKAS
17. Comparative information as at 31 March 2019 has not been restated. Further details on the impact of the transition to HKFRS 16 are set out in note 2(c).
ANNUAL REPORT 2019/20 099
NOTES TO THE
FINANCIAL STATEMENTS
24 Capital, reserves and dividends
-
Movements in components of equity
The reconciliation between the opening and closing balances of each component of the Group's consolidated equity is set out in the consolidated statement of changes in equity. Details of the changes in the Company's individual components of equity between the beginning and the end of the year are set out below:
Retained | |||||
earnings/ | |||||
Share | Share | Contributed | (Accumulated | ||
capital | premium | surplus | losses) | Total | |
Company | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 |
Balance at 1 April 2018
Change in equity for 2019: Loss and total comprehensive
income for the year
90,448 | 318,791 | 47,076 | 76,863 | 533,178 |
- | - | - | (42) | (42) |
Balance at | 31 | March 2019 | and | |||||
1 April 2019 | 90,448 | 318,791 | 47,076 | 76,821 | 533,136 | |||
Loss and total comprehensive | ||||||||
income for the year | - | - | - | (431,160) | (431,160) | |||
Balance at | 31 | March 2020 | 90,448 | 318,791 | 47,076 | (354,339) | 101,976 |
- Dividends
The Board does not recommend the payment of a final dividend for the year ended 31 March 2020 (2019: Nil). - Share capital
Authorised and issued share capital
2020 | 2019 | ||||
No. of shares | Amount | No. of shares | Amount | ||
HK$'000 | HK$'000 | ||||
Authorised: | |||||
Ordinary shares of HK$0.1 | each | 10,000,000,000 | 1,000,000 | 10,000,000,000 | 1,000,000 |
Issued and fully paid: | |||||
Ordinary shares of HK$0.1 | each | 904,483,942 | 90,448 | 904,483,942 | 90,448 |
100 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
24 Capital, reserves and dividends (continued)
-
Share capital (continued)
Authorised and issued share capital (continued)
The holders of ordinary shares are entitled to receive dividends as declared from time to time and are entitled to one vote per ordinary share at general meetings of the Company. All ordinary shares rank equally with regard to the Company's residual assets. - Nature and purpose of reserves
-
Share premium
Under the Companies Law of the Cayman Islands, the funds in the share premium account of the Company are distributable to the shareholders of the Company provided that immediately following the date on which the dividend is proposed to be distributed, the Company will be in a position to pay off its debts as they fall due in the ordinary course of business. - Merger reserve
The merger reserve represents the aggregate of: - Pursuant to the Group's reorganisation effected on 24 January 2006 (the "Reorganisation"), the Company acquired the share capital of Koladen Enterprises Inc. in consideration of allotment and issue of 539,999,925 shares to its corporate shareholders, Silver Compass Holdings Corp. and Silver Hendon Enterprises Corp. Under the merger basis of accounting, the difference between the nominal value of the shares of subsidiaries acquired over the nominal value of the share capital of the Company issued in exchange amounting to approximately HK$53,982,000 was debited to the merger reserve of the Group.
- Pursuant to the sale and purchase agreement dated 5 July 2011 ("SPA") entered into between BE Universal Limited ("BE Universal", a subsidiary of the Company) as purchaser and Dr. Tsang as vendor, BE Universal conditionally agreed to acquire the entire equity interest in Zegna Management Limited ("Zegna") together with its subsidiaries (collectively referred to as the "Zegna Group") from Dr. Tsang at a consideration of HK$250,000,000 which is to be satisfied by the issue of convertible note ("CN") at conversion price of HK$1.05 per share (hereinafter referred to as the "Business Combination").
-
Share premium
On 30 September 2011, BE Universal and Dr. Tsang entered into a supplemental sale and purchase agreement ("Supplemental SPA") to amend and supplement certain terms of the SPA including
- the businesses of two subsidiaries of Zegna, namely Modern Beauty Salon (S) Pte. Limited ("MBSS") and Splendid Overseas Pte. Limited ("Splendid") to be taken up by another newly set- up subsidiary; (ii) MBSS shall execute a deed of waiver in favour of Euro King Limited ("Euro King", a then subsidiary of Zegna) to discharge and release its obligations to settle any amounts due to MBSS as ascertained in a special audit up to a maximum amount of HK$70,000,000 (the "Waiver"); and (iii) the entire issued share capital of Euro King shall be transferred by Zegna to Dr. Tsang (or her nominee) at nil consideration, representing deemed partial consideration of the Business Combination; in fact that Euro King shall not form part of the Zegna Group in the Business Combination. Details of the SPA and Supplemental SPA relating to the Business Combination are set out in the announcement and circular of the Company dated 5 July 2011 and 30 September 2011 respectively.
The Business Combination was completed on 10 January 2012 when all the precedent conditions to the Business Combination were fulfilled and the issue of the CN has taken place.
ANNUAL REPORT 2019/20 101
NOTES TO THE
FINANCIAL STATEMENTS
24 Capital, reserves and dividends (continued)
- Nature and purpose of reserves (continued)
-
Merger reserve (continued)
The merge reserve arising from the acquisition of Zegna Group comprised of: - A debit amount of approximately HK$71,488,000, representing the deemed partial consideration of the Business Combination, being the net assets value of Euro King after the Waiver disposed to Dr. Tsang at nil consideration, pursuant to the Supplemental SPA of the Business Combination; in fact that Euro King did not form part of the Zegna Group in the Business Combination.
- A credit balance of approximately HK$549,000, being the difference between the aggregate amount of nominal value of the shares of subsidiaries acquired by Zegna and the relevant consideration paid.
- A net debit amount of HK$248,332,000, being the difference between (i) the value of the CN amounting to HK$250,000,000 issued for the Business Combination; (ii) the nominal value of the share capital of Zegna; and (iii) the investment cost in the book of BE Universal.
-
Contributed surplus
The contributed surplus of the Company arose as a result of the Reorganisation and represented the excess of the fair value of the subsidiaries acquired, over the nominal value of the share capital of the Company issued in exchange therefore. - Exchange reserve
The exchange reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations. The reserve is dealt with in accordance with the accounting policies set out in note 2(s). - Property revaluation reserve
The property revaluation reserve has been set up to deal with the fair value changes arising from the Group's property, plant and equipment reclassified to investment properties.
-
Merger reserve (continued)
- Distributability of reserves
At 31 March 2020, the aggregate amount of reserves available for distribution to equity shareholders of the Company was HK$11,528,000 (2019: HK$442,688,000). After the end of reporting period the directors did not propose a final dividend (2019: nil per ordinary share) (note 24(b)). Any dividend proposed after the end of reporting period has not been recognised as a liability at the end of the reporting period.
102 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
- Capital, reserves and dividends (continued)
-
Capital management
The Group's primary objectives when managing capital are to safeguard the Group's ability to continue as a going concern in order to maximise returns for shareholders and benefits for other stakeholders and to maintain an optimal capital structure to reduce cost of capital.
In order to maintain or adjust the capital structure, the Group may adjust the amount of dividends paid to shareholders, return capital to shareholders, issue new shares or sell assets to reduce debt.
The only externally imposed capital requirement is that for the Group to maintain its listing on the Stock Exchange it has to have a public float of at least 25% of the shares. The Group receives a report from the shares registrars monthly on substantial share interests showing the non-public float and it demonstrates continuing compliance with the 25% limit throughout the year.
-
Capital management
- Employee benefits
Defined contribution retirement plans
The Group operates a Mandatory Provident Fund Scheme ("the MPF scheme") under the Hong Kong Mandatory Provident Fund Schemes Ordinance for employees employed under the jurisdiction of the Hong Kong Employment Ordinance. The MPF scheme is a defined contribution retirement plan administered by independent trustees. Under the MPF scheme, the employer and its employees are each required to make contributions to the plan at 5% of the employees' relevant income, subject to a cap of monthly relevant income of HK$30,000. Contributions to the plan vest immediately.
Details of the accounting policies adopted by the Group over the defined contribution retirements plans are disclosed under note 2(o)(ii).
26 Financial risk management and fair values of financial instruments
Exposure to credit, liquidity and currency risks arises in the normal course of the Group's business. The Group's exposure to these risks and the financial risk management policies and practices used by the Group to manage these risks are described below.
-
Credit risk
Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in a financial loss to the Group. The Group's credit risk is primarily attributable to trade receivables and trade deposits retained by banks/credit card companies. Management has a credit policy in place and the exposures to these credit risks are monitored on an ongoing basis.
ANNUAL REPORT 2019/20 103
NOTES TO THE
FINANCIAL STATEMENTS
26 Financial risk management and fair values of financial instruments (continued)
-
Credit risk (continued)
The credit risks on trade receivables and trade deposits retained by banks/credit card companies are limited because the counterparties are banks/financial institutions with high external credit ratings. In addition, the directors of the Group consider those not credit-impaired trade receivables were collectible based on historical observed default rates over the expected life of the debtors and adjusted for forward-looking information that is available without undue cost or effort. Therefore, allowance for impairment was insignificant and thus negligible to be made. Further quantitative disclosure in respect of the Group's exposure to credit risk arising from trade receivables is set out in note 16.
The Group does not provide any guarantees which would expose the Group or the Company to credit risk. The maximum exposure to credit risk is represented by the carrying amount of each financial asset in the statement of financial position. - Liquidity risk
The Group's policy is to regularly monitor its liquidity requirements to ensure that it maintains sufficient reserves of cash and adequate committed lines of funding from major financial institutions to meet its liquidity requirements in the short and longer term.
The following tables show the remaining contractual maturities at the end of the reporting period of the Group's financial liabilities, which are based on contractual undiscounted cash flows (including interest payments computed using contractual rates or, if floating, based on rates current at the end of the reporting period) and the earliest date the Group can be required to pay:
Contractual undiscounted cash outflow | |||||||
Less than | Between | Between | |||||
1 year or | 1 and 2 | 2 and 5 | Over | Carrying | |||
on demand | years | years | 5 years | Total | amount | ||
HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | ||
At 31 March 2020 | |||||||
Trade and other payables, | |||||||
deposits received and | |||||||
accrued expenses | 79,702 | - | - | - | 79,702 | 79,702 | |
Lease liabilities (note) | 50,393 | 26,297 | 6,664 | - | 83,354 | 80,883 | |
130,095 | 26,297 | 6,664 | - | 163,056 | 160,585 | ||
104 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
26 Financial risk management and fair values of financial instruments (continued)
- Liquidity risk (continued)
Contractual undiscounted cash outflow | ||||||
Less than | Between | Between | ||||
1 year or | 1 and 2 | 2 and 5 | Over | Carrying | ||
on demand | years | years | 5 years | Total | amount | |
HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | |
At 31 March 2019 | ||||||
Trade and other payables, | ||||||
deposits received and accrued | ||||||
expenses | 86,832 | - | - | - | 86,832 | 86,832 |
Note: The Group has initially applied HKFRS 16 using the modified retrospective approach and adjusted the opening balances at 1 April 2019 to recognise lease liabilities relating to leases which were previously classified as operating leases under HKAS 17. Lease liabilities include amounts recognised at the date of transition to HKFRS 16 in respect of leases previously classified as operating leases under HKAS 17 and amounts relating to new leases entered into during the year. Under this approach, the comparative information is not restated. See note 2(c).
-
Currency risk
The Group is exposed to currency risk primarily through sales and purchases which give rise to receivables, payables and cash balances that are denominated in a foreign currency, i.e. a currency other than the functional currency of the operations to which the transactions relate. The currency giving rise to this risk is primarily Renminbi. Given the insignificant net exposure to Renminbi, any change in the exchange rate of Renminbi relative to Hong Kong dollars is considered to have an insignificant impact on the Group's loss after tax (and retained earnings). - Fair value measurement
The carrying amounts of the Group's financial instruments carried at amortised cost are not materially different from their fair values as at 31 March 2020 and 2019.
27 Commitments
-
Operating lease commitments
At 31 March 2019, the total future minimum lease payments under non-cancellable operating leases are payable as follows:
2019 | |
HK$'000 | |
Within 1 year | 88,170 |
After 1 year but within 5 years | 40,223 |
128,393 |
ANNUAL REPORT 2019/20 105
NOTES TO THE
FINANCIAL STATEMENTS
27 Commitments (continued)
-
Operating lease commitments (continued)
The Group is the lessee in respect of certain of its beauty service centres and warehouses under leases which were previously classified as operating leases under HKAS 17. The Group has initially applied HKFRS 16 using the modified retrospective approach. Under this approach, the Group adjusted the opening balances at 1 April 2019 to recognise lease liabilities relating to these leases (see note 2(c)). From 1 April 2019 onwards, future lease payments are recognised as lease liabilities in the statement of financial position in accordance with the policies set out in note 2(i), and the details regarding the Group's future lease payments are disclosed in note 23. - Capital commitments
Capital commitments outstanding at 31 March 2020 not provided for in the financial statements were as follows:
2020 | 2019 | |
HK$'000 | HK$'000 | |
Contracted but not yet provided for: | ||
Acquisition of plant and equipment | 130 | 4,927 |
28 Contingent liabilities
During the course of business, the Group has received complaints and claims concerned with the provision of beauty services in respect of breach of contract, content of advertisement, tenancy dispute and personal injuries in relation to the services provided, including claims of insignificant or unspecified amounts. The directors are of the opinion that the loss or settlement for such complaints and claims have no material financial impact to the Group.
29 Material related party transactions and balances
-
Key management personnel remuneration
Remuneration for key management personnel of the Group, including amounts paid to the Company's directors as disclosed in note 8 and certain of the highest paid employees as disclosed in note 9, is as follows:
2020 | 2019 | |
HK$'000 | HK$'000 | |
Short-term employee benefits | 15,259 | 15,170 |
Post-employment benefits | 226 | 242 |
15,485 | 15,412 |
Total remuneration is included in "employee benefit expenses" (see note 6(a)).
106 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
29 Material related party transactions and balances (continued)
-
Material related party transactions
In addition to those related party transactions disclosed elsewhere in the consolidated financial statements, the Group had the following material transactions with its related parties during the year:
Note | 2020 | 2019 | |
HK'000 | HK'000 | ||
Rental expenses paid to related companies: | (i) | ||
Chain Tech International Limited | 2,550 | 2,550 | |
Dimension Development Limited | 1,468 | 1,224 | |
East Union Industries Limited | - | 1,301 | |
Joy East Limited | 745 | 745 | |
Luck Elegant Industrial Limited | 3,335 | 3,335 | |
Lucky Forever Limited | 6,144 | 9,669 | |
NP Development Limited | 500 | - | |
Golden National Limited | - | 6,415 | |
Precious Development Limited | 1,418 | 354 | |
Precise Development Limited | 1,969 | 1,640 | |
United Industries Limited | 3,274 | 1,938 | |
Victor Development Limited | 1,244 | 830 | |
Well Faith International Enterprise Limited | 7,454 | 9,639 | |
Wise World Limited | 3,570 | 3,570 | |
(vi) | 33,671 | 43,210 | |
Rental income received from a related company: | (ii) | ||
Grateful Heart Charitable Foundation Limited | 423 | 1,015 | |
Salaries and other benefits in kind paid | |||
to related parties: | |||
Related party A | (iii) | 1,883 | 1,809 |
Related party B | (iv) | 2,198 | 2,213 |
Related party C | (v) | 527 | 552 |
4,608 | 4,574 |
ANNUAL REPORT 2019/20 107
NOTES TO THE
FINANCIAL STATEMENTS
29 Material related party transactions and balances (continued)
- Material related party transactions (continued)
Notes:
- The pricing of the related party transactions are mutually agreed by the Group and the related companies. Dr. Tsang is the ultimate controlling party of the related companies.
- The amount represented rental income received for area leased to a related company for use as office at a monthly rental mutually agreed by both parties. Dr. Tsang is the member of the related company.
- Related party A is the spouse of a director, Dr. Tsang.
- Related party B is the son of a director, Dr. Tsang.
- Related party C is the spouse of a director, Mr. Yip Kai Wing.
- The related party transactions in respect of rental expenses above constitute connected transactions or continuing connected transactions as defined in Chapter 14A of the Listing Rules. The disclosures required by Chapter 14A of the Listing Rules are provided in the Report of the Directors of the annual report for the year ended 31 March 2020.
-
Balances with related parties
The amounts due from/to related companies and the ultimate controlling party are unsecured, interest-free and recoverable/repayable on demand. Dr. Tsang or her close family members is the ultimate controlling party of those related companies.
Amounts due from related companies disclosed with reference to section 383(1) of the Hong Kong Companies Ordinance, are as follows:
Balance at | Balance at | Maximum amount | |
31 March | 1 April | outstanding | |
2020 | 2019 | during the year | |
HK$'000 | HK$'000 | HK$'000 | |
All Link International Limited | 1 | - | 163 |
Grateful Heart Charitable Foundation Limited | 4 | 525 | 2,013 |
United Industries Limited | - | 1 | 1 |
Lucky Forever Limited | - | - | 1 |
Luck Elegant Industrial Limited | - | - | 1 |
Lucky Forever (S) Pte. Limited | 53 | 53 | 53 |
Swisscelin Distribution Limited | - | - | 72 |
Advanced Natural Australia PTY Ltd | 5 | 5 | 5 |
Golden National Ltd | - | - | 1 |
MCB Limited | - | - | 1,937 |
Hong Kong Beauty Industry Alliance Limited | - | - | 5 |
63 | 584 | 4,252 |
108 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
30 Company-level statement of financial position
31 March | 31 March | ||
Note | 2020 | 2019 | |
HK$'000 | HK$'000 | ||
Non-current assets | |||
Investment in a subsidiary | 15 | 101,076 | 101,076 |
Current assets | |||
Amounts due from subsidiaries | - | 431,158 | |
Cash and bank balances | 910 | 912 | |
910 | 432,070 | ||
Current liabilities | |||
Other payables | 10 | 10 | |
10 | 10 | ||
Net current assets | 900 | 432,060 | |
NET ASSETS | 101,976 | 533,136 | |
CAPITAL AND RESERVES | 24(a) | ||
Share capital | 90,448 | 90,448 | |
Reserves | 11,528 | 442,688 | |
TOTAL EQUITY | 101,976 | 533,136 |
ANNUAL REPORT 2019/20 109
NOTES TO THE
FINANCIAL STATEMENTS
31 Critical judgements and key estimates
Key sources of estimation uncertainty
Notes 12(a), 13(d) and 14 contain information about the assumptions and their risk factors relating to valuation of investment properties, goodwill impairment and intangible assets. Other key sources of estimation uncertainty are as follows:
-
Property, plant and equipment and depreciation
The Group determines the estimated useful lives, residual values and related depreciation charges for the Group's property, plant and equipment. This estimate is based on the historical experience of the actual useful lives and residual values of property, plant and equipment of similar nature and functions. The Group will revise the depreciation charge where useful lives and residual values are different to those previously estimated, or it will write-off or write-down technically obsolete or non-strategic assets that have been abandoned or sold. - Impairment of property, plant and equipment and right-of-use assets
The Group conducts impairment reviews of property, plant and equipment and right-of-use assets whenever events or changes in circumstances indicated that their carrying amounts may not be recoverable. Determining whether an asset is impaired requires an estimation of the value in use, which requires the Group to estimate the future cash flows and a suitable discount rate in order to calculate the present value. Where the actual future cash flows are less than expected, a material impairment loss may arise. - Revenue
Revenue recognition on provision of services is dependent on the estimation of the utilisation pattern of treatments. Based on the Group's historical experience, the Group makes estimates of an expected amount of breakage. Actual utilisation may be higher or lower than those estimated at the end of each reporting period, which would affect the revenue and profit recognised in future year.
32 Non-adjusting events after the reporting period
The outbreak of the 2019 Novel Coronavirus ("COVID-19") and the subsequent quarantine measures imposed by the Singaporean and Hong Kong government have been affecting the Group's business and is expected to have negative impact on the Group's financial performance in 2020. However, at the date of 29 June 2020, it is not practicable to estimate its full financial effect to the Group. The Group has actively put in place measures in mitigating its impact. The Group will closely monitor the development and will keep its alleviating measures under regular review.
110 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
NOTES TO THE
FINANCIAL STATEMENTS
33 Comparative figures
The Group has initially applied HKFRS 16 at 1 April 2019 using the modified retrospective approach. Under this approach, comparative information is not restated. Further details of the changes in accounting policies are disclosed in note 2(c).
34 Possible impact of amendments, new standards and interpretations issued but not yet effective for the year ended 31 March 2020
Up to the date of issue of these financial statements, the HKICPA has issued a number of amendments and a new standard, HKFRS 17, Insurance contracts, which are not yet effective for the year ended 31 March 2020 and which have not been adopted in these financial statements. These developments include the following which may be relevant to the Group.
Effective for accounting periods beginning on or after
Amendments to HKAS 1 and HKAS 8, Definition of material | 1 January 2020 |
The Group is in the process of making an assessment of what the impact of these developments is expected to be in the period of initial application. So far it has concluded that the adoption of them is unlikely to have a significant impact on the consolidated financial statements.
35 Approval of financial statements
The financial statements were approved and authorised for issue by the Board of Directors on 29 June 2020.
ANNUAL REPORT 2019/20 111
PROPERTIES HELD
BY THE GROUP
Location | Category of the lease | Use |
Unit 7, 8, 9, East Wing, | Medium-term lease | Rented to a related party |
Twenty-seventh Floor, | ||
Tuen Mun Central Square, | ||
No. 22 Hoi Wing Road, | ||
Tuen Mun, | ||
New Territories | ||
Unit 10, 11, 12 and 15, East Wing, | Medium-term lease | Spa and beauty treatment |
Twenty-seventh Floor, | ||
Tuen Mun Central Square, | ||
No. 22 Hoi Wing Road, | ||
Tuen Mun, | ||
New Territories | ||
Unit 16, West Wing, | Medium-term lease | Spa and beauty treatment |
Twenty-seventh Floor, | ||
Tuen Mun Central Square, | ||
No. 22 Hoi Wing Road, | ||
Tuen Mun, | ||
New Territories |
112 | MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED |
(formerly known as Modern Beauty Salon Holdings Limited) |
FIVE YEARS
FINANCIAL SUMMARY
Consolidated Results
Year ended 31 March | |||||||
2020 | 2019 | 2018 | 2017 | 2016 | |||
HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | |||
(Restated) | |||||||
Revenue | 522,606 | 576,017 | 599,018 | 693,284 | 775,391 | ||
(Loss)/profit before taxation | (27,640) | (6,964) | (25,184) | 43,641 | 14,323 | ||
Income tax (expense)/credit | (4,389) | (5,833) | 2,339 | (9,766) | (3,601) | ||
(Loss)/profit for the year | (32,029) | (12,797) | (22,845) | 33,875 | 10,722 | ||
Consolidated Assets and Liabilities | |||||||
As at 31 March | |||||||
2020 | 2019 | 2018 | 2017 | 2016 | |||
HK$'000 | HK$'000 | HK$'000 | HK$'000 | HK$'000 | |||
(Restated) | |||||||
Total non-current assets | 174,834 | 123,238 | 129,284 | 111,472 | 145,210 | ||
Total current assets | 445,163 | 456,259 | 481,632 | 544,137 | 671,389 | ||
Total assets | 619,997 | 579,497 | 610,916 | 655,609 | 816,599 | ||
Total non-current liabilities | (32,851) | (458) | (457) | (1,970) | (1,634) | ||
Total current liabilities | (435,036) | (392,143) | (522,031) | (528,199) | (742,000) | ||
Total liabilities | (467,887) | (392,601) | (522,488) | (530,169) | (743,634) | ||
Net assets | 152,110 | 186,896 | 88,428 | 125,440 | 72,965 | ||
MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED
Workshops Nos. 66-68,
6/F, Sino Industrial Plaza,
9 Kai Cheung Road, Kowloon Bay, Kowloon, Hong Kong
Tel: (852) 2866 2377
Fax: (852) 2804 6607
Email: ir@modernhealthcaretech.com
Website: www.modernhealthcaretech.com
現代健康科技控股有限公司
香港九龍九龍灣啟祥道9號信和工商中心6樓66-68號工場 電話 : (852) 2866 2377 傳真 : (852) 2804 6607
電郵 : ir@modernhealthcaretech.com
網址 : www.modernhealthcaretech.com
Attachments
- Original document
- Permalink
Disclaimer
Modern Beauty Salon Holdings Limited published this content on 23 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 July 2020 04:10:09 UTC